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Abstract 
 
The Mig10/RIAM/Lpd (MRL) family of adapter proteins have been recognised in transducing 
signals derived from growth factor receptors to alterations in cell motility and adhesion via 
changes in actin dynamics. Reduction in the levels of MRL proteins results in diminished cell 
division rates, growth retardation, an increase in monomeric (G): filamentous (F) actin ratios, 
loss of cell migration, and lethality. Conversely, overexpression of MRL proteins reduces the 
ratio of G:F actin, thereby promoting Serum Response Factor (SRF) signalling, lamellipodia 
formation, cellular invasion and coordinated cell growth and proliferation. Members of the MRL 
family all share common structural characteristics, most notably the presence of highly 
conserved central Ras-association (RA) and Pleckstrin homology (PH) domains in addition to an 
N-terminal Talin binding site and multiple C-terminal SH3 and proline rich motifs capable of 
interacting with Ena/VASP and Profilin.  
 
This report extends previous work carried out on Pico, the Drosophila MRL homologue, by 
demonstrating physical interactions with Chickadee (Profilin), Rhea (Talin), Ras, and Protein 
Phosphatase 1 (PP1). Many of these binding partners were found to co-localise with Pico within 
highly dynamic membrane ruffles during Drosophila cell spreading, while only Enabled 
(Ena/VASP) co-localised at the periphery of cells once they had reached a maximal size and 
spreading had ceased, pointing to the existence of distinct Pico-associated complexes.   
 
This work also details the presence of a highly conserved MAPK-binding site adjacent to the RA 
domain which had not been previously recorded in the literature. Site-directed mutagenesis 
revealed this MAPK-binding motif to be required for Pico's interactions with the Erk1/2 
homologue Rolled, while conservation of MAPK binding ability was demonstrated in both 
human Lpd and RIAM orthologues. Further analysis showed that Rolled might phosphorylate 
Pico at a serine residue (Ser 819) previously identified by high-throughput phosphoproteomics, 
which may in turn promote Pico's interactions with PP1. Wing growth assays performed using 
site-directed Pico mutants indicated that PP1 plays a role in negative regulation of Pico-mediated 
growth, although the relevant targets of the phosphatase remain to be identified. Interestingly, 
reporter gene experiments confirmed that Pico induced SRF-dependent gene expression in 
ii 
 
Drosophila cells while ectopic SRF signalling has been found to increase expression of rolled, 
suggesting the potential existence of a Rolled/PP1 mediated negative feedback loop regulating 
Pico functionality. 
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1. Introduction 
 
1.1. Introducing cellular migration 
 
Directed cell migration is a highly orchestrated, multistep process that plays a central role in 
many fundamental physiological mechanisms required in the development and maintenance of 
multicellular organisms. During early embryonic development, cell motility is essential for 
various morphogenic processes like gastrulation and tissue formation (Keller, 2005). Cellular 
migration remains crucial throughout the lifetime of higher organisms, enabling mechanisms 
such as wound healing and chemotactic responses of the immune system to take place (Luster et 
al., 2005).  
  
Aberrant control of the migratory machinery can have serious consequences and is thought to be 
an underlying cause of various neurological disorders and vascular diseases. In addition, 
abnormal cell migration in cancerous cells often leads to the formation of secondary tumours 
(metastasis) and is responsible for approximately 90% of cancer related deaths (Sporn, 1996, 
Wang et al., 2005). Developing a comprehensive understanding of the mechanisms involved in 
migration is crucial for the future development of novel therapeutic treatments to combat these 
disorders; but it is also becoming important to emerging areas of biotechnology which focus on 
cellular transplantation and the manufacture of artificial tissues. 
 
1.1.1. The mechanisms involved in migration 
 
Migration varies significantly from one cell type to another; however, the underlying 
mechanisms involved are thought to be similar. To migrate, a cell must first attain a 
characteristic polarised morphology in response to extracellular chemical or mechanical signals, 
such as the presence of a Netrin gradient or increasing substrate stiffness respectively (Le 
Clainche and Carlier, 2008, Li et al., 2002, Lo et al., 2000). At the newly formed cell front, 
branched actin filaments polymerise at their barbed ends through ATP hydrolysis and 
depolymerise at their pointed ends at a similar rate (Theriot and Mitchison, 1991). This instigates 
a mechanism known as ‘treadmilling’ which allows the filaments to move forward while 
2 
 
maintaining the same length (Wang, 1985). The resultant force is believed to push against the 
membrane to drive the formation of flat membrane protrusions termed lamellipodia; enabling 
extension of the cell front in the direction of migration (Small et al., 2002).  
 
 
 
Figure 1.1.1. Schematic illustration of cellular migration. Actin assembly at the newly created 
cell front drives lamellipodia formation. Adhesions form at the leading edge to connect the 
extracellular matrix to the actin cytoskeleton enabling further extension of the protrusions. 
Fingerlike filopodia protrusions extend beyond the leading edge of the lamellipodia to sense the 
environment. Lastly, the cell combines actomyosin contractility and rear adhesion disassembly to 
retract its trailing edge (adapted from Le Clainche and Carlier, 2008). 
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At the leading edge of these advancing lamellipodia, the cell forms focal adhesions (FAs) via 
extracellular adhesion receptors which connect the extracellular matrix to the actin cytoskeleton 
(Brown et al., 2006). These attachments anchor the cell body to the substrate and enable 
extension of the protrusion by providing traction for the actin filaments (Le Clainche and Carlier, 
2008). The migrating cells also extend fingerlike filopodia protrusions, containing 15-20 tightly 
bundled parallel filaments, beyond the lamellipodia leading edge to sense the environment 
(Lewis and Bridgman, 1992). Finally, to move forward, the cell retracts its trailing edge by 
combining actomyosin contractility and adhesion disassembly at the rear (Figure 1.1.1) (Le 
Clainche and Carlier, 2008).  
 
1.1.2. Regulating cellular migration 
 
Cells regulate the speed of migration by controlling the protrusive force generated by the actin 
filaments in the lamellipodia and filopodia. One way this is achieved is by managing the rate of 
actin treadmilling. As the treadmilling of pure actin is too slow to allow for the rate of movement 
required by many cells, control is brought about by accelerating the process. 
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Figure 1.1.2. Regulation of actin treadmilling. (1) ADF enhances pointed end 
depolymerisation, increasing the concentration of monomeric actin. (2) Profilin increases the rate 
of exchange of ATP for ADP. (3) Capping proteins funnel ATP-actin to uncapped barbed ends. 
(4) Arp2/3 promotes filament branching (Le Clainche and Carlier, 2008). 
 
ADF (Actin Depolymerising Factor) is located throughout the lamellipodium, with the exception 
of the leading edge, and binds to the side of ADP-actin filaments to alter their structure and 
induce pointed end depolymerisation (Svitkina and Borisy, 1999, Carlier et al., 1997). This 
increases the steady state concentration of monomeric (G) actin, which promotes faster barbed 
end growth to compensate for the heightened breakdown of the pointed end (Carlier et al., 1999). 
Profilin enhances the action of ADF by binding to G-actin and increasing the exchange rate of 
ADP for ATP to recycle the actin monomers near the barbed ends (Yarmola and Bubb, 2006). 
The combined effects of ADF and profilin alone have been shown to enhance the treadmilling 
rate by 125-fold (Didry et al., 1998). 
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The polymerisation rate is further amplified by the presence of numerous capping proteins that 
block the majority of actin filament barbed ends (Schafer et al., 1996). This aids in limiting 
filament length and funnels the flux of actin monomers to the rare, non-capped filaments, which 
individually grow faster (Figure 1.1.2) (Pantaloni et al., 2001, Wiesner et al., 2003). To 
counterbalance the effects of these capping proteins and maintain the overall treadmilling rate, 
migratory cells continuously generate new actin filaments.  
  
In the lamellipodium, the nucleating factor is the Arp2/3 complex. The Arp2/3 complex localises 
at the leading edge of migrating cells where it mimics actin nuclei to initiate actin assembly 
(Svitkina and Borisy, 1999, Kelleher et al., 1995). The complex also assists in promoting 
filament branching by binding directly with the sides of pre-existing filaments near the barbed 
ends to initiate lateral branch formation (Amann and Pollard, 2001). This leads to a significant 
increase in the number of barbed ends (Goley and Welch, 2006). The Arp2/3 complex is 
normally repressed, but can be activated by members of the WASP (Wiskott-Aldrich syndrome 
protein) family of proteins, such as SCAR and WAVE, which are in turn activated through small 
G-proteins (e.g. Cdc42) that are integrated into many signalling cascades (Etienne-Manneville 
and Hall, 2002, Machesky et al., 1999). Through localised activation, Arp2/3 complexes are able 
to assist with the directionality of the protrusions in addition to their role in fuelling treadmilling 
with new actin filaments. 
  
Ena/VASP proteins further aid the progression and directionality of lamellipodia through their 
function as anti-capping proteins (Krause et al., 2003). Ena/VASP proteins also operate within 
other actin associated cellular mechanisms such as morphology change, adhesion and cell-cell 
interactions, however their precise role is yet to be determined (Pula and Krause, 2008).  
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Figure 1.1.3. Regulating treadmilling force. Adhesion acts as a “molecular clutch” to convert 
the force generated by actin assembly into protrusion. In this figure, the actin network is 
represented in gray, while newly polymerized actin is represented in red. (a) The molecular 
clutch is engaged enabling traction between the polymerizing actin network and the substrate to 
result in membrane protrusion. (b) The molecular clutch is disengaged reducing traction between 
focal adhesions and the actin cytoskeleton preventing protrusion formation as actin treadmilling 
force is predominantly converted into retrograde flow (adapted from Le Clainche and Carlier, 
2008).  
  
In addition to regulating the rate of actin treadmilling, cells control migration through 
modulating the extent of mechanical coupling between the actin cytoskeleton and the 
extracellular matrix. These cell matrix adhesions act as a 'molecular clutch' which, when 
engaged, provide traction to the polymerising actin network. This enables the force generated 
through treadmilling at the leading edge of the lamellipodium to be converted into protrusion 
formation (Figure 1.1.3.a). Contrastingly, when the clutch is disengaged, traction is lost and 
slippage occurs between the polymerising actin filaments and the extracellular matrix adhesions 
resulting in retrograde flow and a decrease in protrusion rate (Figure 1.1.3.b) (Hu et al., 2007, 
Macdonald et al., 2008). The clutch also controls the transmission of the actomyosin contractile 
force applied on focal adhesions which facilitates traction of the cell body and retraction of tail 
(Webb et al., 2002). 
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Engagement of the molecular clutch is controlled through a variety of molecular interactions at 
different levels. The integrins are a large family of finely regulated heterodimeric transmembrane 
adhesion receptors that connect the cell to the extracellular matrix and are activated by inside-out 
signaling (Hynes, 2002, Humphries et al., 2006). Talin binds to the intracellular portion of the 
receptor, inducing a conformational change that exposes the sites of ligand binding enabling 
other receptors, e.g., chemokines or growth factor receptors, to control integrin activation 
through 'receptor cross talk' (Schwartz and Ginsberg, 2002). Talin mediated conformational 
change also leads to an increased affinity of the extracellular domain to components of the 
extracellular matrix, enhancing the overall affinity between focal adhesions and the substrate 
(Shattil et al., 2010). 
  
A variety of actin binding proteins, most notably Talin, Vinculin and α-actinin, interact either 
directly or indirectly with the cytoplasmic tails of the integrins to 'engage the clutch' and enable 
traction with the extracellular matrix  (Vicente-Manzanares and Horwitz, 2011). Talin is able to 
directly bind both integrin and actin simultaneously and plays an important role in linking 
integrin receptors to the actin cytoskeleton (Humphries et al., 2006). Moreover, Talin proteins 
are able to dimerise and may intervene in the clustering of integrin dimers to form focal 
adhesions (Shattil et al., 2010). Vinculin does not interact directly with the integrins, but does 
bind both talin and actin to play a key role in the stabilisation of the adhesive structures during 
the maturation of focal complexes into focal adhesions (Burridge and Mangeat, 1984, Hemmings 
et al., 1996). α-actinin is a homodimer that cross links actin filaments into parallel bundles to 
control their stiffness which is thought to potentially influence the transmission of the contractile 
force (Esue et al., 2009). Its direct interactions with the integrins and Vinculin are believed to 
play a key role in α-actinins function in linking actin filaments and focal adhesions (Otey et al., 
1990, Wachsstock et al., 1987, Rajfur et al., 2002). 
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1.2. Cellular growth and proliferation 
 
Cellular growth and proliferation is a tightly controlled, multifaceted process required for both 
the development and maintenance of all multicellular organisms. During an organism's early life, 
cell division is essential for morphogenesis of tissues and organs, in addition to growth of the 
organism itself; while throughout its existence, cellular proliferation plays a key role in 
mechanisms such as tissue renewal and repair, immunity, and sexual reproduction. Incorrect 
regulation of cell growth can lead to devastating consequences, ranging from severe 
developmental defects through to cancer. Indeed, analysis of the numerous factors involved in 
cancer progression has led to the identification of many oncogenes and tumour suppressor genes 
involved in controlling growth and proliferation. 
 
1.2.1. A standard model for control  
 
For a cell to divide, it must first respond to a series of external growth signals mediated either by 
environmental changes or, as is more common in multicellular organisms, the presence of 
growth factors such as PDGF (platelet-derived growth factor) and EGF (epidermal growth 
factor). In this example, PDGF and EGF are ligands for the cell surface tyrosine kinase receptors 
PDGFR (PDGF receptor) and EGFR (EGF receptor) respectively. In both cases ligand binding 
results in receptor dimerisation at the cell surface, followed by internalisation and 
autophosphorylation of their intracellular tyrosine kinase domains (Heldin et al., 1998, Herbst, 
2004). The phosphorylated tyrosine kinase residues serve as distinct binding sites for a variety of  
domains such as SH2 (Src homology 2), SH3 (Src homology 3), PTB (phosphotyrosine binding), 
PH (pleckstin homology), and PDZ domains (Heldin et al., 1998, Herbst, 2004). This enables the 
recruitment and subsequent activation of numerous signal transducers and activators of 
intracellular substrates, such as Ras, PI3K (phosphoinositide 3-kinase) and PLC-γ 
(Phospholipase C-γ), which in turn stimulate further intracellular signal transduction cascades 
(Figure 1.2.1) (Heldin et al., 1998, Herbst, 2004).  
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Figure 1.2.1. Schematic illustration of example signaling pathways initiated by PDGF and 
EGF receptor activation. Ras activity is regulated by Grb2/Sos1 mediated activation and GAP 
repression. Ras can initiate the RAF-MEK-MAPK signaling cascade and activate Rho GTPases, 
triggering cell proliferation, and cell growth and migration respectively. PI3K also regulates Rho 
activity and has been further implicated in Akt activation leading to suppression of apoptosis 
(Heldin et al., 1998, Herbst, 2004). 
 
Ras activates several pathways, including the RAF-MEK-ERK/MAPK cascade, which transmits 
signals downstream and results in the transcription of genes involved in controlling several 
cellular mechanisms including growth, proliferation, and senescence (Santarpia et al., 2012, 
McCubrey et al., 2007). Net Ras activity is determined by balancing activation by Grb2/Sos1 
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following direct or SHP-2/Shc mediated interactions with the receptor, and deactivation by GTP 
hydrolysation inducing GAP (GTPase-Activating Protein) (van der Geer et al., 1997).  
 
Ras has also been shown to bind and activate PI3K, while both proteins are able to stimulate 
members of the Rho GTPase family (Rodriguez-Viciana et al., 1994, Nobes et al., 1995). In its 
active state, Rho binds to downstream effectors and stimulates intracellular signaling pathways 
involved in regulating processes such as cytoskeleton organization, gene transcription, cell 
proliferation, migration and growth (Lazer and Katzav, 2011). In addition, PI3K is involved in 
activating Akt, which in turn phosphorylates the tumor suppressor TSC2 (tuberous sclerosis 
complex 2) and apoptosis inducing BAD (Bcl-2-associated death promoter), suppressing their 
growth inhibitory and apoptotic effects respectively (Huang and Manning, 2009, Datta et al., 
1997). Indeed, the PI3K/Akt/mTOR (mammalian target of rapamycin) pathway has been shown 
to play a key role in a wide range of physiological processes, including cell cycle progression, 
differentiation, survival, transcription, translation, endocytosis, motility, metabolism, and 
autophagy (Figure 1.2.1) (Yuan and Cantley, 2008, Steelman et al., 2011). 
 
While numerous other pathways involved in regulating cellular growth and proliferation exist, 
many follow a similar mechanism to the one described above, with responses to extracellular 
signals inducing proliferation specific signal transduction cascades, which trigger cell division. 
However, a surprising mechanism for actin mediated cell proliferation has been identified that 
links cytoskeletal dynamics to cell growth. 
 
1.2.2. Actin mediated cellular proliferation 
 
It originally seems remarkable that proteins implicated in the regulation of actin dynamics could 
be involved in nuclear gene expression of factors governing cellular growth and proliferation; 
however, a model whereby a depletion in the cytoplasmic levels of G-actin leads to an increase 
in cell division has been developed (Miralles et al., 2003).  
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Figure 1.2.2. Pathways for SRF activation. Extracellular stimuli triggers the MAPK signaling 
cascade, enabling TCF-SRF complex formation and SRE binding. Conversely, activation of actin 
regulatory proteins leads to an increase in the F:G actin ratio. The decrease in G-actin levels 
reduces the binding of G-actin to MAL, allowing MAL to enter the nucleus and enhance SRF 
mediated gene expression (Posern and Treisman, 2006).  
 
SRF (serum response factor) is a highly conserved mitogen responsive MADS-box transcription 
factor expressed in most plants and animals (Shore and Sharrocks, 1995, Arsenian et al., 1998). 
It binds to the SRE (serum response element) within promoter regions of 'immediate-early' 
genes, such as c-fos, when in complex with the TCF (ternary complex factor) proteins Elk-1, 
SAP-1 and Net; enabling regulation of apoptosis, cell growth, cell cycle control, and 
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differentiation (Norman et al., 1988, Treisman, 1995). This interaction with members of the TCF 
family enables control of transcription via MAPK (mitogen-activated protein kinase) signalling, 
however, a TCF independent pathway controlled by Rho-family GTPases also exists (Figure 
1.2.2) (Treisman, 1994, Hill et al., 1995). 
 
MAL, an SRF cofactor encoded by a ubiquitously expressed gene, predominantly localises to the 
cytoplasm where it binds directly to monomeric G-actin. These interactions with G-actin inhibit 
nuclear import of MAL, preventing associations with SRF and subsequent enhancement of SRE 
mediated gene expression (Miralles et al., 2003, Wang et al., 2002). Stimulation of actin 
treadmilling by Rho GTPases, such as Rac, RhoA and Cdc42, leads to an accumulation of F-
actin and a commensurate depletion of G-actin, alleviating the inhibition on MALs nuclear 
import (Miralles et al., 2003, Settleman, 2003). Upon translocation to the nucleus, MAL 
complexes with SRF to enable transcription of a subset of SRE-containing genes (Figure 1.2.2) 
(Miralles et al., 2003, Gineitis and Treisman, 2001). Notably, not all SRF-regulated genes are 
sensitive to Rho-actin signaling, with the MAL-SRF complex found to selectively bind to 
promoter regions of Rho-sensitive genes (Gineitis and Treisman, 2001, Settleman, 2003). Indeed, 
NF-κB and C/EBP have been identified as transcription factors that mediate the activation of 
SRF by Rho, indicating that multiple downstream pathways may contribute to SRF activation 
and specificity (Montaner et al., 1999, Settleman, 2003). 
 
Of course, as with the majority of signal transduction pathways, there is more complexity to the 
actin-MAL-SRF mechanism than can be accounted for by a simple linear cascade from the cell 
surface to the nucleus. For example, MAL has been found to undergo serum-induced 
phosphorylation that is only partially blocked by Rho inhibition, indicating that pathways 
independent of Rho may also influence MAL-SRF activity (Miralles et al., 2003). Indeed, Ras-
RAF-MEK signalling pathways, LIM kinase, Profilin, mDia1, mDia2, VASP, WASP and N-
WASP have been implicated in activating MAL and inducing nuclear translocation (Miralles et 
al., 2003). Also, some mutant actin monomers have been shown to remain competent for MAL 
binding yet promote its nuclear accumulation, which is hard to reconcile with a simple model 
(Posern et al., 2004, Posern and Treisman, 2006). Consequently, it has been proposed that MAL 
may constitutively shuttle in and out of the nucleus, and that a reduction in actin binding shifts 
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the balance towards import either by increasing nuclear translocation or decreasing nuclear 
export (Posern and Treisman, 2006). Lastly, while Rho, Rac, and Cdc42 can each promote F-
actin assembly, they have been found to exhibit widely varying potency as SRF activators, 
further implicating downstream pathways in regulating SRF activity and specificity (Hill et al., 
1995, Settleman, 2003). 
 
1.3. The RA-PH family of adapter proteins 
 
Adapter proteins play a fundamental role in regulating a diverse range of cellular activities 
through the coupling of extracellular signalling events with intracellular signal transduction 
pathways. While these proteins tend to lack any intrinsic enzymatic activity themselves, they 
often possess multiple protein and lipid binding domains which determine their function by 
facilitating the formation of various protein complexes. These adapter protein recruited 
complexes form the cornerstone of many biological processes as the close proximity of the 
specific binding partners enhances the control and speed of the cellular response to a signalling 
event. 
  
One class of molecular adaptors are the RA (Ras-association) and PH domain containing 
proteins. This class of proteins are divided into two small but distinct families; the Grb (Growth 
Factor Receptor-Bound) 7/10/14 family and the MRL (Mig-10/RIAM/Lamellipodin) family 
(Figure 1.3.1) (Shen and Guan, 2004, Lafuente et al., 2004). Unlike the MRL proteins, Grb 
proteins are only found in higher multicellular organisms; with no orthologues identified in 
either Caenorhabditis elegans (C. elegans) or Drosophila melanogaster, indicating that the 
acquisition of Grb7/10/14 structure and function appears to have been relatively late in 
evolutionary terms (Holt and Siddle, 2005). 
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Figure 1.3.1. Dendrogram of the full-length proteins of the Grb7/10/14 and MRL families. The 
MRL family (boxed in red) and the Grb7/10/14 family represent two distinct sub-groups of the RA-
PH superfamily. No Grb7/10/14 orthologues are found in C. elegans or Drosophila melanogaster. 
 
1.3.1. The Grb7/10/14 family 
 
Grb7, Grb10 and Grb14 all share a common domain structure and constitute the Grb7/10/14 
family of adapter proteins. In addition to the central RA and PH domains mentioned previously, 
they also possess an N-terminally located proline-rich region, a C-terminal SH2 domain and a 
BPS (Between the PH and SH2) domain (Figure 1.3.2) (Han et al., 2001). 
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Figure 1.3.2. A schematic representation of the Grb7/10/14 family of proteins. The 
Grb7/10/14 all possess central RA and PH domains in addition to an N-terminal proline rich 
region and a C-terminal SH2 domain. The BPS domain appears to be unique to the Grb7/10/14 
family. 
 
The Ras superfamily of proteins are prolific signal-transducing GTPases that cycle between 
inactive GDP-bound and active GTP-bound forms. They interact with a spectrum of effector 
molecules enabling them to act through various signalling pathways; most notably those 
involved in cell proliferation, cellular adhesion, and membrane trafficking (Bourne et al., 1990, 
Wennerberg et al., 2005). Many Ras-like GTPases, such as R-Ras, K-Ras and Rap, activate their 
effectors through direct interactions with characteristic RA domains (Ponting and Benjamin, 
1996). Consistently, the RA domains present in the Grb7/10/14 have been reported to facilitate 
interactions with members of the Ras superfamily. Grb7 has been shown to bind to N-Ras, K-
Ras and H-Ras as well as activated Rap1 and Rap2, albeit with a much weaker affinity 
(Rodriguez-Viciana et al., 2004). Grb10 and Grb14, on the other hand, have only been found to 
bind to N-Ras but not Rap1 or Rap2 so far, with further experimentation required to determine if 
other Ras family GTPases interact (Depetris et al., 2009). 
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PH domains are small protein modules typically around 120 amino acids in length that are found 
in numerous proteins involved in cellular signalling (Haslam et al., 1993, Lemmon and 
Ferguson, 2000, Mayer et al., 1993). They are thought to predominantly function in targeting 
their host protein to the plasma membrane through direct interactions with PIs 
(phosphoinositides), a minor component localised on the cytosolic side of eukaryotic membranes 
(Lemmon, 2007, Rameh et al., 1997). In some cases PI(4,4)P2 is the ligand, while in others, 
products of agonist-stimulated PI3K are the targets (Franke et al., 1995, Rameh and Cantley, 
1999). While these products, PI(3,4)P2 and PI(3,4,5)P3, are barely detectable in resting 
mammalian cells, they are transiently generated in relatively significant quantities by PI3Ks 
following the activation of almost all known cell-surface receptors (Vanhaesebroeck and 
Waterfield, 1999, Lemmon and Ferguson, 2000, Cantley, 2002). In addition to their role in 
membrane localisation, PH domains have also been reported to interact with a small number of 
proteins, such as heterotrimeric G-proteins and isoforms of PKC (protein kinase C) (Tsukada et 
al., 1994, Robinson et al., 1993). 
 
As expected, the PH domains of the Grb7/10/14 proteins have been shown to bind with a range 
of specific phosphoinositides. Grb7 has been reported to interact strongly with PI(3)P and 
PI(5)P, while only moderate or weak binding was observed with PI(4)P, PI(3,5)P2, PI(3,4)P2 and 
PI(3,4,5)P3 (Shen et al., 2002). The PH domain of Grb10 was shown to have a fairly strong 
affinity for PI(5)P, PI(4,5)P2, PI(3,4)P2 and PI(3,4,5)P3, whereas Grb14 only interacted weakly 
with PI(3,4,5)P3 (Depetris et al., 2009). These differences in phosphoinositide binding 
specificities are generally attributed to a number of flexible loop regions attached to β-sheets that 
make up the domain (Fruman et al., 1999). Despite significant sequence homology (over 60%) 
and considerable 3D structural similarity between the Grb7/10/14 PH domains, the lengths of the 
aforementioned loops vary between the domains and is thought to determine phosphoinositide 
preference (Fruman et al., 1999, Lemmon and Ferguson, 2000). Interestingly, a loss of binding to 
phosphoinositide headgroups in vitro through a single point mutation in the PH domain of 
Grb14, lead to a reduction in co-immunoprecipitation with Ras; indicating that Grb14 PH 
domain mediated membrane association is important for the interaction of Grb14 with Ras 
(Depetris et al., 2009). 
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The SH2 domain forms the most highly conserved region amongst the Grb7/10/14 family and 
acts as a phosphotyrosine-binding module allowing interactions with receptor tyrosine kinases 
and other intracellular signaling proteins (Holt and Siddle, 2005). Despite the high degree of 
similarity, the binding preferences of this region generally vary between the proteins. The SH2 
domains of all three Grb7/10/14 members have been shown to interact with the activated IR 
(insulin receptor), however, the affinity with which they associate differs significantly and may 
be important in influencing the outcome of IR-dependent signaling (Kasus-Jacobi et al., 2000, 
Hansen et al., 1996, Kasus-Jacobi et al., 1998). Grb7 associates with the receptor tyrosine kinase 
ErbB2 and the cytoplasmic tyrosine kinase FAK (focal adhesion kinase) via its SH2 domain, 
while both Grb10 and Grb14 do not (Frantz et al., 1997, Han and Guan, 1999, Janes et al., 1997). 
SH2 domains have also been implicated in dimerisation following structural analysis of the 
superficially similar APS (Adapter protein with PH and SH2 domains) SH2 region; and may be a 
feature of adapter proteins involved in signaling from receptors such as the IR and IGFR (type I 
insulin-like growth factor receptor) (Hu et al., 2003, Holt and Siddle, 2005). 
 
The BPS domain is a short region approximately 80 amino acids long found exclusively in the 
Grb7/10/14 proteins and named due to its location between the PH and SH2 domains (He et al., 
1998). It appears to be intrinsically unstructured yet the isolated domain retains physiological 
activity by interacting with activated IR and IGFR, and inhibiting IR catalytic activity (Moncoq 
et al., 2003, Stein et al., 2001, Bereziat et al., 2002). It is believed to function by cooperating 
with the SH2 domain to facilitate interactions with tyrosine-phosphorylated signalling molecules, 
including receptor tyrosine kinases (He et al., 1998). In addition, despite its high sequence 
conservation amongst the Grb7/10/14 proteins, it is thought that the BPS domain acts as an 
important receptor binding determinant to impart specificity amongst the family (Holt and 
Siddle, 2005). 
 
Lastly, the N-terminal regions of the Grb7/10/14 proteins contain a conserved proline rich 
sequence in addition to other PXXP motifs, enabling interaction with SH3 domain containing 
proteins such as c-Abl (Abelson) by Grb10 (Frantz et al., 1997). Tandem proline rich regions in 
the N-terminus of Grb10 have also been found to interact with GIGYF (Grb10-interacting GYF) 
1 and 2; two proteins implicated in EGFR mediated Akt activity regulation, via GYF motifs 
18 
 
rather than SH3 domains (Giovannone et al., 2003, Ajiro et al., 2010). In addition, the N-terminal 
region of Grb14 binds to an ankyrin repeat region of the poly(ADP-Ribose) polymerase 
tankyrase 2; however, neither the functional significance or exact site of this interaction have yet 
been determined (Lyons et al., 2001). No N-terminal binding partners have been identified for 
Grb7 thus far. 
 
 
 
Figure 1.3.3. The differing functions of the Grb7/10/14 family. Grb7/10/14 interactions play a 
key role in their functionality (adapted from Holt and Siddle, 2005). 
 
The Grb7/10/14 family proteins all share significant structural and sequence homology, however, 
due to their different binding partners they have been found to regulate distinct cellular functions 
and pathways, with only some functional overlap existing between Grb10 and Grb14 (Figure 
1.3.3).  
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Grb7 is thought to act as a positive regulator of cell migration through its interactions with FAK 
and ErbB2. FAK is localised predominantly within focal adhesions and mediates several integrin 
signalling pathways including those involved in the promotion of cell migration, proliferation 
and cell spreading (Cary and Guan, 1999). ErbB2 is part of the EGFR family and has been 
shown to play a key role in the pathogenesis and progression of a variety of aggressive breast 
cancers, evolving to become an important biomarker and target for treatment of the disease 
(Olayioye, 2001). 
 
Grb10 and Grb14 have been found to play a significant role in the control of cellular growth, 
proliferation and metabolism by directly binding and inhibiting activated IR to prevent insulin 
induced activation of signalling cascades involved in metabolic and mitogenic pathways (Wick 
et al., 2003, Kairouz et al., 2005, Kasus-Jacobi et al., 1998). Grb10 and Grb14 binding is thought 
to both inhibit the catalytic activity of the IR, and also block access of substrates to the activated 
receptor (Bereziat et al., 2002, Wick et al., 2003, Langlais et al., 2004). Contradicting this, some 
studies have implied that Grb10/14 might act as positive mediators of insulin signalling, with 
Grb10 reportedly interacting with and increasing the activity of the insulin signalling pathway 
molecule Akt; while Grb14 was shown to constitutively associate with PDK-1 enabling 
recruitment to the activated IR and promoting Akt phosphorylation and insulin signal 
transduction (Jahn et al., 2002, King and Newton, 2004, Holt and Siddle, 2005). 
 
Grb10 and Grb14 have also been implicated in mediating ubiquitination and possible degradation 
of IGFR through interactions with Nedd4 (neuronal precursor cell expressed developmentally 
down-regulated), although, Grb14 has only been found to interact in yeast two-hybrid studies so 
far (Morrione et al., 1999, Lyons et al., 2001, Vecchione et al., 2003). Lastly, it has been 
suggested that Grb10 may assist in repressing apoptosis as SH2 mutated forms of Grb10 that are 
unable to interact with either Raf-1 or MEK (MAP kinase/Erk kinase) have induced apoptosis, 
while co-expression of wild type Grb10 reversed the effect (Nantel et al., 1998). It should be 
noted that this section should not be regarded as a comprehensive review of the Grb7/10/14 and 
merely exists to highlight how differential binding properties of conserved domain regions 
significantly affects adaptor protein functionality. 
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1.3.2. The MRL family 
 
The MRL family of adapter proteins are comprised of the C. elegans orthologue Mig-10 
(abnormal cell migration protein 10), two mammalian paralogues RIAM (Rap1-GTP-interacting 
adapter molecule) and Lpd (Lamellipodin), and the most recently characterised Drosophila 
orthologue Pico (Annotation symbol: CG11940) (Manser and Wood, 1990, Krause et al., 2004, 
Lafuente et al., 2004, Lyulcheva et al., 2008). It is thought that members of this recently 
identified family facilitate in transducing signals derived from membrane receptors to changes in 
the actin cytoskeleton enabling regulation of actin dynamics, cell adhesion, migration and growth 
(Krause et al., 2004, Lafuente et al., 2004, Lyulcheva et al., 2008, Colo et al., 2012b). 
 
 
 
Figure 1.3.4. Schematic representation of the domain structure of Grb7/10/14 and MRL 
family proteins. The MRL proteins all possess central RA and PH domains in addition to an N-
terminal coiled-coil motif and C-terminal proline rich regions. RIAM also contains an additional 
proline rich region and coiled-coil motif in its N-terminus. The MRL family do, however, lack 
the characteristic BPS and SH2 domains found in the Grb7/10/14 proteins (Colo et al., 2012b). 
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Much like the Grb7/10/14 family members, the MRL proteins all possess well defined central 
RA and PH domains; however, they lack the characteristic Grb7/10/14 BPS and SH2 domains 
while only RIAM contains an N-terminal proline rich region (Figure 1.3.4). The RA domain is 
approximately 90 amino acids long and directly interacts with specific Ras-like GTPases, 
potentially playing a crucial role in activation of the protein and/or its other associated factors 
(Holt and Daly, 2005). The PH domain spans roughly 100 amino acid residues and is thought to 
target the MRL proteins to the plasma membrane through direct interactions with 
phosphoinositides (Holt and Daly, 2005, Krause et al., 2004). 
 
In addition to the RA and PH domains, the MRL proteins also possess a highly charged N-
terminal region around 55 amino acids in length, while amphipathic helical structured talin 
binding sites have been identified within the first 100 amino acids of RIAM and Lpd (Krause et 
al., 2004, Lafuente et al., 2004, Lee et al., 2009). Adjacent to the N-terminus of the RA domain, 
MRL proteins also contain a characteristic 27 amino acid putative coiled-coil motif that may 
function in promoting homodimeric or heterodimeric interactions (Legg and Machesky, 2004, 
Lupas, 1996). Lastly, all MRL proteins possess a relatively unstructured proline rich C-terminus, 
with multiple FPPPP motifs allowing interactions with EVH1 (Ena/VASP homology 1) domains 
found in the actin regulatory proteins Enabled and VASP; as well as XPPPP motifs that bind to 
profilin and other SH3-binding motif containing proteins (Colo et al., 2012b, Krause et al., 2004, 
Lafuente et al., 2004). 
 
The two mammalian MRL proteins, RIAM and Lpd, have well conserved RA and PH domains, 
however, their N-terminal and C-terminal regions show considerable divergence explaining their 
differing yet overlapping functionality. At its N-terminus, RIAM contains an additional proline-
rich region with two putative EVH1 binding sites and an extra coiled-coil motif not found in the 
other MRL members (Figure 1.3.4) (Lafuente et al., 2004). The RIAM C-terminus possesses a 
proline-rich motif comprised of five profilin-binding sites and five EVH1 binding motifs, while 
the larger C-terminal proline rich region of Lpd consists of eight potential SH3 binding sites, six 
EVH1 domain binding regions and three profilin interacting motifs (Lafuente et al., 2004, Krause 
et al., 2004). 
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Both RIAM and Lpd interact with Ena/VASP proteins and Profilin via their EVH1 and profilin 
binding sites respectively; potentially facilitating their recruitment towards the leading edge to 
enable regulation of the actin cytoskeleton (Lafuente et al., 2004, Krause et al., 2004). Indeed, 
RIAM and Lpd can co-localise with Ena/VASP proteins and F-actin at lamellipodia and 
filopodia tips, and have been shown to regulate actin dynamics in an Ena/VASP dependent 
manner (Jenzora et al., 2005, Lafuente et al., 2004, Krause et al., 2004). When overexpressed, 
RIAM promotes cell spreading and lamellipodia formation while Lpd increases lamella 
protrusion velocity. The increased lamellipodial protrusion velocity resulting from Lpd 
overexpression can be suppressed by blocking Ena/VASP functionality (Krause et al., 2004). 
Contrastingly, knockdown of Lpd impaired lamella formation in addition to reducing actin 
branching density and F-actin levels within the lamellipodium; whilst RIAM silencing decreases 
F-actin quantities as well (Lafuente et al., 2004, Krause et al., 2004). RIAM and Lpd also share a 
capacity to bind to Talin via N-terminal amphipathic helices, enabling integrin activation and 
promotion of cell adhesion (Lafuente et al., 2004, Lee et al., 2009, Han et al., 2006, Watanabe et 
al., 2008). Furthermore, RIAM has been found to co-localise with Vinculin and actin in early 
focal adhesions during initial cell spreading, but is absent in more mature formations (Han et al., 
2006). Fitting in with its role of controlling actin dynamics and integrin mediated adhesion, 
RIAM has also been shown to regulate the directionality of cell migration and play a role in FA 
disassembly through an integrin-RIAM dependent MEK/Erk activated feedback-loop 
(Hernandez-Varas et al., 2011, Colo et al., 2012a). 
 
Despite the high level of conservation within the RA and PH domains and the presence of similar 
binding sites located throughout their C-terminal regions, RIAM and Lpd demonstrate differing 
binding preferences. RIAM interacts predominantly with active Rap-1, a well known regulator of 
integrin activation, although it can bind active Ras at a significantly lower affinity (Lafuente et 
al., 2004, Bos, 2005). This interaction requires both the RA and PH domains, and is enhanced by 
the RIAM N-terminus (Lafuente et al., 2004). Contrastingly, Lpd has been reported to associate 
with active K-Ras, N-Ras, H-Ras, R-Ras and Rac, however, no interaction with Rap-1 has yet 
been observed (Rodriguez-Viciana et al., 2004, Jenzora et al., 2005, Krause et al., 2004). RIAM 
and Lpd also display differential PH domain binding preferences, with RIAM associating with 
the more common PI(3)P and PI(5)P, while Lpd interacts with the relatively rarer PI(3,4)P2 
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(Jenzora et al., 2005, Krause et al., 2004, Lemmon, 2008). Since PIs represent early polarizing 
molecules during cell activation, the differential binding capacities of the Lpd and RIAM PH 
domains may contribute to the characteristic temporal and spatial localisations observed in these 
proteins (Lemmon, 2003, Colo et al., 2012b). At the cellular level, RIAM is found both in the 
cytoplasm and in lamellipodia at the leading edge of the cell membrane, while Lpd is 
predominantly located at the plasma membrane (Lafuente et al., 2004, Jenzora et al., 2005, 
Krause et al., 2004). 
  
Further protein interactions and post-translational modifications are also thought to assist in the 
regulation of RIAM and Lpd, enabling tight control over their divergent downstream functions. 
In stimulated T cells, RIAM was found to be a substrate for the tyrosine kinases Fyn, Lck and 
ZAP-70, enabling the C-terminal proline-rich region to interact with the SH3 domain of PLC-γ1. 
RIAM then assists in the translocation of PLC-γ1 to the actin cytoskeleton where, through 
interactions with PI(4,5)P2, a signaling cascade is initiated by PLC-γ1 that increases Ras-GTP 
formation, MEK/Erk activation, and changes in gene expression (Patsoukis et al., 2009). Lpd, on 
the other hand, is able to bind the SH2 domain of c-Abl tyrosine kinase following 
phosphorylation of key tyrosine residues within Lpd (Michael et al., 2010). Abl family kinases 
are important regulators of cytoskeletal dynamics and have been implicated in axon guidance in 
both Drosophila and mammals (Lanier and Gertler, 2000). In fibroblasts, Lpd phosphorylation 
by c-Abl downstream of PDGF regulated dorsal ruffle formation by recruiting Ena/VASP 
proteins (Michael et al., 2010). Regulation of axon morphogenesis in primary hippocampal 
neurons is also reported to be mediated by Lpd in cooperation with c-Abl (Michael et al., 2010). 
Lastly, in primary fibroblasts Lpd interactions with the SH3 domain of srGAP3 (SLIT-ROBO 
Rho GTPase activating protein) negatively regulates lamellipodial dynamics. It is thought that 
srGAP3 associates with Lpd near the membrane, releasing the binding between Rac1 and Lpd, 
causing inhibition of membrane protrusions associated with a reduction in the local Rac1-GTP 
levels (Endris et al., 2011). 
 
While RIAM and Lpd have both been implicated in cell growth and proliferation, the 
mechanisms through which they act are thought to be different. The reduction in integrin 
dependent adhesion in RIAM silenced cells was shown to correlate with decreased activation of 
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Erk1/2 and PI3K, two central molecules controlling cell growth and survival (Hernandez-Varas 
et al., 2011). These cells exhibited inhibition of anchorage-independent growth, as well as 
impaired tumor growth and delayed metastasis; suggesting that RIAM mediated activation of 
Erk1/2 and PI3K may contribute to cellular proliferation (Hernandez-Varas et al., 2011, Colo et 
al., 2012b). Lpd, on the other hand, has been implicated in mammalian cell proliferation through 
regulation of SRF. Lpd is thought to trigger an increase in F-actin levels, releasing the cofactor 
MAL from its association with G-actin, and allowing its transport to the nucleus where it acts as 
a cofactor for SRF mediated growth related gene expression (Pinheiro et al., 2011, Colo et al., 
2012b, Lyulcheva et al., 2008). Indeed, the ability of Lpd to regulate SRF activity has already 
been implicated in directing pyramidal neurons to select a radial migration pathway along glia 
rather than a tangential migration mode (Pinheiro et al., 2011). 
 
Mig-10, the only C. elegans MRL homologue, possesses the characteristic central RA and PH 
domains, C-terminal proline rich regions and N-terminal coiled-coil motif common in all MRL 
proteins (Manser and Wood, 1990, Colo et al., 2012b). It shares significant homology with Lpd 
and is required for successful long-range antero-posterior migration of embryonic CANs (canal-
associated neurons), ALMs (anterior lateral microtubule cells) and HSNs (hermaphrodite-
specific neurons), as well as efficient development of excretory canals used in osmoregulation; 
processes requiring well controlled directional migration (Colo et al., 2012b, Manser et al., 1997, 
Manser and Wood, 1990, Chang et al., 2006). However, unlike the other members of the MRL 
family, Mig-10 has not yet been found to play a role in cellular growth and proliferation (Colo et 
al., 2012b). 
 
MIG-10, much like Lpd, contains consensus EVH1 binding sites thought to mediate interactions 
with members of the Ena/VASP family to assist in their recruitment to the leading edge, enabling 
cytoskeletal changes and enhancement of migration (Holt and Daly, 2005, Drees and Gertler, 
2008). Indeed, disrupted embryonic cell migration responses instigated by mig-10 mutants 
resemble those of mutants for unc-34, the C. elegans Ena/VASP ortholog (Forrester and Garriga, 
1997). Moreover, during neuronal development, MIG-10 and UNC-34 cooperate to guide axons 
toward UNC-6 (Netrin) and away from SLT-1 (Slit), with UNC-34 required for the formation of 
filopodia and MIG-10 enhancing their numbers (Chang et al., 2006, Quinn et al., 2006). 
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However, double mutants of unc-34 and mig-10 cause much more severe defects than either 
mutant separately, while in unc-34 mutants alone, developing axons that lack filopodia are still 
guided to UNC-6 through MIG-10 mediated lamellipodial growth; suggesting that the two 
proteins may act in overlapping functional pathways (Chang et al., 2006). In particular, it is 
thought that MIG-10 is likely to associate with actin polymerization machinery via additional 
partner molecules, although interactions with UNC-34 through a common pathway are still 
probable (McShea et al., 2013, Chang et al., 2006). 
 
MIG-10 has also been found to localise asymmetrically in response to external directional 
signals such as UNC-6 or SLT-1, enabling control over the directionality of cellular migration 
(Quinn et al., 2006). Experiments showed that overexpression of MIG-10 in the absence of these 
guidance cues led to the development of a multipolar phenotype with undirected outgrowths, 
while the addition of UNC-6 or SLT-1 resulted in the monopolar formation of a single 
overgrowth with enhanced guidance (Quinn et al., 2006). It has been proposed that in the 
absence of UNC-6, its receptor UNC-40 (DCC) is distributed uniformly, however, when a UNC-
6 gradient is present, UNC-40 becomes polarized to the side of the growth cone closest to the 
source of UNC-6, leading to localised PI(3,4)P2 production by AGE-1 (PI3K) and activation of 
Rac (Adler et al., 2006, Quinn et al., 2008). As with Lpd, localisation of MIG-10 is thought to be 
mediated by upstream Ras superfamily controlled interactions with PI(3,4)P2 via the PH domain 
(Krause et al., 2004, Quinn et al., 2008). Indeed, a fragment of MIG-10 containing only the RA 
and PH domains bound specifically to the activated Rho GTPase CED-10 (Rac1); however, 
mutation of ced-10, or either age-1 or daf-18 (PTEN) which have also been implicated in 
regulating PI(3,4)P2 turnover, disrupted correct MIG-10 localisation in response to UNC-6 
(Quinn and Wadsworth, 2008, Quinn et al., 2008, Adler et al., 2006). Consequently, it is thought 
MIG-10 binds to the UNC-40 co-localised PI(3,4)P2 and activated Rac, enabling asymmetric 
actin-based protrusive activity and control over the directionality of migration (Adler et al., 2006, 
Quinn et al., 2008). Recently, MIG-10 has been shown to localise to presynaptic regions in 
response to this pathway, mediating synaptic vesicle clustering and F-actin organisation (Stavoe 
and Colon-Ramos, 2012). This involvement in vesicle trafficking may be related to MIG-10's 
function in excretory cell outgrowth, as formation of the lumen of these tubule shaped single 
26 
 
cells, fundamental to the development and function of many tissues and organs in metazoan 
organisms, requires localisation and fusion of vesicles (Buechner, 2002). 
 
As described previously, the Arp2/3 complex is responsible for nucleating branched actin 
filaments, and plays a crucial role in regulating lamellipodial dynamics (Goley and Welch, 
2006). WAVE (WASP family Verprolin-homologous protein) is a WASP family protein 
involved in activating the Arp2/3 complex downstream of Rac and is constitutively associated 
with the WRC (WAVE regulatory complex) proteins ABI-1 (Abi-1), GEX-2 (Sra-1), GEX-3 
(Nap-1), and HSPC300 (Miki et al., 1998, Eden et al., 2002, Stovold et al., 2005). The WRC 
inhibits WAVE activity in the absence of migratory signalling events and is critical for 
controlling WAVE localisation and stability (Chen et al., 2010, Ismail et al., 2009, Kunda et al., 
2003). Recently, it was demonstrated that MIG-10 directly interacts with the SH3 domain of 
ABI-1 and that abi-1 mutant or abi-1 RNAi treated animals show similar defects in ALM 
migration and excretory cell canal outgrowth as those with mutant mig-10; indicating that MIG-
10 and ABI-1 are involved in a common pathway (McShea et al., 2013). Additionally, in C. 
elegans ABI-1 and ABL-1 (Abl) have been shown to interact in vitro and have opposing 
functions in the regulation of cell engulfment of apoptotic cells (Hurwitz et al., 2009). In 
mammals, Abi-1 is a downstream target and modulator of Abl activity, with their interaction 
shown to promote phosphorylation of the Ena/VASP family member Mena, although it remains 
unclear how this influences Enabled activity (Shi et al., 1995, Michael et al., 2010, Tani et al., 
2003). Lpd is also a target of Abl, however a role for Abi-1 in this interaction has not been 
described (Michael et al., 2010). It is therefore not beyond reason to suggest that MIG-10 may 
interact with ABL-1 to mediate ABI-1 regulation of downstream ARP2/3 actin filament 
branching. 
 
The Drosophila ortholog Pico (CG11940) is the most recently characterised MRL family 
member and, akin to Mig-10, comprises the only MRL member in Drosophila and shares 
considerable homology with Lpd. Two transcripts generated from alternative transcription start 
sites were identified, pico and pico-L; with Pico-L encoding an 1159 amino acid protein identical 
to the shorter form, except for the presence of additional 128 N-terminal amino acids (Lyulcheva 
et al., 2008). Unsurprisingly, Pico contains the distinctive RA and PH domains, as well as the N-
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terminal coiled-coil motif and C-terminal proline-rich Ena/VASP binding sites characteristic of 
all MRL members (Lyulcheva et al., 2008).  
 
Studies in pico mutant larvae revealed a dramatic reduction in size and early death, suggesting 
that Pico is required for tissue and organismal growth, as well as viability. In addition, RNAi 
mediated silencing of pico in Drosophila wing discs led to a significant reduction in wing area, 
due primarily to a reduction in cell proliferation and size rather than induced apoptosis 
(Lyulcheva et al., 2008). Further investigations demonstrated that homozygous pico mutant 
clones generated in Drosophila imaginal discs, exhibited severe growth and proliferation defects 
and were gradually extruded from the otherwise wild type tissue (Lyulcheva et al., 2008). 
Conversely, overexpression of Pico was shown to induce hyperplastic growth at both the tissue 
and whole organism level, owing to a co-ordinated increase in both cell number and cell size 
(Lyulcheva et al., 2008).  
 
It has been reported that Pico's ability to regulate cell growth and proliferation is dependent on 
EGFR activity. Indeed, ectopic expression of a dominant negative form of EGFR (EGFR
DN
), 
thought to interfere with signaling by forming inactive heterodimers with the wild type receptors, 
resulted in dramatically reduced, narrow wings (Kashles et al., 1991, Guichard et al., 1999). 
Wings coexpressing Pico and EGFR
DN
 resembled those of EGFR
DN
 alone, while RNAi mediated 
silencing of pico suppressed the overgrowth effects of EGFR overexpression (Lyulcheva et al., 
2008). Consequently, it is thought that EGFR may activate Ras-like GTPases, which in turn 
binds to and activates the MRL proteins (Rodriguez-Viciana et al., 2004). 
 
The Pico RA-PH region was reported to be capable of binding constitutively active forms of Ras 
and Rap1 in yeast two hybrid studies, suggesting that Pico may constitute a Ras or Rap1 GTPase 
effector downstream of EGFR. Furthermore, Pico interacts with the EVH1 domain of the 
Drosophila Ena/VASP homologue Ena (Enabled), and influences actin dynamics in an Ena 
dependent manner (Lyulcheva et al., 2008). Overexpression of Pico alone promoted F-actin 
formation in imaginal wing discs, while pico RNAi reduced F-actin levels; although total actin 
content was consistent throughout indicating that Pico regulates the ratio of G:F actin (Lyulcheva 
et al., 2008). Homozygous ena mutants dominantly suppressed Pico-mediated F-actin 
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accumulation and wing growth, suggesting that Ena is limiting for Pico function. Wings 
expressing Ena with pico RNAi resembled those with pico RNAi alone while co-overexpression 
of Ena and Pico phenotypically resembled the effect of overexpressing either gene alone, 
indicating that both function in the same pathway (Lyulcheva et al., 2008).  
 
As with Lpd, Pico has been implicated in mediating cellular growth and proliferation through 
regulation of MAL/SRF dynamics (Lyulcheva et al., 2008). Genetic analysis has revealed that 
MAL/SRF levels are important for pico-mediated regulation of tissue growth. Co-overexpression 
of MAL and Pico in wings phenotypically resembled the effect of overexpressing MAL alone, 
while MAL-mediated overgrowth could not be suppressed by pico RNAi; implying MAL acts 
downstream of Pico. Furthermore, Pico-mediated wing overgrowth was dominantly suppressed 
by a hypomorphic mutation in bs (blistered), the Drosophila SRF homologue (Lyulcheva et al., 
2008). It is thought that by increasing F actin levels, Pico promotes the release of the SRF 
cofactor MAL from its interaction with G-actin. MAL then translocates to the nucleus where it 
associates with, and activates SRF, leading to increased transcription of growth related genes 
(Pinheiro et al., 2011, Colo et al., 2012b, Lyulcheva et al., 2008). Conversely, a recent report has 
challenged this finding by demonstrating that pico RNAi leads to a crumpled wing phenotype 
rather than a clean tissue undergrowth phenotype, suggesting that Pico is required for correct 
wing morphogenesis (Thompson, 2010). However, this report neglected to highlight the 
predicted off-target effects of commercially available Pico RNAi strains potentially used to 
generate this contradictory data, despite the Lyulcheva et al. 2008 paper employing a customised 
strain with no anticipated erroneous targeting outcomes.  
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1.4. Using Drosophila melanogaster as a model for growth and migration 
 
While studies using cultured cell lines have significantly improved our understanding of cellular 
migration and growth, it is not possible to effectively replicate the full complexity of these 
processes within this system alone. One of the principal limitations is the lack of a natural cell 
microenvironment, although cultured cells also often exhibit changes to their normal 
morphology, function and gene expression. Indeed, various studies have served to highlight the 
importance of interactions between cells and their surrounding tissues on coordinated cell growth 
and migration; a process that cannot be reproduced in vitro (Bissell and Radisky, 2001). 
Consequently, in vivo models have been utilised to complement and verify the research 
conducted with cultured cells.  
 
Experiments in mice have contributed extensively to our understanding of cellular migration and 
proliferation within the context of the whole organism. Indeed, genetically engineered mice with 
gain-of-function mutations in oncogenes, and loss-of-function mutations in tumour-suppressor 
genes, have enabled the functionality of a range of proteins involved in growth and migration to 
be extensively characterised (Singh and Johnson, 2006, Van Dyke and Jacks, 2002). However, 
the genetic alterations required to investigate how these multiple proteins operate remain 
exceptionally difficult and time-consuming to generate (Brumby and Richardson, 2005). 
Analysis within the model system C. elegans has also provided a wealth of insight into pathways 
related to growth and migration. This is in part due to the successful work mapping the 
developmental fate of every single somatic cell, although their optical transparency and ease of 
gene overexpression and RNAi mediated silencing have also contributed (Johnson, 2003). 
Nonetheless, C. elegans is evolutionarily far from humans, with many physiologically important 
systems absent in the nematode and approximately 35% of genes possessing human homologues 
(Johnson, 2003). 
 
Drosophila melanogaster, represents a simple model system in which cellular growth and 
migration can be analysed in vivo. Drosophila has been extensively used as a model organism for 
over a century, due in part to the ease with which stocks can be reared in the laboratory, its short 
generation time and the abundance of powerful genetic techniques that have been developed 
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within the system (Matthews et al., 2005, St Johnston, 2002). Furthermore, despite assumptions 
indicating that humans and flies diverged from one another over 700 million years ago, a 
significant number of biological and developmental processes have been shown to be conserved 
between the two organisms; with about 75% of known human disease genes having a 
recognizable match in the genetic code of fruit flies, and over 50% of fly protein sequences 
possessing mammalian analogues (Reiter et al., 2001). Moreover, many of the genes known to 
influence cellular growth and migration in mammals possess homologous genes in Drosophila 
which have been shown to produce similar phenotypes and act in similar signalling pathways as 
their human counterparts. It is for these reasons that Drosophila melanogaster has become an 
important model system for investigating cellular growth and migration. 
 
1.4.1. Genetic techniques available in Drosophila 
 
As mentioned previously, an assortment of powerful genetic tools have been developed in the 
Drosophila system, allowing a wide variety of in vivo experiments to be performed. Large scale 
forward genetic screens can be carried out to identify genes involved in the regulation of specific 
biological processes, such as development, growth, or migration. Multiple independent gene 
mutations can be generated within the Drosophila genome through either chemical mutagenesis 
following exposure to mutagens such as EMS (ethyl methanesulfonate), or transposable element 
insertion using P-elements (St Johnston, 2002, Adams and Sekelsky, 2002). This allows a large 
number of genes to be screened for a specific phenotype of interest, however, genes with 
redundant functions often fail to produce a visible phenotype when mutated (St Johnston, 2002, 
Brumby and Richardson, 2005). 
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Figure 1.4.1. The Gal4-UAS bipartite expression system. GAL4 gene expression is controlled 
by nearby genetic enhancers. A range of GAL4 enhancer lines are available which express the 
transcription activator in tissue- and temporal-specific patterns. The GAL4 protein binds to any 
UAS sites present in the Drosophila genome and any gene that lies immediately downstream of 
the activating sequence will be expressed in the same spatial and temporal pattern as the GAL4 
gene (Duffy, 2002, Adams and Sekelsky, 2002, St Johnston, 2002). 
 
This issue can be circumvented by performing mis-expression screens that exploit the yeast 
GAL4-UAS bipartite expression system to induce tissue specific ectopic gene expression (St 
Johnston, 2002, Adams and Sekelsky, 2002). In brief, P-elements carrying the yeast upstream 
activating sequence (UAS) element and a gene of interest are initially inserted into the 
Drosophila germline. Progeny that have the UAS construct incorporated into their genome are 
subsequently crossed to flies which, under the control of an endogenous promoter, express the 
yeast transcriptional activator GAL4 in a defined spatial and temporal pattern. Once expressed, 
GAL4 binds to the UAS site and enables expression of any gene that lies immediately 
downstream of the activating sequence in the same tissue/temporal specific pattern (Figure 1.4.1) 
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(Duffy, 2002, Adams and Sekelsky, 2002, St Johnston, 2002). It is also possible to knockdown 
expression of genes by using the GAL4-UAS system to express double-stranded hairpin RNA 
resulting in sequence-specific post-translational silencing of the targeted gene through RNAi 
(Duffy, 2002). This allows a number of genes of interest to be overexpressed or silenced in 
relevant specific tissues, permitting easy screening for phenotypic changes. Any genes producing 
a phenotype of interest can then be used to identify further genes acting in the same pathway. 
This is achieved by analysing the ability of other genes to enhance or suppress the original 
phenotype (St Johnston, 2002, Adams and Sekelsky, 2002). 
 
Once genes regulating a biological process of interest have been identified, further analysis using 
similar techniques can be performed to characterise the proteins they encode. For example, 
overexpression or knockdown studies can be carried out using the GAL4-UAS system to examine 
the effects of ectopic protein expression within a range of different tissues (Brand and Perrimon, 
1993, Duffy, 2002). Similarly, known homologues of the genes of interest can be ectopically 
expressed to determine if they can produce similar phenotypes. Lastly, modified proteins 
produced by in vitro genetic alterations can be expressed, enabling examination of the various 
binding domains and post translational modification sites' responsibility in correct protein 
function.  
 
In addition to whole tissue or organism expression analysis, techniques have been developed that 
allow small areas of cells containing genetic alterations to be produced in a wild type 
background. This mosaic patterning is created using the FLP recombinase – FLP recombinase 
target (FLP/FRT) system, and can be exploited to allow both mis-expression and homozygous 
mutant clones (Golic, 1991). Briefly, tissue or developmental specific expression of the yeast 
FLP recombinase drives mitotic recombination between two FRT sites present on homologous 
chromosome arms. If one chromosome arm contains a mutant allele of the gene of interest, 
clones of homozygous mutant cells can be produced (Figure 1.4.2.a) (Theodosiou and Xu, 1998). 
On the other hand, mis-expression clones are generated by coupling the FLP/FRT recombination 
system with the UAS-GAL4 system. In this instance, induction of FLP recombinase induces 
recombination between two FRT sites flanking a reporter/silencer cassette. The excision of this 
cassette brings the GAL4 gene in trans with a constitutive promoter enabling expression of 
33 
 
GAL4, which in turn drives the expression of any UAS-linked genes (Figure 1.4.2.b) (Theodosiou 
and Xu, 1998). 
 
 
 
Figure 1.4.2. Generating mosaic clones using FLP/FRT-mediated mitotic recombination. (a) 
Expression of the FLP enzyme can induce recombination between FRT sites on homologous 
chromosomes, enabling daughter cells homozygous for a mutant allele to be generated. (b) 
Conversely, activation of FLP can initiate recombination between two FRT sites flanking a 
reporter/silencer cassette leading to its excision. This brings the GAL4 gene in trans with a 
constitutive promoter enabling expression of GAL4, and in turn UAS-linked genes (Theodosiou 
and Xu, 1998). 
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1.5. Research Aims 
 
The overarching aim of the research presented in this report was to elucidate the molecular 
mechanisms by which the Drosophila MRL homologue Pico functions to promote tissue 
overgrowth and identify the pathways involved in the regulation of its function. Due to the 
notable homology between the MRL proteins in flies and higher eukaryotes, it was anticipated 
that any insights obtained would be of use in guiding future studies within more complex 
systems, such as mammals. As a first step towards understanding Pico's role as an adapter 
protein and the potential mechanisms involved in its regulation, bioinformatic software was 
utilised to identify novel binding motifs and characterise the key functional domains present 
within MRL proteins. The findings from this work was then used in the development of site-
directed pico mutants affecting motifs deemed fundamental to Pico's role in the hope of 
disrupting or altering their function. The ability of wild type or mutant Pico variants to interact 
with a selection of actin modifying and regulatory proteins then was assessed through co-
immunoprecipitation assays. Due to the ectopic nature of these experiments, additional 
investigations were also carried out to confirm whether endogenous Pico was expressed within 
the same tissues as the associated proteins, and therefore have the potential to naturally come 
into contact in vivo. Lastly, as a means of identifying novel interaction partners not previously 
described in the literature, mass spectrometry was also employed on Pico pulldowns. 
 
The next objective was to ascertain the subcellular localisation of Pico and determine if any of 
Pico's interactions contributed to its positioning. This was achieved by analysing the location of 
fluorescently tagged Pico wild type and mutant constructs within Drosophila cells spreading 
across a substrate. Co-localisation studies were also performed via immunostaining to visualise 
the endogenous proteins.  
 
The final aim of this project was to determine the ability of pico mutants to induce overgrowth of 
the developing Drosophila wing. These data were collated with findings from interaction and 
localisation studies to identify putative roles for the domains of Pico investigated in this thesis. 
This subsequently enabled a preliminary model for the regulation of Pico by a phosphorylation 
cascade involving MAPK and PP1 to be proposed. 
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2. Materials and methods 
 
2.1. Commonly used media and solutions 
 
LB (Lysogeny broth) Media: 
LB medium required for growth of bacterial strains was composed of 1.0% Tryptone, 0.5% 
Bacto-yeast Extract, and 1.0% NaCl dissolved in RO water with a pH of 7.0. The resultant 
solution was autoclaved before use. 
 
LB Agar: 
LB agar required for growth of bacterial strains on solid plates was comprised of 1.0% Tryptone, 
0.5% Bacto-yeast Extract, 1.0% NaCl, and 1.6% agar dissolved in RO water with a pH of 7.0. 
The mixture was autoclaved and left to cool to 55°C before an appropriate antibiotic was added 
and the mixture poured into plates to set.  
 
SOC (Super Optimal Broth) media:  
SOC media is a nutrient-rich bacterial broth enabling heightened transformation efficiencies of 
plasmids. It was comprised of 2.0% Tryptone, 0.5% Bacto-yeast Extract, 0.05% NaCl, and 2.5 
mM KCl dissolved in RO water and possessing a pH of 7.0. The solution was autoclaved before 
the addition of 1 mM MgCl2 and 20mM glucose. 
 
Complete S2 Media:  
The complete medium required for S2 cells is Schneider’s Drosophila Medium (Sigma) 
modified with 10% (v/v) heat-inactivated Foetal Calf Serum (FCS) (Sigma) and Penicillin-
Streptomycin (Invitrogen) to a final concentration of 50 units Penicillin G and 50 µg 
Streptomycin sulphate per millilitre of medium. 
 
Kinase Buffer:  
Kinase buffer was used to assay protein kinase activity and contains 50 mM Tris-HCl, 100 μM 
ATP, 10 mM MgCl2, 1 mM EGTA (Ethylene Glycol Tetraacetic Acid), 2 mM DTT 
(Dithiothreitol), and 0.01% Brij 35. 
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TE Buffer:  
TE buffer was used to solubilise DNA or RNA, while protecting it from degradation and 
contains 10 mM Tris-Cl pH 7.5 and 1 mM EDTA (Ethylenediaminetetraacetic acid). 
 
RIPA (Radio-Immunoprecipitation Assay) Buffer:  
RIPA buffer enabled efficient cell lysis and protein solubilisation while avoiding protein 
degradation and interference with the proteins immunoreactivity and biological activity. It was 
composed of 50 mM Tris (pH 7 - 8), 150  mM NaCl, 0.1% SDS (Sodium Dodecyl Sulfate), 0.5% 
sodium deoxycholate, and 1% Triton X 100. 
 
ChromoTek lysis buffer:  
ChromoTek lysis buffer has been optimised by the manufacturer for GFP-Trap co-
immunoprecipitation and enables efficient cell lysis and protein solubilisation while avoiding 
protein degradation and interference with the proteins immunoreactivity and biological activity. 
It contains 10 mM Tris/Cl pH 7.5, 150 mM NaCl, 0.5 mM EDTA, and 0.5% NP-40. 
 
2x SDS-Sample Buffer:  
2x SDS-Sample buffer was used for preparation and loading of protein samples into an SDS-
polyacrylamide gel for SDS-PAGE and Western blotting. It was composed of 50 mM Tris-Cl 
pH6.8, 100 mM dithiothreitol, 2% SDS, 0.1% bromophenol blue, and 10% glycerol. 
 
1x SDS-PAGE Running Buffer:  
1x SDS-PAGE running buffer enables protein separation by SDS-polyacrylamide gel 
electrophoresis to occur and was comprised of 25 mM Tris, 250 mM glycine pH 8.3, and 0.1% 
SDS. 
 
Coomassie Staining Solution:  
Coomassie stain is used to visualise proteins within polyacrylamide gels and is made up of 0.1% 
Coomassie G-250, 10% acetic acid, and 40% methanol. 
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Coomassie Destaining Solution:  
Coomassie destain was used to enhance visualisation and clarity of coomassie stained proteins 
within polyacrylamide gels and was composed of 20% methanol and 10% acetic acid. 
 
Tris-glycine Transfer Buffer:  
Tris-glycine transfer buffer allows protein transfer from SDS-polyacrylamide gels to a solid 
phase support, such as nitrocellulose or PVDF membranes. The solution was comprised of 25 
mM Tris, 193 mM glycine, and 20% methanol. 
 
PBS (Phosphate Buffered Saline)/PBST:  
PBS is a buffer solution designed to replicate the osmolarity and ion concentrations of normal 
cells and was composed of 137 mM NaCl, 2.7 mM KCl, 8 mM Na2HPO4, and 1.46 mM 
KH2PO4. PBST is made up of 1 x PBS with 0.1% Tween-20. 
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2.2. Commonly used strains 
 
2.2.1. Bacterial lines utilised 
 
One Shot® Top 10 chemically competent E. coli (Invitrogen) 
F- mcrA ∆(mrr-hsdRMS-mcrBC) φ80lacZ∆M15 ∆lacX74 recA1 araD139 ∆(ara-leu) 7697 
galU galK rpsL (StrR) endA1 nupG 
 
One Shot® ccdB Survival™ 2 T1R competent cells (Invitrogen) 
F
-
mcrA Δ(mrr-hsdRMS-mcrBC) Φ80lacZΔM15 ΔlacX74 recA1 araΔ139 Δ(ara-leu) 7697 
 galU galK rpsL (Str
R
) endA1 nupG fhuA::IS2 
 
Growth and storage of bacterial cells were as described in Sambrook (2001) unless stated 
otherwise. Frozen stocks were generated by adding 50% filter-sterilised glycerol to cell cultures 
to give a final concentration of 15% and stored at -80ºC. Ampicillin and kanamycin were 
prepared as 100 mg/ml and 50 mg/ml filter-sterilised stock solutions respectively and stored at -
20ºC. Ampicillin was used at a concentration of 100 µg/ml and kanamycin used at 50 µg/ml. 
 
2.2.2. Cell lines used 
 
Drosophila Schneider (S2) Cells 
Drosophila Schneider (S2) cells are a cell line derived from a primary culture of late stage (20-
24 hours old) Drosophila melanogaster embryos and formed a loose, semi-adherent monolayer 
in tissue culture flasks (Schneider, 1972).  
 
Drosophila Schneider Receptor + (S2R+) Cells 
Drosophila Schneider Receptor + (S2R+) cells are a line, again derived from the Schneider lab, 
which possess the wingless receptors Dfrizzled-1 and Dfrizzled-2 and formed a highly adherent 
monolayer in tissue culture flasks (Yanagawa et al., 1998).  
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The cells were initiated, maintained and stored using the following procedures: 
 
Initiating cultures from frozen stocks: 
To initiate cultures from a frozen stock, cells were quickly thawed at 30ºC and transferred to a 
25cm
2
 flask containing 5 ml of room temperature Complete S2 Medium. The cells were then 
incubated at 28ºC for 30 minutes before being resuspended and centrifuged at 1000 x g for 5 
minutes. The medium was decanted to remove DMSO, and the cells plated in 5 ml fresh 
Complete S2 Medium in a new 25cm
2 
flask. The cells were incubated at 28ºC for 3-4 days until 
they reached a density of 6-20 x 10
6 
cells/ml. 
 
Passaging S2 cells: 
When cells reached an optimum density of 6–20 x 106 cells/ml, the conditioned medium was 
pipetted up and down several times to break up clumps of cells and wash the surface of the flask 
to remove adherent cells. The cells were split at a 1:2 to 1:5 dilution into new culture vessels and 
fresh Complete S2 Medium added to create a final density of 2-4 x 10
6
 cells/ml. The cells were 
then incubated at 28ºC until an optimum density was reached. 
 
Freezing S2 cells: 
To create a frozen stock, cells were grown to a density of 1-2 x 10
7
 cells/ml and pelleted by 
centrifuging at 1000 x g for 5 minutes. The cells were then washed in 10 ml PBS and pelleted 
again before being resuspended at a density of 1.1 x 10
7
 cells/ml in Freezing Medium (45% 
conditioned Complete S2 Medium, 45% fresh Complete S2 Medium, and 10% DMSO). 1 ml of 
the cell suspension was aliquoted per vial and the cells were frozen in a control rate freezer to -
80ºC for 24 hours before being transferred to liquid nitrogen for long term storage. 
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2.2.3. Drosophila stocks employed 
 
act5C-GAL4 
w; 13B/CyO; act5C-GAL4/MKRS 
Expresses GAL4 ubiquitously in the pattern of the Act5C gene. 
 
da-GAL4 
w; 13B/CyO; da-GAL4/MKRS 
Ubiquitous expression of GAL4 under the control of daughterless. 
 
enGAL4 
w; enGAL4/CyO 
Expresses GAL4 in the posterior compartment of embryonic segments in the pattern of the 
engrailed gene. 
 
hsGAL4 
w; hsp70-GAL4/ hsp70-GAL4 
Heat shock inducible ubiquitous expression of GAL4. 
 
MS1096-GAL4 
MS1096-Gal4 on X 
Expresses GAL4 across the wing pouch in early third instar larval wing discs and predominantly 
in the in dorsal half of the wing disc in mid-late third instar larvae. 
 
Fly stocks were kept at 18ºC or 25ºC on standard yeast/dextrose medium (1% (w/v) agar, 7.3% 
(w/v) dextrose, 5% (w/v) yeast, 6.7% (w/v) organic wholemeal flour, 0.25% (v/v) nipagin, 0.3% 
(v/v) propionic acid) in 30/50ml vials or 250ml bottles as appropriate. Flies were anaesthetised 
with CO2 and examined using Nikon SMZ-645 or Nikon SMZ-800 microscopes and Photonics 
200 lightsources using standard fly-pushing techniques
 
(Roberts, 1998, Greenspan, 2004). All fly 
stocks described were obtained from the Bloomington Drosophila Stock Centre 
(http://flystocks.bio.indiana.edu) unless stated otherwise. 
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2.3. Bioinformatic analysis 
 
2.3.1. Identification and alignment of MRL family proteins 
 
BLAST (Basic Local Alignment Search Tool) analysis was performed on human Lpd, human 
RIAM, C. elegans MIG-10, and Drosophila Pico protein sequences using the NCBI 
(http://blast.ncbi.nlm.nih.gov/), Uniprot (http://www.uniprot.org/), and Ensemble (http://www. 
ensembl.org/) databases to identify corresponding homologues within a range of apposite 
species. T-Coffee accurate, an enhanced version of the multiple sequence alignment T-Coffee 
package incorporating additional 3D structural and homology extension algorithms, was 
employed to align the MRL sequences discovered during the BLAST searches (Notredame et al., 
2000, Armougom et al., 2006, Di Tommaso et al., 2011). As a means of manually assessing the 
accuracy of the alignments, BOXshade 3.21 (http://www.ch.embnet.org/software/ 
BOX_form.html) and Ali2D 2.17 (http://toolkit.tuebingen.mpg.de/ali2d) were used to assess 
respective sequence and secondary structure homology between the aligned sequences, allowing 
adjustments to be made when necessary. 
 
2.3.2. Phylogenetic analysis 
 
MRL alignments from T-Coffee accurate were assessed for pairwise distances using Tree-Puzzle 
5.2 (Schmidt et al., 2002) and the outcomes analysed further with the distance based phylogeny 
reconstruction algorithm FastME 2.07 (Desper and Gascuel, 2002). The highly accurate PHYML 
3.0 algorithm (Guindon et al., 2010), commonly used to estimate large phylogenies by maximum 
likelihood, was then utilised to enhance precision before the resulting tree was visualised by 
FigTree 1.4 (http://tree.bio.ed.ac.uk/software/figtree/). 
 
2.3.3. Domain conservation/sequence analysis 
 
Individual T-Coffee accurate alignments were generated for the single orthologue, Lpd, and 
RIAM groupings alone, in addition to the complete MRL alignments from Chapter 2.3.1. These 
alignments were analysed by Plotcon (EMBOSS) to ascertain the extent of conservation between 
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the sequences using the EBLOSUM62 scoring matrix and a window size of 16. Those areas 
displaying a high degree of sequence similarity were then assessed using the ELM (Eukaryotic 
Linear Motif) resource which, in addition to utilising the more standard SMART/Pfam, 
GlobPlot, and IUPred searches, identifies short linear motifs within unstructured protein regions 
(Dinkel et al., 2012, Davey et al., 2012).  
 
2.4. Phosphorylation site analysis 
 
2.4.1. Peptide array design and production 
 
A peptide array was designed consisting of diminutive 15mer peptides representing every serine, 
threonine and tyrosine residue contained within Pico. The residue to be assessed was positioned 
in the centre of each short peptide to increase the opportunity for prospective target sequences 
flanking either side to be recognised, while substituting the amino acid with a suitable alanine or 
phenylalanine acted as a negative control. As some peptide regions contained more than one 
potentially phosphorylatable residue, control peptides were also included whereby serine, 
threonine or tyrosine residues not under investigation were replaced with an appropriate alanine 
or phenylalanine. A further set of peptides containing specific consensus target sequences for a 
variety of MAPKs was included to act as a positive control. The complete list of 598 peptide 
sequences proposed for use in this study can be found in Appendix 2. The peptide array was 
synthesised using the SPOT-synthesis technique (Frank, 2002) by the Peptide Synthesis Core 
Technology Facility (CRUK London Research Institute). 
 
2.4.2. Kinase phosphorylation analysis 
 
The peptide array was thoroughly moistened in ethanol before being incubated overnight at room 
temperature in Kinase buffer (New England Biolabs) supplemented with 0.2 mg/ml BSA 
(Bovine Serum Albumin) (Sigma) and 100 mM NaCl, but lacking ATP. The membrane was then 
incubated in 15 ml blocking solution consisting of 1x Kinase Buffer with 1 mg/ml BSA (New 
England Biolabs) and 100 mM NaCl at 30˚C for 45 minutes after which the array was exposed to 
13 ml Kinase buffer (New England Biolabs) supplemented with 0.2 mg/mL BSA, 120 units of an 
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appropriate kinase, and 24μCi γ-32P-ATP for 2 hours at 30˚C. Ten 15 minute washes in 1 M 
NaCl, three 5 minute washes in H3PO4, three 5 minute washes in distilled water, and two 2 
minute washes in 100% ethanol were performed. The membrane was allowed to air dry before 
being wrapped in Saran wrap, placed on a phosphor cassette overnight, and subjected to 
autoradiography analysis using a Storm 860 Phosphorimager (GE Healthcare). 
 
2.4.3. Phosphatase analysis 
 
The peptide array was thoroughly moistened in ethanol before being incubated overnight at room 
temperature in NEBuffer for PMP (Protein MetalloPhosphatases) (New England Biolabs). The 
membrane was then incubated in 15 ml PMP buffer (New England Biolabs) supplemented with 1 
mM MnCl2 and either 10 units of activated PP1 (New England Biolabs) or 2000 units of active λ 
Phosphatase (New England Biolabs) for 2 hours at 30˚C. Ten 15 minute washes in 1 M NaCl, 
three 5 minute washes in H3PO4, three 5 minute washes in distilled water, and two 2 minute 
washes in 100% ethanol were performed. The membrane was allowed to air dry before being 
wrapped in Saran wrap, placed on a phosphor cassette overnight, and subjected to 
autoradiography analysis using a Storm 860 Phosphorimager (GE Healthcare). 
 
2.5. Polymerase Chain Reaction (PCR) 
 
Synthetic oligonucleotides complementary to the ends of the nucleotide sequence were designed 
in the region to be amplified, while annealing temperatures were ascertained using the formula 
TA = (2 x TA) + (4 x GC). Repeated cycles of heating, primer hybridisation and DNA synthesis 
allow the nucleotide sequence flanked by the two oligonucleotides to be selectively amplified 
exponentially. All PCR reactions were performed using a Technie TC-512. The reaction mixes 
and typical cycling programs are given below: 
 
Reaction mixes 
Taq Polymerase (Qiagen) 20 μl reaction mix 
10x reaction buffer - 2.0 μl; 100 mM dNTPs - 0.6 μl; Forward Primer - 1.0 μl; Reverse Primer - 
1.0 μl; Template DNA – 10 pg – 200 ng; Taq Polymerase (5 units/μl) - 0.3 μl; ddH2O to 20 μl. 
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Platinum
®
 Pfx DNA Polymerase (invitrogen) 20 μl reaction mix 
10x reaction buffer - 2.0 μl; 50 mM MgSO4 – 0.4 μl; 100 mM dNTPs - 0.6 μl; Forward Primer - 
1.0 μl; Reverse Primer - 1.0 μl; Template DNA – 10 pg – 200 ng; Pfx Polymerase (2.5  units/μl) 
- 0.3 μl; ddH2O to 20 μl. 
 
Typical Cycling Programs 
Two-step Cycling:  94ºC for 2 min 30sec, 
   92ºC for 20 sec,  
                                   68ºC for 1 min per kb*,  
                                  68ºC for 5 min 
   4 ºC forever 
 
Three-step Cycling:  94ºC for 2 min 30sec, 
                                   92ºC for 20 sec,  
                              Tm-5ºC for 45 sec,  
                             68ºC for 1 min per kb*, 
                             68ºC for 5 min 
   4ºC forever 
 
*Extension times were 1min/kb for Platinum
®
 Pfx polymerase (Invitrogen) at 68°C and 15-30 
sec/kb for Taq polymerase (Qiagen) at 72°C. 
 
2.6. List of oligonucleotides 
 
All oligonucleotides were designed according to general primer design guidelines 
(PremierBiosoft International) and synthesized by MWG Biotech. The lyophilised primers were 
diluted in TE buffer pH 8.0, to make 100 μM stocks and stored at -20 ºC. Dilutions of 10 µM and 
3.2 µM were used for PCR and sequencing reactions respectively. 
 
Primers for pico mutagenesis:  
-A270K-fwd: 5’ - CCGCCTGCTGAAGGACAAGAACCACGTGCAGATGCAGAG - 3’ 
x 35 
x 35 
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-A270K-rev: 5’ - GGTTCTTGTCCTTCAGCAGGCGGGTCACGTGTCCGC - 3’ 
-K272A-fwd: 5’ - GCTGGCCGACGCGAACCACGTGCAGATGCAG - 3’ 
-K272A-rev: 5’ - GCACGTGGTTCGCGTCGGCCAGCAGGCG - 3’ 
 
Primers for testing pico insertion:  
-M13-fwd: 5’ - TTGTAAAACGACGGCCAGTC - 3’ 
-M13-rev: 5’ - TGCCAGGAAACAGCTATGAC - 3’ 
-Pico-fwd: 5’ - GTAGCTCCAGCGGCATCAGC - 3’ 
-Pico-rev: 5’ - CGGCGTAGTTCATGGCCAGC - 3’ 
 
Sequencing primers for pico constructs:  
-Pico_Seq1: 5’ - GGCATGATGGTCCAACCGC - 3’ 
-Pico_Seq2: 5’ - GGGCTGCGGACACGTGACC - 3’ 
-Pico_Seq3: 5’ - CTGTTCCACGGCCACAACGTG - 3’ 
-Pico_Seq4: 5’ - ACGCCTTCGATAGCGAGTTC - 3’ 
-Pico_Seq5: 5’ - GCTGTCGCTGGCCTCCCTG - 3’ 
-Pico_Seq6: 5’ - TGAGCAGCCTGTCCAACGGC - 3’ 
-Pico_mut: 5’ - AACAGCTCCCACTACTACCG - 3’ 
 
2.7. Agarose gel electrophoresis 
 
DNA molecules were separated by size using agarose gel electrophoresis. Agarose gels were 
prepared and run as described in Sambrook (2001). Ethidium bromide (Sigma) was added to the 
gel at a final concentration of 0.2-0.5 μg/ml. Samples were diluted with 1 x loading buffer (10 x 
agarose loading buffer, 30% (v/v) glycerol, 0.35% (v/v) bromophenol blue) before being loaded 
on the gel. The samples were electrophoresed in 1 x TAE at 100 volts for 30-45 minutes, using a 
GIBCO BRL electrophoresis power supply and Fisher Brand gel tank. SmartLadder I 
(Eurogentec), a molecular weight marker, was used to determine DNA concentration as well as 
fragment size. The DNA fragments were visualised using an ultraviolet light source (Syngene) 
and documented with a PULNiX TM-300 video camera system and Syngene UP-895MD video 
graphic printer.  
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2.8. Gel extraction 
 
Desired DNA fragments were cut from the gel by scalpel blade and purified using the QIAquick 
Gel Extraction Kit (Qiagen) as per manufacturer’s instructions. Briefly, agarose is dissolved to 
release the DNA, which is then bound to an anion-exchange membrane before the purified DNA 
fragment is eluted in an appropriate volume of TE buffer. Due to the nature of the protocol, DNA 
could only be semi-quantified by gel electrophoresis. 
 
2.9. Restriction digestion 
 
Restriction digests were performed using enzymes and compatible buffers (New England 
Biolabs) according to the manufacturer’s guidelines. Typically, 20 μl reactions were carried out 
using 3 units of each enzyme and 0.1-2 μg of DNA. For double digests i.e. those containing two 
restriction endonucleases, buffers compatible with both enzymes were used. Reactions were 
typically incubated at 37ºC for 2 hours or overnight. 
 
2.10. DNA ligation 
 
Digested products were run on an appropriate percentage agarose gel and fragments extracted 
using the Gel extraction protocol (Chapter 2.8.). Complementary linear DNA fragments formed 
from digestion and extraction were ligated into circular plasmids using a T4 DNA ligase Kit 
(Roche). For ligation, two fragments totalling an approximate 3:1 molar ratio of insert:vector 
were used as per manufacturer’s instructions. The following equation was used to calculate 
appropriate amounts of DNA to use for a 3:1 molecular ratio: 
 
insertofngratiomolarvector:insert
vectorofsizekb
insertofsizekbvectorofng


 
 
Molecular ratios could be altered as needed depending on experimental success. One unit of T4 
DNA ligase was incubated with a total of 100 ng of DNA in T4 reaction buffer (Roche). 
Reaction volumes were kept at 20 µl as per manufacturers guidelines. Reaction mixtures were 
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incubated at 16°C for 20 hours before 2-4µl of the ligation reaction was transformed into One 
Shot® Top 10 chemically competent E. coli (Invitrogen). Ligations were screened by PCR and 
restriction digestion before sequencing was carried out. 
 
2.11. Gateway
®
 LR Recombination Reaction 
 
Gateway
®
 LR reactions were performed to shuttle the RNAi resistant Pico wild type and mutant 
construct ORFs (open reading frames) from the pDONR™221 entry vector into the desired 
destination vectors pTVW (UASt promoter, N-terminal Venus tag), pAVW (act5c promoter, N-
terminal Venus tag) (Drosophila Genomics Resource Center), and pMt-PtA (metallothionein 
promoter, N-terminal Protein A tag) (Paolo D’Avino-University of Cambridge). 50-150 ng of the 
entry clone containing the gene of interest was mixed with 150 ng of the destination vector and 
TE buffer pH 8.0, to give a final volume of 8 μl. The LR clonase II enzyme mix (Invitrogen) was 
thawed on ice for 2 minutes, vortexed briefly, then 2 μl of the enzyme mix was added to the 
reaction mix. Reactions were incubated at 25ºC for a minimum of 1 hour, although overnight 
incubation is recommended for large plasmids (over 10 kb). Following incubation, 1 μl of 
Proteinase K (Invitrogen) solution was added to the reaction mix and incubated at 37ºC for 10 
minutes to stop the reaction. 5 µl of the reaction mix was then transformed into One Shot® 
Top10 Chemically Competent Cells (Invitrogen). The transformed cells were plated onto 
ampicillin-LB agar plates and incubated at 37ºC overnight. Plasmids were extracted from 
colonies and screened by restriction digestion. 
 
2.12. Transformation of chemically competant cells 
 
For each transformation one vial of One Shot® Top10 Chemically Competent Cells (Invitrogen) 
or One Shot® ccdB Survival™ 2 T1R competent cells (Invitrogen) was thawed on ice and 1-5 µl  
of the DNA (10 pg to 100 ng) added and mixed gently. The cells were incubated on ice for 30 
minutes before being heat shocked at 42ºC for exactly 30 seconds. Following heat shock, the 
cells were placed on ice for two minutes and 250 µl of pre-warmed S.O.C Medium (Invitrogen) 
added to each vial. The vial(s) were then shaken horizontally at 225 rpm for 1 hour at 37ºC in a 
shaking incubator before each transformation reaction was spread on pre-warmed selective 
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plates. The plates were inverted and incubated overnight at 37ºC. The following day colonies 
were picked and isolated plasmids analysed by restriction digestion, PCR or sequencing. 
 
2.13. DNA extraction 
 
Small-scale plasmid purification (≤20 µg) was carried out using QIAprep Spin Miniprep Kits 
(Qiagen), while medium (≤100 µg) and large-scale (≤2.5 mg) plasmid purification was carried 
out using QIAfilter Plasmid Midi kits or Mega kits (Qiagen) respectively according to the 
manufacturer’s instructions. Briefly, cells grown overnight in selective LB media were lysed 
under alkaline conditions and clear cell lysates were applied to columns containing a silica gel 
membrane capable of binding DNA, yet allowing contaminants to be washed away. DNA was 
eluted from the columns with an appropriate volume of Qiagen Elution Buffer (Qiagen). The 
concentration of DNA obtained was then measured using a NanoDrop. 
 
2.14. DNA quantification 
 
DNA concentrations were quantified by the Thermo Scientific NanoDrop™ 1000 
Spectrophotometer. The NanoDrop uses a 1-2 µl sample held in place by surface tension of the 
liquid and measures absorbance of the sample over a 220nm-750nm spectrum, reporting DNA 
concentration and relative purity of the sample with 230/260 and 260/280 ratio measurements. 
The NanoDrop was able to measure samples up to 3700 µg/µl and so removed the need for serial 
dilution of DNA samples to ensure accurate measurement. DNA could also be semi-quantified 
by analysing the intensity of DNA run on an agarose gel compared to reference ladder of known 
concentration.   
 
2.15. DNA sequencing 
 
DNA sequencing was carried out by GATC, Germany (gmbH) (http://www. gatc-
biotech.com/en). Enough DNA was provided for a total of 6 reactions at a concentration of 30-
100 ng/µl in 20 µl of ultra pure ddH2O. Sequencing primers were designed with a theoretical 
melting temperature of 60°C and a Guanine/Cytosine composition as close as possible to 50%. 
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Sequencing analysis was performed with MegAlign software (DNA Star) which aligned results 
to predicted sequences allowing comparative assessments to be made. 
 
2.16. Insertion of constructs into flies 
 
Transgenic flies expressing the previously described Venus tagged Pico constructs under the 
control of the upstream activator sequence (UAS) were generated through P-element mediated 
germline transformation by Genetic Services, Inc (Cambridge, MA, USA) (Rubin and Spradling, 
1982, Sentry and Kaiser, 1992). The Pico constructs were injected into W
1118 
embryos along 
with the helper plasmid pUChsDelta2-3, which provided a source of P-element transposase.  
 
The progeny were screened for non-white eyes indicating that the constructs, which carried a 
white
+
 minigene, had successfully been transformed into the germline cells. The chromosome 
harbouring each independent insert was determined by crossing individual transgene-carrying 
males to w; Tft/CyO and then crossing the progeny to w; Tft/CyO; MKRS/TM6B. Each insert was 
then balanced with an appropriate, dominantly marked, balancer chromosome (Greenspan, 
2004). Verification and analysis of ectopic protein expression was carried out by visualisation of 
fluorescent Venus in larvae carrying the engrailed-GAL4 driver and one copy of the transgene of 
interest.  
 
2.17. Transfection of S2 and S2R+ cells 
 
2.17.1. Transient transfection with Effectine 
 
For transient transfection S2R+ cells were plated at 3.5 x 10
5
 in 4 ml growth media 
(approximately 60% confluency) in 6 well dishes. The cells were then transfected with Effectene 
as per manufacturer’s instructions (Qiagen). Briefly, 0.4 µg total plasmid DNA was condensed 
by interactions with 3.2 µl of Enhancer in EC Buffer to a final volume of 100 µl and incubated 
for 5 minutes. 10 µl Effectene Reagent was then added to the condensed DNA to produce 
condensed Effectene–DNA complexes. The Effectene–DNA complexes were mixed with 1.4 ml 
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medium to aid faster diffusion and directly added to the cells. Cells were incubated for 48 hours 
following transfection to enable suitable gene expression. 
 
2.17.2. Generating stable lines using Cellfectin 
 
3 x 10
6
 S2 cells were plated into each well of a 6 well dish in a final volume of 2 ml Complete 
S2 Medium without antibiotics. The cells were then allowed to adhere to the bottom of the plate 
for a minimum of 2 hours at 25ºC. A solution containing 5 µg of the pAVW Pico constructs and 
0.5 µg of the pCoBlast (Blasticidin reistance) plasmid (Invitrogen) in 0.1 ml Complete S2 
Medium without antibiotics was combined and mixed gently with a solution containing 15 µl 
Cellfectin (Invitrogen) in 0.1 ml Complete S2 Medium without antibiotics.  
 
The resultant mixture was incubated at room temperature for 30 minutes before 0.8 ml Complete 
S2 Medium without antibiotics was added. The 2 ml of original medium was then removed from 
the S2 cells and replaced with the new solution containing the DNA/Cellfectin mix. The cells 
were incubated overnight at 25ºC before the media containing the transfection mix was removed 
and replaced with 3 ml of fresh Complete S2 Medium (containing antibiotics). Following 
incubation at 25ºC for 48 hours, the old medium was removed and fresh Complete S2 Medium 
containing 20 µg/ml Blasticidin (Sigma) added.  
 
If the cells were in suspension, they were centrifuged at 1000 g for 5 minutes before the fresh 
medium was added. After 1-2 days the contents of each well were transferred into single 25cm
2
 
flasks in a final volume of 6 ml Complete S2 Medium containing 20 µg/ml Blasticidin. When 
the cells became over confluent they were transferred into single 75cm
2
 flasks in a final volume 
of 15 ml Complete S2 Medium containing 20 µg/ml Blasticidin. The cells were maintained 
using normal procedures and Complete S2 Medium containing 20 µg/ml Blasticidin. 
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2.18. Immunoprecipitation 
 
2.18.1. Pulldown of Myc/FLAG-tagged proteins 
 
Appropriate flies expressing Myc or FLAG tagged proteins were selected, snap frozen in liquid 
nitrogen, and then crushed before 0.5 ml of ice cold RIPA buffer was added. The flies were 
crushed further in the RIPA buffer until completely lysed and immediately place on ice. The 
resulting lysate was centrifuged for 10 minutes at 10,000 rpm at 4°C to pellet the fly debris 
before the supernatant was carefully removed using a pipette, transferred to a clean labelled 
eppendorf tube and set on ice. A small sample was taken as a positive control and 5 µl of anti-
Myc (A14) (Santa Cruz) or anti-FLAG (M2) (Sigma) was added to the eppendorf. The contents 
were then briefly mixed using a vortex mixer and subjected to over-end mixing for 1 hour at 
4°C. Before the hour long incubation was complete, 50 µl of EZview Red Protein G Affinity 
beads (Sigma) were added to a clean labelled eppendorf tube. 750 µl of ice-cold RIPA buffer 
was added to the beads and the solution briefly mixed using a vortex mixer. The tube was then 
centrifuged at 10,000 rpm for 30 seconds at 4°C and the supernatant removed and discarded. 
This washing process was performed two more times before the bead pellet was placed on ice.  
 
Once the hour long incubation of lysate with antibody was finished, the tube was briefly 
centrifuged for 2-3 seconds to collect the contents in the bottom of the tube. The entire sample 
was then removed, transferred to the tube containing the EZview beads, and the resulting 
solution mixed using a vortex mixer. The contents were then subjected to over-end mixing for 1 
hour in the cold room before being spun down at 10,000 rpm for 30 seconds at 4°C and placed 
on ice. The supernatant was removed and the beads washed three times in 750 µl of ice-cold 
RIPA buffer, after which 25 µl of ice-cold RIPA buffer and 25 µl of 2x SDS-sample buffer were 
added to the beads and the samples boiled for 10 minutes. The tube was again centrifuged at 
10,000 rpm for 30 seconds to pellet the beads and the supernatant directly loaded into a 
polyacrylamide gel for SDS-PAGE (Chapter 2.19.).  
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2.16.2. GFP-Trap mediated pulldown of Venus-Pico 
 
Flies expressing Venus-Pico were selected by detection of the Venus-tag under a fluorescent 
sterodissecting microscope, snap frozen in liquid nitrogen and then crushed. 200 µl of 
ChromoTek lysis buffer (ChromoTek) was added and the sample placed on ice before being 
repeatedly crushed every 5 minutes for 30 minutes. The lysate was then centrifuged at 10,000 
rpm for 10 minutes at 4°C to pellet the fly debris before the supernatant was carefully removed 
using a pipette, transferred to a clean labelled eppendorf tube and set on ice. The volume was 
adjusted to 500 µl with ice cold ChromoTek dilution buffer (ChromoTek) and 50 µl of sample 
removed to act as a positive control. Next, 20 µl of GFP-Trap beads were equilibrated by 
washing three times in 500 µl ice cold ChromoTek dilution buffer. Between each wash step the 
beads were pulled down using a DiaMag1.5 magnetic separator (Diagenode) and the supernatant 
removed. Once equilibrated, the Drosophila lysate was added to the beads and subjected to over-
end mixing for 2 hours at 4°C. 
 
Following the 2 hour incubation, the GFP-Trap beads were pellated using the magnetic separator 
and the supernatant removed. The beads were then washed five times 500 µl ice cold 
ChromoTek dilution buffer before being boiled for 20 minutes in 100 µl 2x SDS-Sample buffer. 
The beads were once again pulled down using the magnetic separator and the remaining 
supernatant loaded into a polyacrylamide gel for SDS-PAGE. 
 
2.16.2. Pulldown of SUBO-tagged peptides 
 
Hela and S2R+ cells were harvested and pelleted by centrifugation at 1000 x g for 5 minutes. 
The cell medium was removed and the pellet transferred to an eppendorf to which 0.5 ml of ice 
cold RIPA buffer was added. The cells were lysed for 20 minutes on ice and centrifuged at 
10,000 rpm for 10 minutes at 4°C to remove the cell debris. The supernatant was carefully 
removed using a pipette, transferred to a clean labelled eppendorf tube. Meanwhile, thirty W
1118
 
flies were collected, snap frozen in liquid nitrogen, and then crushed before 0.5 ml of ice cold 
RIPA buffer was also added. The flies were crushed further in the RIPA buffer until completely 
lysed and immediately place on ice. The resulting lysate was centrifuged for 10 minutes at 
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10,000 rpm at 4°C to pellet the fly debris before the supernatant was carefully removed using a 
pipette and transferred to a clean labelled eppendorf tube. 
 
200 μg of a SUBO-tagged RIAM fragment corresponding to residues 147-174 (Thomas 
Zacharchenko-University of Liverpool) was added to each of the lysates and the solutions 
subjected to over-end mixing at 4˚C for 2 hours. For each sample, 10 μl of SUMO-Qapture resin 
(Enzo Life Sciences) was equilibrated in separate eppendorfs by adding 500 µl ice cold RIPA 
buffer and mixing the solution briefly using a vortex mixer. The tubes were then centrifuged at 
10,000 rpm for 30 seconds at 4°C and the supernatant removed and discarded. This washing 
process was performed two more times before the resin pellet was placed on ice. 
 
Once the 2 hour incubation of lysates with SUBO-RIAM was finished, the tubes were briefly 
centrifuged for 2-3 seconds to collect the contents in the bottom of the tube. The entire samples 
were then removed, transferred to tubes containing the SUMO-Qapture resin, and incubated for 1 
hour at 4˚C with over-end mixing. Next the samples were spun down at 10,000 rpm for 30 
seconds at 4°C and placed on ice. The supernatant was then removed from each sample and the 
resin washed three times in 750 µl of ice-cold RIPA buffer, after which 25 µl of ice-cold RIPA 
buffer and 25 µl of 2x SDS-sample buffer was added to the resin and the samples boiled for 10 
minutes. The tubes were again centrifuged at 10,000 rpm for 30 seconds to pellet the beads and 
the supernatant directly loaded into a polyacrylamide gel for SDS-PAGE (Chapter 2.19.). 
 
2.19. SDS-PAGE 
 
Proteins were separated on the basis of molecular weight on SDS-polyacrylamide gels as 
described in Sambrook (2001). In brief, whole flies or third instar larvae were frozen in liquid 
nitrogen and then ground up in 2x SDS-Sample buffer. The resulting mixture was then boiled for 
10 minutes and centrifuged at 10,000 rpm for 3 minutes to remove debris. The supernatant was 
run on Tris-buffered SDS-polyacrylamide gels in 1 x SDS-PAGE Running Buffer, with the 
acrylamide concentration of the separating gel varying depending on the size of the proteins 
being separated. A pre-stained protein ladder (New England Biolabs) was employed to allow the 
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size of separated proteins to be estimated and Mini-Protean II Vertical Electrophoresis apparatus 
(Bio-Rad) was used according to the manufacturer’s instructions.  
 
2.19.1. Coomassie staining 
 
Following protein separation by SDS-PAGE gel electrophoresis, Coomassie staining was 
performed as a means of visualising proteins present at 0.5 μg or above within loaded samples. 
The polyacrylamide gel was initially removed from the glass plates and placed into a suitably 
sized container and rinsed once in ddH2O (Sambrook, 2001). The gel was then incubated with 
Coomassie stain solution for 1 hour on a rocking table before being rinsed again in ddH2O two 
more times. Next, the gel was incubated with Coomassie de-stain solution to remove excess dye 
from the background gel matrix. The de-stain solution was replaced every 30-60 minutes until a 
sufficient level of de-staining had been reached. 
 
2.19.2. Western blotting 
 
Following sufficient separation of proteins by SDS-PAGE, proteins were transferred overnight, at 
4ºC, to a pre-wetted Immobilon-P PVDF membrane (Millipore) in Tris-glycine transfer buffer, using 
Bio-Rad electrophoretic transfer apparatus as per the manufacturer’s instructions. After blotting, 
membranes were stained briefly with Ponceau S solution (Sigma Aldrich) to determine adequate 
electrophoretic transfer. The lanes were appropriately marked with a pencil and the membranes 
rinsed with water and PBST to remove the stain.  
 
Membranes were incubated in blocking buffer (PBST + 5% w/v Marvel skimmed milk powder) for 
90 minutes, at room temperature, to reduce non-specific binding of the antibody before being 
incubated a suitable primary antibody, diluted in blocking buffer, under optimised conditions 
detailed in Table 2.19.1. The membranes were then washed three times in PBST for 10 minutes and  
incubated with an appropriate horseradish peroxidase (HRP)-conjugated secondary antibody (Table 
2.19.2.), diluted in blocking buffer, for 90 minutes at room temperature. Next, the membranes were 
washed three times in PBST for 10 minutes and once in PBS for 10 minutes.  
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1˚ Antibody Supplier Species Concentration Conditions Predicted Size 
Myc (A14) Santa Cruz Rabbit 1:100 2 hrs at RT - 
FLAG (M2) Sigma Rabbit 1:300 2 hrs at RT - 
GFP (ABfinity) Invitrogen Rabbit 1:2000 O/N at 4˚C - 
GFP (12A6) DSHB Mouse 1:500 2 hrs at RT - 
Chickadee (chi 1J) DSHB Mouse 1:2000 O/N at 4˚C 18 kDa 
Talin (A22A) DSHB Mouse 1:2000 O/N at 4˚C 200-250 kDa 
Ras (05-516) Millipore Mouse 1:2000 2 hrs at RT 22 kDa 
Rap-1 (121) Santa Cruz Rabbit 1:500 O/N at 4˚C 24 kDa 
PP1 (3529) In-house Rabbit 1:2000 O/N at 4˚C 37 kDa 
Erk1/2 (137F5) Cell Signalling Rabbit 1:2000 2 hrs at RT 42-44 kDa 
pErk1 (ab24157) Abcam Rabbit 1:1000 O/N at 4˚C 42-44 kDa 
pPico (0140) In-house Rabbit 1:1000 O/N at 4˚C 124 kDa 
 
Table 2.19.1. Primary antibodies used in Western blots.  
 
N.B. Anti-GFP (12A6) used to detect Venus in Figure 5.5.1.a has only been available since April 
2013 and therefore could not be used for examination of Venus-Pico expression levels in flies or 
co-IP controls. 
 
2˚ Antibody Supplier Species Concentration Conditions 
Anti-mouse HRP Cell Signalling Goat 1:2000 2 hrs at RT 
Anti-rabbit HRP Cell Signalling Goat 1:2000 2 hrs at RT 
 
Table 2.19.2. Secondary antibodies used in Western blots. 
 
SuperSignal® West Pico chemiluminescent substrate (Pierce) was used according to the 
manufacturer’s instructions to detect the HRP-conjugated secondary antibodies. Light emitted 
from the chemiluminescent reagent was detected by exposure to Amersham Hyperfilm ELC (GE 
Healthcare Ltd) for 30 seconds to 2 hours depending on the signal intensity before the X-ray film 
was subsequently developed and fixed with Kodak developer/fix according to the manufacturer’s 
instructions.  
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2.20. Mass Spectrometry 
 
GFP-Trap mediated pulldowns of hs-GAL4 Venus-Pico
WT
 and W
1118
 were carried out and the 
beads from each sample split in separate eppendorf tubes. One half of the beads were boiled in 
50 μl 2x SDS-Sample buffer and directly loaded into a polyacrylamide gel for SDS-PAGE, while 
the other half were stored in 40 μl of 25 mM ammonium bicarbonate. Once SDS-PAGE was 
complete, the polyacrylamide gel was stained using the Coomassie staining protocol (Chapter 
2.19.1.) and used for SDS-PAGE mediated mass spectrometry. 
 
2.20.1. SDS-PAGE mediated mass spectrometry 
 
SDS-PAGE mediated mass spectrometry was carried out by Lynn McLean, (Protein Function 
Group, Institute of Integrative Biology). Briefly, excised bands (plugs) were de-stained with 50% 
acetonitrile/50% 100 mM ammonium bicarbonate. Gel plugs were reduced with 10 mM 
dithiothreitol for 30 minutes at 37°C, then alkylated for 60 minutes at 37°C in 55 mM 
iodoacetamide. The plugs were then dehydrated using acetonitrile at 37°C for 15 minutes. The 
acetonitrile was removed and the gel plugs allowed to dry. Finally, trypsin (0.02 μg/μl final 
concentration) was added and the digestion proceeded for 16 hours at 37°C. At the end of the 
digestion, the reaction was stopped and the surfactant inactivated and precipitated by addition of 
formic acid to a final concentration of 0.5%. Peptides were analysed using a Bruker Amazon ion 
trap mass spectrometer coupled to a Waters nanoACQUITY UltraPerformance liquid 
chromatography®
 
(UPLC®
 
) system. The samples were injected onto a reverse phase column 
(Acquity BEH C18, 75µm x 150mm 1.7µm) and eluted over a 1 hour gradient. The mass 
spectrometer was set up in positive ion mode and calibrated with Bruker calibration mix.  
Spectra were acquired between 300-1800m/z with an ICC target of 200,000. Up to five precursor 
ions above a threshold of 10,000 were selected for MSMS fragmentation per MS scan. Each 
precursor was fragmented twice and then the mass was excluded for 1 minute. Singly charged 
ions were excluded. Data was analysed using both Peaks and Mascot software. 
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2.20.2. Mass spectrometry of total pulldowns 
 
Mass spectrometry of total pulldowns was performed by Lynn McLean using the GFP-Trap 
magnetic beads stored in 40 μl of 25 mM ammonium bicarbonate. Briefly, 2.5 μl of 1% 
RapiGest
TM
 (Waters MS Technologies) was initially added to the samples and the solutions 
incubation at 80°C for 10 minutes. Samples were reduced with 2.5 μl of 60 mM dithiothreitol for 
10 minutes at 60°C and then alkylated for 30 minutes at room temperature in the dark, with 2.5 
μl of 180 mM iodoacetamide. Finally, trypsin (0.01 μg/μl final concentration) was added and the 
digestion proceeded for 16 hours at 37°C. At the end of the digestion, the reaction was stopped 
and the surfactant inactivated and precipitated by addition of trifluoroacetic acid to a final 
concentration of 0.5%. After incubating for 45 minutes at 37°C, samples were clarified by 
centrifugation at 15,000 x g for 15 minutes. Digests were analysed as tryptic peptides, resolved 
by high resolution liquid chromatography (Waters nanoAcquity) prior to tandem mass 
spectrometry on a Thermo LTQ-Orbitrap Velos system. For each digested sample analysed by 
LC MS, 1 μl was injected onto a 75μm x 150 mm BEH C18 column and the peptides resolved 
over a 90 minute linear organic gradient of 3-40% buffer B (0.1% FA in acetonitrile). Data 
acquisition was data dependent, with the top 20 most intense peptides in each MS scan selected 
for fragmentation. Data was analysed using Peaks and Mascot searches. 
 
2.21. S2R+ spreading on ConA coated substrates 
 
500 μl of 15 μg/ml Concanavalin A (Sigma) was plated onto glass bottomed 6-well dishes 
(IWAKI) and allowed to dry overnight at room temperature. 2 ml of S2R+ cells at 2x10
5
 cells/ml 
were plated into each well and allowed to adhere for either 20 or 30 minutes before being fixed 
in 10% paraformaldehyde in PBST for 10 minutes.  
 
2.21.1. Staining S2R+ cells 
 
The fixed cells were subjected to three 10 minutes washes with PBS and then blocked with 
PBST + 5% FCS for a minimum of two hours at 4ºC. Cells were then incubated with primary 
antibodies diluted in PBST + 5% FCS (Table 2.21.1.) overnight at 4ºC before being washed a 
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further three times for 20 minutes in PBST. Secondary antibodies were diluted in PBST + 5% 
FCS (Table 2.22.2.), added to the wells and incubated at room temperature in the dark for two 
hours. The cells were then subjected to a further three 15 minute PBST washes and one 15 
minute wash in PBS. Lastly, 0.5 ml of mounting medium (85% glycerol, 2.5% n-propylgallate) 
was added to each well and the dishes stored in the dark for no longer than a week at 4ºC. 
 
1˚ Antibody Supplier Species Concentration 
Chickadee (chi 1J) DSHB Mouse 1:1000 
Enabled (5G2) DSHB Mouse 1:2000 
Talin (A22A) DSHB Mouse 1:1000 
Ras (05-516) Millipore Mouse 1:200 
Erk1/2 (137F5) Cell Signalling Rabbit 1:200 
PP1 (0140) In-house Rabbit 1:500 
 
Table 2.21.1. Primary antibodies used in S2R+ staining.  
 
1˚ Antibody Supplier Species Concentration 
Anti-mouse AF555 Invitrogen Goat 1:500 
 
Table 2.21.2. Secondary antibodies used in S2R+ staining. 
 
2.22. Wing disc dissection and staining 
 
Wing imaginal discs were dissected from wandering third instar larvae in cold PBS, transferred 
to a watchglass, and fixed with 4% paraformaldehyde in PBST for 20 minutes at room 
temperature. The tissues were subjected to three 10 minutes washes with PBS and then blocked 
with PBST + 5% FCS for a minimum of two hours at 4ºC. The wing discs were then incubated 
with primary antibodies diluted in PBST + 5% FCS (Table 2.22.1.) overnight at 4ºC before being 
washed a further three times for 20 minutes in PBST. Secondary antibodies were diluted in 
PBST + 5% FCS (Table 2.22.2.), added to the tissues and incubated at room temperature in the 
dark for two hours. The tissues were then subjected to a further three 15 minute PBST washes 
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and one 15 minute wash in PBS. Lastly, the wing discs were mounted on microscope slides in 
17.5 µl of Vectashield mounting medium (Vector Laboratories) and covered with a raised 
coverslip. The sides were sealed with clear nail polish and slides stored in the dark for no longer 
than a week at 4ºC. 
 
1˚ Antibody Supplier Species Concentration 
Pico (3531) In-house Rabbit 1:1000 
Chickadee (chi 1J) DSHB Mouse 1:2000 
Enabled (5G2) DSHB Mouse 1:2000 
Talin (A22A) DSHB Mouse 1:1000 
Ras (05-516) Millipore Mouse 1:500 
Erk1/2 (137F5) Cell Signalling Rabbit 1:500 
PP1 (0140) In-house Rabbit 1:2000 
 
Table 2.22.1. Primary antibodies used in wing disc staining.  
 
1˚ Antibody Supplier Species Concentration 
Anti-rabbit AF488 Invitrogen Goat 1:500 
Anti-mouse AF555 Invitrogen Goat 1:500 
 
Table 2.22.2. Secondary antibodies used in wing disc staining. 
 
2.23. Confocal microscopy 
 
Tissues prepared using the above immunostaining protocols were examined using an LSM 710 
confocal microscope (Zeiss) and Zen 2011 confocal software (Zeiss). GFP and Venus fusion 
proteins were excited at 488nm using an argon laser and Cy3 conjugates excited with a He/Ne 
laser operating at 561nm. Fluorescence was measured by the 32-channel internal detector and 
images visualised using Zen 2011 Lite (Zeiss). S2R+ cells were imaged using 2 μm slices while 
wing discs were assessed by multiple 2.5 μm sliced z-stacks. 
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Quantification of the relative fluorescence intensity was carried out using the linear plot profile 
tool within ImageJ (National Institute of Health) and data analysed within Microsoft Excel 2010. 
Maximal Venus-Pico intensity within S2R+ cells was calculated by averaging the six highest 
intensity values reported in the linear plot profile results. 
 
2.24. SRF luciferase assay 
 
SRF-luciferase assays were carried out using the Qiagen Cignal SRE Reporter Kit and Dual-
Glo® Luciferase Assay System (Promega) as per manufacturer’s instructions. Briefly 2x104 
S2R+ cells were plated into individual wells in a 96-well plate and transfected with 100 ng pA-
renilla and 100 ng SRE-firefly either alone as a control, or alongside 200 ng of a vector of 
interest using Effectine (Qiagen). Triplicate transfections were carried out on the same batch of 
cells to minimise variability among treatment groups after which the cells were incubated for 48 
hours enable suitable gene expression. Cells were then lysed in 20 μl Passive Lysis Buffer 
(Promega) for 15 minutes at room temperature on an orbital shaker before the lysate was 
transferred to a new 96-well plate. 100 μl of Luciferase Assay Reagent II (Promega) was added 
to each well and analysis carried out using an automated luminometer to record the firefly 
luciferase activity. Next, 100 μl of Stop & Glo® Reagent (Promega) was added to the wells and 
analysis of the Renilla luciferase activity performed using the automated luminometer. Firefly 
luciferase activity was divided by Renilla luciferase activity to determine the degree of SRF 
activity. Single factor Anova tests were then performed on the data to determine if there were 
statistically significant differences between groups (p-values less than 0.05 were deemed 
statistically significant. 
 
2.25. Wing size analysis 
 
For wing preparations, appropriate adult flies were stored in 75% ethanol for at least 24 hours to 
dehydrate and preserve the wings. Wings were removed from flies using dissection tweezers 
(Dumont Medical) and placed on a microscope slide to dry. Twenty-five wings, from individual 
flies, were dissected per genotype. Once dry, the wings were transferred to a small drop of 
mounting medium (1:1 methylsalicylate/ Canada balsam) where air bubbles could be removed. 
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The wings were then transferred to a fresh 15μl drop of mounting medium on a new slide and 
covered with a coverslip. The slides were examined using a Leica MZ10F microscope. A Leica 
DFC420 digital camera and Leica application suite software (Version 2.8.1) were used to take 
images of the tissues. Wing areas were measured using the polygon tool within ImageJ to mark 
the area of the wing to be measured, and the area calculated using the measurement function. The 
wing blade but not the wing hinge was included in this measurement as shown in Figure 2.25.1. 
T-tests were carried out to validate apparent mean differences and p-values of less than 0.05 
considered to be statistically significant. 
 
 
 
Figure 2.25.1. Example of wing size analysis in ImageJ. The wing blade but not the wing 
hinge was used to calculate the tissue size of adult Drosophila wings. 
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3. Bioinformatic analysis of the MRL family 
 
3.1. Introduction 
 
The MRL family constitutes a group of molecular adaptor proteins which facilitate the 
transduction of signals derived from membrane receptors to changes in cytoskeletal dynamics, 
enabling regulation of cell shape, adhesion, migration and growth (Krause et al., 2004, Lafuente 
et al., 2004, Lyulcheva et al., 2008). As adapter proteins, the MRLs possess numerous protein 
and lipid binding domains, but have no intrinsic enzymatic activity, instead functioning by 
bringing specific binding partners into close proximity to enhance and control the cellular 
response to signalling events.  
 
Previous research has already identified and characterised many of these binding domains, with 
the most notable being the highly conserved and well defined central RA and PH domains 
(Figure 3.1.1.) (Colo et al., 2012b). Briefly, the RA domain has been shown to directly interact 
with specific Ras-like GTPases and is thought to play a crucial role in activation of the MRL 
protein or its other associated factors, while the PH domain binds to PIs and is believed to enable 
recruitment of MRL protein complexes to the plasma membrane (Holt and Daly, 2005, Krause et 
al., 2004). Adjacent to the N-terminus of the RA domain, MRL proteins contain a characteristic 
putative coiled-coil motif which is thought to promote homo- or hetero-dimeric interactions, 
although the biological function of this interaction has yet to be ascertained (Chang et al., 2013, 
Legg and Machesky, 2004, Lupas, 1996).  
 
In addition, the MRL proteins possess a relatively unstructured proline rich C-terminus with 
multiple FPPPP and XPPPP motifs allowing interactions with the actin regulatory proteins 
Ena/VASP and Profilin respectively (Krause et al., 2004, Lafuente et al., 2004). Amphipathic 
helical structured talin binding sites have also been identified within the first 100 amino acids of 
RIAM and Lpd, and are thought to assists in linking associated proteins to FAs (Lee et al., 2009, 
Han et al., 2006). Lastly, a PP1 binding motif has been found within a C-terminal proline rich 
region of Pico and most likely functions in regulating the activity of either Pico or its interaction 
partners (Lyulcheva, 2006). 
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Figure 3.1.1. A schematic representation of the MRL family functional domains. The MRL 
proteins all possess central RA and PH domains in addition to an unstructured proline rich C-
terminus (P) and a putative coiled-coil motif (CC) adjacent to the RA domain. Talin binding sites 
have also been identified within the first 100 amino acids of RIAM and Lpd. 
 
Taken together, it is clear to see how binding partner interactions may play a key role in MRLs 
functionality, with Ras and PP1 potentially assisting in the regulation of associated cytoskeletal 
modification proteins such as Enabled, Profilin and Talin. Consequently, to better understand the 
mechanisms through which the MRL proteins act, further comprehension of their domain 
structure must first be established so that fundamental interactions can be ascertained.  
 
3.1.1. Aims 
 
The aim of the research presented in this chapter was to characterise, through examination of 
conserved regions, key MRL binding domains with a view to identifying novel functional motifs 
present within the protein sequence. To perform this analysis effectively, MRL protein 
alignments were generated using BLAST identified sequences from a wide variety of 
multicellular eukaryotes. Phylogenetic analysis was performed on the alignments to confirm 
correct MRL sequence identification before investigating potential domain occurrence within 
those regions possessing a high level of sequence conservation. Further sequence analysis was 
carried out as a means of isolating potentially important binding motifs that displayed a 
conserved presence, but lacked consistent structural localisation. 
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3.2. Phylogenetic analysis of the MRL family 
 
Basic Local Alignment Search Tool algorithms were initially used to identify MRL homologues 
in a wide variety of species. Sequence alignments were then performed on all rational hits using 
the T-Coffee Accurate alignment tool before being manually assessed for accuracy with 
BoxShade and Ali2D. Lastly, a phylogenetic tree of the MRL proteins was generated using Tree-
Puzzle, FastME and PHYML. This was used to verify correct MRL sequence identification as 
well as accurately separate and categorise the Lpd and RIAM paralogues.  
 
Initial BLAST screening revealed no orthologues to be present in Protista, Plantae or Fungi 
kingdoms, indicating that the MRL proteins emerged exclusively during animal evolution. MRL 
homologues were identified in both Amphimedon queenslandica (sponge) and Trichoplax 
adherens (placazoa), suggesting MRLs emerged at an early stage in animal evolution. Tetraodon 
nigroviridis (pufferfish) and Danio rerio (zebrafish) represent the earliest organisms to possess 
the two paralogues Lpd and RIAM, while only a single orthologue was found in Ciona 
intestinalis (sea squirt), part of the phylum Chordata. This implies that the duplication event 
leading to two copies of the MRL gene occurred at some point during primitive vertebrate 
evolution. Interestingly, the recently sequenced early vertebrate Petromyzon marinus (lamprey) 
appears to have copies of both Lpd and RIAM, however, the protein sequence for both is 
currently incomplete (Smith et al., 2013) and was therefore not included in later analysis. 
 
Figure 3.2.1. shows a radial dendrogram of the phylogenetic tree generated (a rectangular 
arrangement can be found in Appendix 1). Three distinct groups can be clearly seen representing 
the single MRL orthologues (green), Lpd (red) and RIAM (blue), enabling accurate classification 
of the Lpd and RIAM paralogues. In addition, no significant outliers were observed, validating 
the MRL sequences identified through the BLAST screen. The data from this figure also shows 
that considerable divergence of the protein sequence has occurred amongst those species 
possessing only one MRL homologue. This is demonstrated by the long lines emerging from 
each branch point in this grouping, and isn't surprising given the substantial evolutionary 
distances between these organisms. The single orthologue sequences also appear to show a 
greater similarity to Lpd than RIAM.  
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Figure 3.2.1. Radial dendrogram of MRL phlogenetic tree. MRL sequence alignments were 
used to generate a phylogenetic tree to confirm appropriate MRL sequence identification and 
classification of Lpd and RIAM paralogues. Three distinct groupings representing the single 
MRL orthologues (green), Lpd (red) and RIAM (blue) can be seen enabling characterisation of 
Lpd and RIAM, while a lack of outliers substantiates the accuracy of sequences identified 
through BLAST searches. 
 
Interestingly, Lpd displays a significant degree of sequence conservation, with only Tetraodon 
nigroviridis and Danio rerio exhibiting relatively slight variance. RIAM, on the other hand, 
exhibits notably greater divergence, albeit nowhere near the levels found within the single 
orthologues. This result implies that the more constrained Lpd probably functions within core 
processes, while RIAMs divergence may have assisted in the more complex structural 
development found in vertebrates. 
 
3.3. Domain Analysis 
 
3.3.1. Domain conservation analysis 
 
Once the accuracy of the MRL sequence characterisation had been confirmed, new individual T-
Coffee Accurate alignments were generated for the single orthologue, Lpd and RIAM groupings 
alone. These new alignments, in addition to the complete MRL alignment used for the 
phylogenetic tree, were analysed by plotcon to ascertain the extent of conservation between the 
sequences. Those areas displaying a high degree of sequence similarity were then assessed using 
the Eukaryotic Linear Motif (ELM) resource which, in addition to utilising the more standard 
SMART/Pfam, GlobPlot, and IUPred searches, identifies short linear motifs within unstructured 
protein regions not previously assessed within the MRLs (Dinkel et al., 2012, Davey et al., 
2012). Domain conservation analysis was performed on the basis that regions containing key 
functional domains will be highly conserved and show little divergence compared to those 
lacking fundamental functionality. Similarity plots annotated with the predicted functional 
domains from each alignment are shown in Figure 3.3.1. 
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Figure 3.3.1. Predicted MRL conserved functional sites. Sequence alignments for all (a) 
single orthologue, (b) Lpd, (c) RIAM, and (d) MRL proteins were analysed to identify highly 
conserved areas before predicted functional sites present within these regions were characterised. 
Functional domains are represented using the following colour scheme: RA domain (green); PH 
domain (yellow); MAPK binding site (red); Proline rich region (blue); SH3 binding site (Purple); 
Talin binding region (Pink); coiled-coil motif (dark blue); ambiguous/potential modification site 
(grey); PP1 binding site (orange). 
 
Data from all the alignments studied in Figure 3.3.1. highlighted considerable conservation 
within the characteristic RA and PH domains. Even the relatively divergent single orthologue 
species displayed significant sequence homology within these two regions, emphasising their 
importance to MRL functionality. The data also revealed a previously uncharacterised, yet highly 
conserved, MAPK binding site adjacent to the RA domain. This binding motif was present in all 
MRL proteins analysed and displayed a comparable level of similarity to that found within the 
RA and PH domains, underlining its potentially significant role in the fundamental functionality 
of MRLs. 
 
As expected, multiple proline rich regions and SH3 binding sites were identified within the 
unstructured C-terminus of all MRL sequences analysed, while a highly conserved talin binding 
motif is present at the N-terminus of both Lpd and RIAM. Contrastingly, the single orthologues 
do not appear to possess a conserved talin binding site, raising questions as to whether this 
interaction is limited to vertebrate species. Interestingly, a highly conserved coiled-coil region 
was only observed in RIAM, with neither Lpd or the single orthologues found to possess one 
using this method. Further analysis revealed this site to be the second coiled-coil region 
previously described in RIAM, while the characteristic coiled-coil domain recognised as a 
common feature amongst all MRL proteins is lacking. This highlighted the limitations of ELM in 
identifying short secondary structures. 
 
Numerous conserved regions with no putative binding properties were also observed, particularly 
in the single orthologues and Lpd. This may be an artefact of the alignment software actively 
seeking homology, however, these areas of sequence were characterised as potential sites of 
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post-translational modification. While this hypothesis may indeed be true, it is worth noting that 
these regions do not appear to be spatially conserved amongst the MRL proteins; with RIAM 
containing none, the single orthologues possessing them exclusively within the N-terminus, and 
Lpd's being found in both the N-terminus and adjacent to the C-terminus of the PH domain.  
 
Finally, a reasonably well conserved PP1 binding motif was observed in the single orthologues, 
however, similar sites were not found within either Lpd or RIAM. Upon closer inspection, it was 
established that this conserved site was exclusive to the four insecta species sequences studied, 
although all MRL proteins appeared to possess a common PP1 binding site at the C-terminus of 
the RA domain (data not shown). 
 
3.3.2. Domain sequence analysis 
 
While domain conservation analysis proved a useful tool in identifying key domains common to 
all MRLs, the issues emanating from the partially conserved PP1 binding site drew attention to 
the limitations of this method in recognising potentially important domains that may display a 
conserved presence, but lack a consistent position within the protein structure. Consequently, 
analysis was performed whereby the entire protein sequence was examined to identify all 
functional domains present. Employing ELM analysis on all the MRL sequences from the 
BLAST screen was deemed impractical, therefore only the previously well characterised 
peptides from H. sapiens and the model organisms C. elegans and D. melanogaster were 
examined. Accordingly, hRIAM, hLpd, Mig10 and Pico full peptide sequences were analysed 
using ELM and the predicted functional domains rationalised to remove apparent false positives. 
Figure 3.3.2. shows an alignment of the protein sequences annotated with predicted functional 
sites displaying either significant homology or a role in regulation, migration, and growth. A 
rough similarity scoring system has been included to aid with the assessment of domain 
conservation. 
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hRIAM        1 M--------------------------------GESSE----------------DIDQMFSTLLGEMDLLTQ   24  
hLpd         1 M--------------------------------EQLSDEEIDHGAEEDSDKEDQDLDKMFGAWLGELDKLTQ   40  
cMig10       1 MDTYDFPDPYPVQIRARPQVPPKPPIDTVRYSMNNIKE----------------SADWQLDELLEELEALET   56  
dPico        1 M--------------------------------ANLED----------------SQESELDQILGELSLLEA   24  
 
cons           *                            : .:                . :  :.  * *:. *       
 
 
hRIAM       25 SLGVDTLP------PPDPNPPRAEFNYSVGFKDLNESLNALEDQDLDALMADLVAD----------------   74  
hLpd        41 SLDSDKPMEPVKRSPLRQETNMANFSYRFSIYNLNEALNQGETVDLDALMADLCSIEQELSSIGSGN-----  107  
cMig10      57 Q----------------------------------------------------------LNSSNGGD-----   65  
dPico       25 Q----------------------------------------------------------ISYTEASMLPAMC   38  
 
cons           .                                                                           
 
 
hRIAM       75 -----------------------------------------------------------------------I   75  
hLpd       108 ---SKRQITETKATQKLPVSRHTLKHGTLKGLSSSSNRIAKPSH---------ASYSLDDVTAQLEQASLSM  167  
cMig10      66 ---QLLLGV--------------------SGIPASSSRENVKSISTLPPPPPALSYHQT--PQQPQLLHHHN  112  
dPico       39 APSAGAQIAPPPGVTQLPGSAPT-----MVSMSASSSRSHSRTN---------STISAD--VSSCSSSGISE   94  
 
cons                                                                                  
 
 
hRIAM       76 SEAEQRTIQ-------AQKE-------------SLQNQHHSASLQA-SIF------SGAASLGYGTNVAATG  120  
hLpd       168 DEAAQQSVL-------EDTK-------------PLVTNQHRRTASA-GTVSDAEVHSISNSSHSSITSAASS  218  
cMig10     113 NHLGYQNGI-------HQIT-------------SINSAAS-SCSSPDGDSAFGDSSSTESSNNRCRNSAFSS  163  
dPico       95 NGHGLGLVLGGPGSAGMMVQPPPPGGMTMGITLGVVTPREPRTESPDNDSAFSDTVSLLSSESSASSNTSLQ  166  
 
cons           .                                 : .       .. .        *   *     . :       
 
 
hRIAM      121 ISQYEDDLPPPPADPV----------------LD-LPLPPPPPEPLSQEEEEAQAKADKIKLALEKLKEAKV  175  
hLpd       219 MDSLDIDKVTRPQELD----------------------LTHQGQPITEEEQAAKLKAEKIRVALEKIKEAQV  268  
cMig10     164 NDSCR-DSLNTPS--------------------------PTQVSPRNGELNAEEAKAQKIRQALEKMKEAKV  208  
dPico      167 QQQQQ-QQQQHHQHQQHHQHQQQQQKPQLAGAEKLHHHGVHGQHGGQQSGANSITKADKIQLALHKLESAPI  237  
 
cons            ..   :                                         .      **:**: **.*::.* :    
 
 
hRIAM      176 KKLVVKVHMNDNSTKSLMVDERQLARDVLDNLFEKTHCDCNVDWCLYEIYPELQIERFFEDHENVVEVLSDW  247  
hLpd       269 KKLVIRVHMSDDSSKTMMVDERQTVRQVLDNLMDKSHCGYSLDWSLVETVSELQMERIFEDHENLVENLLNW  340  
cMig10     209 TKIFVKFFVEDGEALQLLIDERWTVADTLKQLAEKNHIALMEDHCIVEEYPELYIKRVYEDHEKVVENIQMW  280  
dPico      238 RRLFVKAFTSDGASKSLLVDERMGCGHVTRLLADKNHVQMQSNWALVEHLGDLQMERLFEDHELLVDNLMTW  309  
 
cons            ::.:: . .*. :  :::***    ..   * :*.*     : .: *   :* ::*.:**** :*: :  *    
 
 
hRIAM      248 TRDTENKILFLEKEEKYAVFKNPQNFYLDNRGKKESKE-TNEKMNAKNKESLLEESFCGTSIIVPELEGALY  318  
hLpd       341 TRDSQNKLIFMERIEKYALFKNPQNYLLGKKET--------AEMADRNKEVLLEECFCGSSVTVPEIEGVLW  404  
cMig10     281 VQDSPNKLYFMRRPDKYAFISRPELYLLTPKTSDHMEIPSGDQWTIDVKQKFVSEYFHREPVVPPEMEGFLY  352  
dPico      310 HSDAGNRVLFQQRPDKVTLFLRPELYLPGPQMA------PGCQHDEQTRQMLLDEFFDSHN--QLQMDGPLY  373  
 
cons             *: *:: * .: :* :.: .*: :    :           :     :: ::.* *        :::* *:    
 
 
hRIAM      319 LKEDGKKSWKRRYFLLRASGIYYVPKGKTKTSRDLACFIQFENVNIYYGTQHKMKYKAPTDYCFVLKH---P  387  
hLpd       405 LKDDGKKSWKKRYFLLRASGIYYVPKGKAKVSRDLVCFLQLDHVNVYYGQDYRNKYKAPTDYCLVLKH---P  473  
cMig10     353 LKSDGRKSWKKHYFVLRPSGLYYAPKSKKPTTKDLTCLMNLHSNQVYTGIGWEKKYKSPTPWCISIKL---T  421  
dPico      374 MKADPKKGWKRYHFVLRSSGLYYFPKEKTKNTRDLACLNLFHGHNVYTGLGWRKKWKSPTDYTFGFKAVGDS  445  
 
cons           :* * :*.**: :*:**.**:** ** *   ::**.*:  :.  ::* *   . *:*:** : : :*    .    
 
 
hRIAM      388 QIQ-KESQYIKYLCCDDTRTLNQWVMGIRIAKYGKTLYDNYQRAVAKAGLASRWTNLGTVNAAAPAQPSTGP  458  
hLpd       474 QIQ-KKSQYIKYLCCDDVRTLHQWVNGIRIAKYGKQLYMNYQEALKRTESAYDWTSLSSSSIKSGSSSSSIP  544  
cMig10     422 ALQMKRSQFIKYICAEDEMTFKKWLVALRIAKNGAELLENYERACQIRR-----ETLGPASSMSAASSSTAI  488  
dPico      446 SLG-KSCRSLKMLCAEDLPTLDRWLTAIRVCKYGKQLWDSHKSLLEDLCL-SRDDAVSQSSFAASMRSESIS  515  
 
cons            :  * .: :* :*.:*  *:.:*: .:*:.* *  *  .::              :.  .  :   ..:       
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hRIAM      459 -KTGT-----------------TQPNG-QIPQATHS--------VS-AVL----------------------  480  
hLpd       545 -ESQSNHSNQSDSGVSD-----TQPAG-HV-RSQSI--------VS-SVF----------------------  577  
cMig10     489 SEVPHS------------------LSH-HQ-RTPS---------VASSIQLSSHMMNNPTHPLSVNVRNQSP  531  
dPico      516 -SISSAVPSQCGSVSSAISSMSNSTSGRTS-RASSSSSSGCLSDDN-NAF----------------------  562  
 
cons            .                             ::                                            
 
 
hRIAM      481 -----------------------QEAQRHA----ETSKDKKPALGNHHDPAVPRAPHAPK-----------S  514  
hLpd       578 -----------------------SEAWKRGTQLEESSKARMESMNRPYTSLVPPLSPQPKIVTPYTASQPSP  626  
cMig10     532 ASFSVNSCQQSHPSRTSAKLEIQYDEQPTGTIKRAPL-----------------------------------  568  
dPico      563 -----------------------DSEFTTGTIKRKPS----MKPNLPLTTMTRQLKEVGEITIC--------  599  
 
cons                                   .    .     .                                         
 
 
hRIAM      515 SLPPP---------------PP----------------------VRR-----SSDTSGSPATPL------KA  538  
hLpd       627 PLPPPPPPPPPPPPPPPPPPPPLPSQSAPSAGSAAPMFVKYSTITRL-----QNASQHSGALFKPPTPPVMQ  693  
cMig10     569 --------------------DV----------------------LRR----VSRASTSSPTIPQ--------  586  
dPico      600 ----------------------------ESAGGDASSPERSGTLTRRHSRRKSQESNGSGTLKRRPIAVPVA  643  
 
cons                                                        *      .  :  * :                
 
 
hRIAM      539 KGTGGGGLPA-----P-------------------------------PDDFLPPPPPPPPLD----------  564  
hLpd       694 SQSVKPQILV-----PPNGVVPPPPPPPPPPTPGSAMAQLKPAPCAPSLPQFSAPPPPLKIHQVQ----HIT  756  
cMig10     587 ---------------------------------------------------------EESDS----------  591  
dPico      644 TVVKQTEPMGSASSTSSSSNSTPTPTPSICAKPPPGDSASLMCSSTLSLDSLPPPPPPPALDGSEDQDVYGS  715  
 
cons                                                                                    
 
 
hRIAM      565 -------------DPELPPPPPDFMEP---------------------------------------------  578  
hLpd       757 QVAPPTPPPPPPIPAPLPPQAPPKPLVTIPAPTSTKTVAPVVTQAAPPTPTPPVPPAKKQPAFPASYIPPSP  828  
cMig10     592 -------------DEEFPAPPPVASVMRMP------------------------------------------  608  
dPico      716 QLS----------LASLPPPPPPEDVLAMNYA------------------------------------EPSS  741  
 
cons                           :*. .*                                                      
 
 
hRIAM      579 --------------------PPDFVPP--------------------------------------------P  586  
hLpd       829 PTPPVPVPPPTLPKQQSFCAKPPPSPLSPVPSVVKQIASQFPPPPTPPAMESQPLKPVPANVAPQSPPAVKA  900  
cMig10     609 ---------------------PPVTPPKPC------------------------------------------  617  
dPico      742 PSTPTPMSTPMI-MPNSNGSLPPAVPAKPMKPAVKQAAG-----------------------GLKAAPPYKA  789  
 
cons                                *   *                                                 
 
 
hRIAM      587 PPSYAGIAGS---------------------E----------------------------------------  597  
hLpd       901 KPKWQPSSIPVPSPDFPPPPPESSLVFPPPPPSPVPAPPPPPPPTASPTPDKSGSPGKKTSKTSSPGGKKPP  972  
cMig10     618 ------------------------------------------------------------------------  617  
dPico      790 PPDYVGPALLPGPPLPPPPPAQKKVSF-------------------------ADSPVLLRRKMCSPEPVLPQ  836  
 
cons                                                                                       
 
 
hRIAM      598 --------------------------------------------LPPPPPPPAPAPAPV--PD---------  614  
hLpd       973 PTPQRNSSIKSSSGAEHPEPKRPSVDSLVSKFTPPAESGSPSKETLPPPAAPPKPGKLNLSGVNLPGVLQQG 1044  
cMig10     618 ------------------------------------------------------------------------  617  
dPico      837 RSPSTTLSCHSSS-----------------------SAGSAYQ-----------------------------  856  
 
cons                                                                                    
 
 
hRIAM      615 SAR-P--------------------------------------------------------------P-PAV  622  
hLpd      1045 CVSAKAPVLSGRGKDSVVEFPSPPSDSDFPPPPPETDLPLPPIEIPAVFSGNTSPKVAVVNPQPQQWSKMSV 1116  
cMig10     618 -------------------------------------------------------------------TPLTS  622  
dPico      857 ------------------------------------------------------------------------  856  
 
cons                                                                                  
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hRIAM      623 AKRPPV-PPKRQENPGHPG----------------------GAGGGEQDFMSDLMKALQKKR----------  661  
hLpd      1117 KKAPPPTRPKRNDSTRLTQAEISEQPTMATVVPQVPTS-PKSSLSVQPGFLADLNRTLQRKSI--------- 1178  
cMig10     623 KKAPPP-PPKRSDTTKLQSAS----------------------P--MAPAKNDLEAALARRR----------  659  
dPico      857 TYAPGPMLPPRADVARLSSLSNGSSSEV-----TSPKRLQESASNPPRDFLKDLQRVMRKKWQVAQKCKAEP  923  
 
cons              *    * * : .                                     **  .: ::               
 
 
hRIAM      662 ------------------------------------------------------------------------  661  
hLpd      1179 -----------------------TRHGSLSSRMSRAE------------------------------PTA-- 1195  
cMig10     660 ------------------------------------------------------------------------  659  
dPico      924 ATTPHEVLGFRDFSNEDLLAAHNLNSGANSSHYYRETANVSHWVRKHYEYAHNALYENVHAQSAAAAGVPGS  995  
 
cons                                                                                   
 
 
hRIAM      662 ----------------------------------------------------GNVS  665  
hLpd      1196 -TMDDMALPPPPPELLSDQQKAGYGGSHISGYATLRRGPPPAPPKRDQNTKLSRDW 1250  
cMig10     660 ------------------------------------------------EKMATMEC  667  
dPico      996 GEATTPPLPPPPGNS-----------------VAAKKRPPPPPPKRSDKTHLTNRV 1034  
 
cons                                                                   
 
 
Figure 3.3.2. MRL sequence alignment with predicted functional domains. Complete human 
RIAM, human Lpd, C. elegans Mig-10, and Drosophila Pico sequences were assessed 
individually for potential functional sites. This figure shows an annotated protein alignment were 
the predicted functional regions are represented by the following colour scheme: RA domain 
(green); PH domain (yellow); MAPK binding site (red); Proline rich region (blue); SH3 binding 
site (Purple); Talin binding region (Pink); coiled-coil motif (dark blue); PP1 binding site 
(orange). 
 
The data presented in Figure 3.3.2. further supports the findings from the domain conservation 
analysis described earlier. All of the MRL proteins were found to possess clear central RA and 
PH domains, as well as multiple proline rich and SH3 binding regions distributed amongst an 
unstructured C-terminus. The novel MAPK binding site bordering the RA domain (MAPK
site1
) 
was also observed and showed significant sequence conservation, while a talin binding region 
was identified in both RIAM and Lpd, but not Mig-10 or Pico. 
 
Interestingly, while the second coiled-coil motif commonly attributed to RIAM was identified, a 
potentially novel coiled-coil region was observed near the N-terminus of Mig-10. It must be 
noted that the characteristic coiled-coil motif neighbouring the RA domain, highlighted in Lpd, 
RIAM, and Mig-10, but not Pico, was established through a literature search and not by ELM 
analysis. Consequently, assuming this coiled-coil region is common to all MRL proteins as 
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stated in the literature, this result implies that Mig-10, much like RIAM, may contain a second 
coiled-coil structure within its N-terminus (Colo et al., 2012b). Also worthy of note is the 
existence of numerous proline rich regions within the N-terminal region of RIAM, Mig-10 and 
Pico, while SH3 binding sites were identified in the N-terminus of all the proteins studied. 
Whether these motifs play a significant role in MRL functionality remains to be seen, however 
previous investigations had only focused on their presence in RIAM.  
 
An additional MAPK binding domain (MAPK
site2
) was also observed in both Lpd, RIAM, and 
Mig-10 close to the highly conserved novel MAPK
site1
 motif described previously in section 
3.3.1. This site lies adjacent to the C-terminal side of the common coiled-coil region, but is not 
present in Pico. Pico and Lpd do, however, possess further MAPK binding regions within their 
C-terminus, though they do not appear to be conserved and display low ELM probability scores. 
A conserved PP1 binding motif located at the C-terminus of the RA domain was found in all the 
proteins analysed, while an extra PP1 binding site was also revealed within the unstructured C-
terminal region of Pico only. These sites had already been discovered during the domain 
conservation analysis, however, no further potential PP1 binding motifs were identified. 
 
3.4. Establishing the MAPK consensus sequence 
 
Both domain conservation and domain sequence analysis have highlighted the existence of a 
highly conserved MAPK binding motif present in all MRL proteins. Given the potential 
importance of this site in MRL functionality, accurate characterisation was required not only to 
ascertain the reliability of these findings, but to also assist in the development of site specific 
mutants beneficial for future investigations. Accordingly, an alignment of all the MRL sequences 
identified from the BLAST screen was generated and the region containing the proposed MAPK 
motifs isolated and analysed using ELM (Figure 3.4.1.).  
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Ac_Lpd       253 EQAAKLKAEKIRVALEKIKEAQVKKLVIRVHMS-DDSSKTMMVDERQTVRQVLDNLMDKSHCGFSLDWSLVE  323  
Xt_Lpd       248 EQAAKIKAEKIRIALEKIKEAQVKKLVIRVHMS-DDSSKTMMVDERQTVRQVLDNLMDKSHCGYSLDWSLVE  318  
Dr_Lpd       263 EQAAKAKAEKIRVALEKIKEAQVKKLVIRVHMS-DESSKTMMVDERQTVRQVLDSLLDKSHCGYSPDWALVE  333  
Tn_Lpd       297 EQAAKLKAERIRVALEKIKEAQVKKLVIRVHMS-DESSKTMMVDERQTVRQVLDSLLDKSHCGYSPDWSLVE  367  
Ss_Lpd       299 EQAAKLKAEKIRVALEKIKEAQVKKLVIRVHMA-DDSSKTMMVDERQTVRQVLDNLMDKSHCGYSLDWSLVE  369  
Rn_Lpd       247 EQAAKLKAEKIRVALEKIKEAQVKKLVIRVHMS-DDSSKTMMVDERQTVRQVLDNLMDKSHCGYSLDWSLVE  317  
Pt_Lpd       246 EQAAKLKAEKIRVALEKIKEAQVKKLVIRVHMS-DDSSKTMMVDERQTVRQVLDNLMDKSHCGYSLDWSLVE  316  
Md_Lpd       246 EQAAKLKAEKIRVALEKIKEAQVKKLVIRVHMS-DDSSKTMMVDERQTVRQVLDNLMDKSHCGYSLDWSLVE  316  
Gg_Lpd       257 EQAAKLKAEKIRVALEKIKEAQVKKLVIRVHMS-DDSSKTMMVDERQTVRQVLDNLMDKSHCGYSLDWSLVE  327  
Cf_Lpd       298 EQAAKLKAEKIRVALEKIKEAQVKKLVIRVHMS-DDSSKTMMVDERQTVRQVLDNLMDKSHCGYSLDWSLVE  368  
Mm_Lpd       247 EQAAKLKAEKIRVALEKIKEAQVKKLVIRVHMS-DDSSKTMMVDERQTVRQVLDNLMDKSHCGYSLDWSLVE  317  
Hs_Lpd       246 EQAAKLKAEKIRVALEKIKEAQVKKLVIRVHMS-DDSSKTMMVDERQTVRQVLDNLMDKSHCGYSLDWSLVE  316  
Ec_Lpd       298 EQAAKLKAEKIRVALEKIKEAQVKKLVIRVHMS-DDSSKTMMVDERQTVRQVLDNLMDKSHCGYSSDWSLVE  368  
Oc_Lpd       246 EQAAKVKAEKIRVALEKIKEAQVKKLVIRVHMS-DDSSKTMMVDERQTVRQVLDNLMDKSHCGYSLDWSLVE  316  
Zf_Lpd       249 EQAAKLKAEKIRVALEKIKEAQVKKLVIRVHMS-DDSSKTMMVDERQTVRQVLDNLMDKSHCGYSLDWSLVE  319  
Mam_Lpd      246 EQAAKLKAEKIRVALEKIKEAQVKKLVIRVHMS-DDSSKTMMVDERQTVRQVLDNLMDKSHCGYSLDWSLVE  316  
Ac-RIAM      155 DQEAQAKADKIKLALEKLKEAKVKKLVVKVHMN-DNSTKSLMVDERQVTRDVLDNLFEKTHCDCNIDWCLYE  225  
Xt_RIAM      142 ELESKAKTDKIKLALSKMKEAKVKKRIVKIHMT-DGSTKTLMVDELQAVRDVLDNLFEKTHCDCSIEWSLFE  212  
Dr_RIAM      139 EEEEQLKADKIKLALEKLKEAKVKKLVVKVEIT-DGSSKTLMVDERQTVRDVMDNLFEKTHCDCNVDWSVCE  209  
Tn_RIAM      146 EMEAQMKADKIKLALEKLKEAKVKKLVVKVLLN-DGSSKTLMVDERQSVREVLDNLFEKTHCNCNVDWSLCE  216  
Ss_RIAM      150 EKESQAKADKIKLALEKLKEAKVKKLVVKVHMN-DNSTKSLMVDERQLARDVLDNLFEKTHCDCNVDWCLYE  220  
Rn_RIAM      155 EEEALAKADKIKLALEKLKEAKVKKLVVKVHMG-DNSTKSLMVDERQLARDVLDNLFEKTHCDCNVDWCLYE  225  
Pt_RIAM      153 EEEAQAKADKIKLALEKLKEAKVKKLVVKVHMN-DNSTKSLMVDERQLARDVLDNLFEKTHCDCNVDWCLYE  223  
Md_RIAM      154 EEEAQAKADKIKLALEKLKEAKVKKLVVKVHMN-DNSTKSLMVDERQLARDVLDNLFEKTHFNYNLDWCLYE  224  
Gg_RIAM      152 EQEARAKADKIKLALEKLKEAKIKKLVVKVHMY-DNSTKSLMVDERQVTRDVLDNLFEKTHCDCSVDWCLYE  222  
Cf_RIAM      406 EEAAQAKADKIKLALEKLKEAKVKKLVVKVHMN-DNSTKSLMVDERQLARDVLDNLFEKTHCDCNVDWCLYE  476  
Mm_RIAM      156 EEEAKAKADKIKLALEKLKEAKVKKLVVKVHMD-DSSTKSLMVDERQLARDVLDNLFEKTHCDCNVDWCLYE  226  
Hs_RIAM      153 EEEAQAKADKIKLALEKLKEAKVKKLVVKVHMN-DNSTKSLMVDERQLARDVLDNLFEKTHCDCNVDWCLYE  223  
Ec_RIAM      153 EQEAAAKADKIKLALEKLKEAKVKKLVVKVHMN-DNSTKSLMVDERQLARDILDNLFEKTHCDCNIDWCLYE  223  
Oc_RIAM      153 EEEARAKADKIKLALEKLKEAKVKKLVVKVHMN-DNSTKSLMVDERQLARDVLDNLFEKTHCDCSVDWCLYE  223  
Zf_RIAM      155 ELEAKAKADKIKLALEKLKEAKVRKLVIKVHMN-DNSTKSLMVDERQVARDVLDNLFEKTHCDCNVDWCLYE  225  
Mam_RIAM     153 EEEAQAKADKIKLALEKLKEAKVKKLVVKVHMD-DNSTKSLMVDERQLARDVLDNLFEKTHCDCNVDWCLYE  223  
Ce_Mig10     298 LNAEEAKAQKIRQALEKMKEAKVTKIFVKFFVE-DGEALQLLIDERWTVADTLKQLAEKNHIALMEDHCIVE  368  
Dm_Pico      343 GANSITKADKIQLALHKLESAPIRRLFVKAFTS-DGASKSLLVDERMGCGHVTRLLADKNHVQMQSNWALVE  413  
Am_Ortho      35 DAASRVKAEKIRLALEKMREASVQKLFIKAFTL-DGSGKSLLVDEGMSVAHVCRLLADKNHVPMDPKWTVVE  105  
Aa_Ortho       6 NAVESGKQAKIHLALQKLEQATVRRLFVKAFSA-DGASKSLLVDETMTCGHVTRLLADKNHVQMEPNWAIVE   76  
Ag_Ortho     125 NQPDGGKQAKIHLALQKLEQASVRRLFVKAFTA-DGASKSLLVDETMSCGHVTRLLADKNHVQMEPTWAIVE  195  
Nv_Ortho       2 EQQERIKAEKIRIALEKLRAARVKKLVVKVYNDEDPTSKTIAIDQTWTSWEVCKKMMRKNDAEPDPNWVLVE   73  
Ta_Ortho     133 EEEMRVREEKICVALDKIKEANVQKRIVKIYSA-NESSKTILISDKMTAGEICLIMMEKCHVKPDPSWVLVE  203  
Aq_Ortho     326 EVAAKMKDEKMKIAIEKMKIASKRKVAIKVFNN-DGSNKTVVVEEGMTAAIVCYLLVSKNHFEESPNWTIIE  396  
Ci_Ortho     174 EREERIKSEKMREALEKMKEARIQKFVVKVYNK-DDSSKTVVIDERMTVRVVMKQLIEKNHYDTSSNWALIE  244  
Sp_Ortho     319 EKAAKLKSEKIKIALEKLKKARVQKLIVRVYME-DGSSKTMFVDETMRVRQVSHMLVEKNHLDERPDWTIIE  389  
 
Figure 3.4.1. Annotated alignment of the conserved MAPK region present in MRL 
proteins. MRL sequence alignments were generated and the area possessing the proposed 
MAPK motif isolated and examined. A highly conserved MAPK binding site (MAPK
site1
) (red) 
is present throughout all the MRL proteins, while a second adjacent motif (MAPK
site2
) (pink) is 
found only in Lpd, RIAM and Mig-10. This additional site lies between the boundaries of the 
coiled-coil region (dark blue) and the RA doamin (green). 
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The data presented in Figure 3.4.1. confirmed the presence of a highly conserved MAPK binding 
(red) site neighbouring the RA domain in all MRL proteins. In RIAM, Lpd, and Mig-10, this site 
is situated within the coiled-coil motif previously characterised within the literature (Colo et al., 
2012b). However, Lpd, RIAM and Mig-10 also possess a second conserved MAPK binding 
motif (pink) not found in the other single orthologues. This domain is positioned between the 
characteristic coiled-coil motif and RA domains, overlapping the boundary of each slightly. 
Analysis of both domains reveals the presence of conserved consensus sequences distinctive to 
each site. MAPK
site1
 found in all the MRL proteins has a consensus sequence of KXXKIZXAL, 
were X denotes any amino acid and Z represents a basic residue; while MAPK
site2
 has 
KEAK/QVKKLVV/I as its consensus. The presence of a clear consensus sequence for both 
proposed binding sites offers significant support for the concept of MAPK binding. Further 
evidence is provided by the exceptionally high level of sequence similarity that occurs in this 
region; with the MAPK binding sites exhibiting 73%
1
 and 80%
2
 sequence identity compared 
with the 44% and 52 % found within the characteristically conserved RA and PH domains 
respectively. 
 
3.5. Discussion 
 
The methods employed in this chapter were able to identify the highly conserved central RA and 
PH domains, as well as the proline rich and SH3 binding regions present in the unstructured C-
terminus, features previously reported as common to all MRL proteins (Krause et al., 2004, 
Lafuente et al., 2004, Lyulcheva et al., 2008, Colo et al., 2012b). They also detected the talin 
binding sites located at the N-terminus of Lpd and RIAM, but failed to recognise coiled-coil 
motifs present in all MRLs, exposing potential limitations in the prediction of short secondary 
structures (Lee et al., 2009, Colo et al., 2012b, Chang et al., 2013). Due to the generally strong 
correlation with previous findings described in the literature, these results provided sufficient 
confidence in the analytical processes carried out; and as such, novel findings were deemed 
satisfactory enough to warrant further investigative effort. Consequently, the results from the 
investigations carried out in this chapter were used as the basis for much of the research 
presented in this work.  
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3.5.1. Potential MAPK binding 
 
The presence of highly conserved MAPK binding sites close to the RA domain is extremely 
interesting. Given the well established roles MAPK plays in regulation and signal transduction, 
this finding offers potentially key insights into the pathways involved in control of the MRL 
proteins and their associated factors. Indeed, a recent study has already identified a link between 
RIAM and the MAPK Erk1/2 in promoting FA disassembly (Colo et al., 2012a). MAPKs have 
been shown to tightly cooperate with Ras-like GTPases in numerous signalling cascades 
(Krishna and Narang, 2008, Wittinghofer and Nassar, 1996). Consequently, the closeness of the 
MAPK binding sites to the well defined RA domain may be linked to this collaboration and 
should be investigated further. 
 
The conserved MAPK motif present in all MRL proteins is located within the coiled-coil region 
recently shown to contribute to homodimeric binding in Lpd (Chang et al., 2013). How this 
might affect potential MAPK or homodimeric interactions is still unclear, although it could be 
hypothesised that binding to one may influence the ability of the peptide to associate with the 
other. The presence of a second conserved MAPK binding site situated outside the coiled-coil 
motif in Lpd, RIAM, and Mig-10 could represent a newly formed binding motif that is not 
influenced by homo- or hetero-dimeric interactions. As such, further questions surrounding the 
role of these coiled-coil mediated interactions need to be answered before a more complete 
mechanistic insight can be developed; however, a much more pressing issue is whether MAPKs 
actually bind directly, and if so, where? 
 
3.5.2. Other potential findings of note 
 
In addition to the discovery of a potential MAPK binding site, the results presented in this 
chapter also alluded to other possible findings of note, with the first being the identification of a 
second coiled-coil motif at the N-terminus of Mig-10. A second coiled-coil region present in 
RIAM is already commonly acknowledged, however, the motif recognised in Mig-10 was not 
aligned with that found in RIAM (Lafuente et al., 2004). Instead, this site appears to align with 
the talin binding domains present at the N-terminus of Lpd and RIAM (Lee et al., 2009).  
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No distinguishable talin binding sites were identified and no direct interaction has yet been 
reported in either Mig-10 or Pico. Given the key role Talin plays in linking FAs to the 
cytoskeletal matrix, and the clear associations already identified in Lpd and RIAM, it would be 
surprising if this was not a common feature in all MRLs (Goult et al., 2013, Lee et al., 2009). 
Interestingly, the talin binding sites present in RIAM and Lpd were found to possess an 
amphipathic helical structure (Lee et al., 2009). Taken together, the coiled-coil motif identified 
in Mig-10 may act as a site for Talin binding, however, the lack of any such motif in Pico does 
raise questions as to whether this interaction occurs in simpler organisms. As such, determining 
whether Pico can also interact with Talin will be of some importance, even if a precise binding 
site cannot be determined at this stage. 
 
A well conserved PP1 binding site was also identified at the C-terminus of the RA domain in all 
the MRL proteins analysed, while a second C-terminal PP1 motif was found only amongst the 
insecta. Previous work performed in the Bennett lab has confirmed that Drosophila Pico is able 
to interact directly with PP1, however, mutational analysis revealed this association to only take 
place at the insect specific C-terminal site (Lyulcheva, 2006, Bennett et al., 2006). While this 
finding does not preclude the possibility of PP1 binding in the non insecta MRLs, doubts 
obviously exist, even though an interaction with such a fundamental phosphatase would usually 
be mechanistically conserved. It may indeed be the case that PP1 can bind to the site present in 
the RA domain, although it is also possible that another phosphatase may bind or PP1 might 
interact via one of the other MRL associated proteins eg Profilin (Shao and Diamond, 2012). 
Either way, it is essential to discern the role PP1 plays in Pico's overall functionality so that the 
responsibility phosphatases could have in MRL regulation can be ascertained, even if the 
phosphatases in question are not PP1. 
 
Little is currently known about the effects of posttranslational modifications or phosphorylation 
on the MRL proteins. The presence of numerous sites with the potential to be modified in some 
way certainly offers a likely explanation for how MRL protein interactions and/or localisation 
may be regulated. This is especially true considering the presence of conserved MAPK binding 
motifs and the proposed interaction with PP1. Consequently, developing an understanding of 
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how these modifications, particularly phosphorylation, affect MRL interactions and functionality 
will be crucial. 
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4. Tool Generation 
 
4.1. Introduction 
 
To identify proteins that interact with the MRL proteins and determine the precise sites of 
binding, researchers have utilised a variety of techniques; most notably yeast-two-hybrid and 
immunoprecipitation assays to confirm direct interactions of both full and incomplete peptides 
with their associated proteins, and co-localisation studies as further corroboration of their 
findings. Identification of specific binding regions has been achieved by domain mapping 
experiments and the use of arrays consisting of diminutive 15-20mer peptides spotted onto 
membranes (Krause et al., 2004, Lafuente et al., 2004, Jenzora et al., 2005, Lee et al., 2009). 
While these methods have provided clear evidence supporting the existence of various 
interactions, due to the nature of the investigations performed, only limited information can be 
inferred about how these associations affect MRLs binding affinities and overall functionality.  
 
Although deletion analysis where single or multiple binding domains are completely removed 
from the peptide sequence may appear to offer a suitable investigative route, the elimination of 
large binding regions, such as the RA or PH domains, is liable to impair correct tertiary protein 
formation and introduce erroneous findings. Given the complex nature of many protein 
configurations, even the deletion of small motifs may have significant effects. Consequently, 
studies have begun to focus on mutating a small number of key residues required for a specific 
interaction to minimise off-target effects on other regions within the protein structure.  
 
While identifying functionally important amino acids to substitute is straightforward for the 
majority of short, simple motifs such as the PP1 or MAPK binding sites, the more substantial 
and complex RA and PH domains present a significantly tougher challenge. Works published by 
Fridman et al. 2000 and Shirouzu et al. 1999 have gone some way to addressing these issues 
within the RA domain, as modifications to key consensus residues were found to enhance or 
reduce Ras binding respectively in other RA domain containing proteins. Hence, by comparing 
the RA domains used in these studies to those found within the MRL proteins, it may be possible 
to identify the crucial residue changes required to recreate these alterations in Ras affinity. 
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In addition to studying the effects of individual binding site mutations on MRL functionality, it is 
also important to assess the role modifications, such as phosphorylation, play in regulating their 
interactions and overall activity. This is especially true following the identification of MAPK and 
PP1 binding sites, as well as the presence of numerous potential post-translational modification 
sites outlined in the previous chapter. Serine, threonine and tyrosine represent the three most 
commonly phosphorylated amino acids in eukaryotes, however, analysing the effects of 
phosphorylation unequivocally is often impractical. Instead, phosphorylation of these residues 
can be imitated by replacing the amino acid of interest with one displaying structural similarity 
to the phosphorylated form. An illustration of serine phospho-mimicry is shown in Figure 4.1.1.  
 
 
 
Figure 4.1.1. A structural representation of phospho- and dephospho-mimicry of serine. 
Aspartic acid, with its negatively charged carboxylate (COO
-
) ion, is able to partially mimic the 
structure and charge of phosphoserine. Conversely, alanine lacks the -OH group required for 
phosphorylation and can therefore act as a permanently dephosphorylated form of serine. 
 
Serine possesses a characteristic CH2OH group attached to the standard amino acid backbone. 
When phosphorylated, a distinctive highly charged PO4
3-
 phosphate group replaces the hydroxyl 
(OH
-
) ion which typically lacks any resonance structures when attached to R-CH2, and therefore 
carries no formal charge. Aspartic acid, one of only two acidic amino acids occurring naturally,  
displays a very similar backbone to serine, differing only in the presence of a carboxylic acid 
(COOH) group in place of the hydroxyl ion. This acidic group readily loses its hydrogen leading 
to the formation of a negatively charged carboxylate (COO
-
) ion. While this carboxylate ion 
exhibits a lesser charge than a phosphate group, it is often strong enough to mimic the effects of 
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phosphoserine on local tertiary peptide structure, especially when considering the lack of any 
significant charge normally present within serine alone.  
 
The slightly larger glutamic acid forms the second acidic residue present in nature and is 
commonly used as a phosphomimetic for both threonine and tyrosine. Glutamic acid shares a 
reasonable degree of structural homology with threonine and emulates phosphothreonine in a 
similar way to aspartic acid with serine. Tyrosine, on the other hand, possesses a distinctive 
aromatic ring not present in glutamic acid, however, no other suitably structured amino acid 
exists naturally that can replicate a phosphomimetic form of this residue. As such, glutamic acid 
is often used due to its larger size, but must be extensively validated before any decisive 
conclusions are made as this change often displays an effect reminiscent of tyrosine to alanine 
mutations.  
 
As well as mimicking phosphorylation, it is also possible to generate non-phosphorylatable 
mutants where the addition of a phosphate group is impossible. For serine and threonine, alanine 
is utilised as a replacement residue as the lack of an -OH group prevents phosphorylation from 
taking place (Figure 4.1.1.). It must be noted that alanine is smaller than both serine and 
threonine and does not display the nucleophilic properties found in the aforementioned amino 
acids. In the case of tyrosine, phenylalanine can act as a dephosphomimetic residue as it 
possesses the characteristic aromatic ring, but lacks the critical -OH group. 
 
4.1.1. Aims 
 
The purpose of the research untaken in this chapter was to design, and subsequently generate, the 
tools required to achieve the overarching objectives set out for this project. Initially, the potential 
sites of phosphorylation in Pico were assessed by analysing the ability of activated kinases to 
phosphorylate short 15mer peptides representative of every serine, threonine and tyrosine residue 
present in the protein. The ability of PP1 to dephosphorylate these sites was then investigated to 
pinpoint sequences capable of displaying reversible phosphorylation and to better understand the 
role PP1 may play in Pico regulation. The results from these investigations were employed in 
conjunction with previous findings mapping protein phosphorylation sites from a large scale 
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screen of Kc167 cells (Bodenmiller et al., 2007), to assist in the design of phospho- and 
dephospho-mimetic forms of Pico. Protein binding mutants possessing alterations to key residues 
within specific motifs were also devised using the data presented in Chapter 3. The 
aforementioned mutants were then generated and shuttled into appropriate vectors enabling their 
expression in both Drosophila melanogaster and S2 cells. Following incorporation of the 
apposite constructs into fruit flies, the resulting lines were characterised to ascertain the inserts 
chromosome location and relative expression levels. Attempts were also made to generate both 
stable and transiently transfected S2 lines expressing each of the mutant constructs.  
 
4.2. Phosphorylation site analysis 
 
A previous screen carried out by Bodenmiller et al. 2007 mapping phosphorylation sites in a 
variety of proteins identified three distinct phosphorylated serine residues in Pico at position 624, 
627, and 819. In order to confirm these findings and discover potential phosphorylation sites not 
identified by this screen, a peptide array consisting of diminutive 15mer peptides representing 
every serine, threonine and tyrosine residue contained within Pico was produced. The residue 
being assessed was positioned in the centre of each short peptide to increase the opportunity for 
prospective target sequences flanking either side to be recognised, while substituting the amino 
acid with a suitable alanine or phenylalanine acted as a negative control. As some peptide 
regions contained more than one potentially phosphorylatable residue, control peptides were also 
incorporated whereby serine, threonine or tyrosine residues not under investigation were 
replaced with an appropriate alanine or phenylalanine. A further set of peptides containing 
specific consensus target sequences for a variety of MAPKs was included to act as a positive 
control. The complete list of the 598 peptide sequences used in this study can be found in 
Appendix 2. 
 
The array was exposed to radiolabelled (γ-32P) ATP combined with a selection of individual 
kinases considered likely regulators of MRL activity to ascertain potential phosphorylation target 
sites for each enzyme. An activated form of the tyrosine kinase Abl was initially investigated due 
to its previously identified interaction with Lpd (Michael et al., 2010). The resultant findings 
from autoradiography analysis are shown in Figure 4.2.1. 
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Figure 4.2.1. Results of peptide array following exposure to γ-32P ATP and the tyrosine 
kinase Abl. (a) The peptide array was exposed to γ-32P ATP and activated Abl kinase before 
autoradiography fluorescence was assessed to determine the sites of phosphorylation. This 
analysis identified Y395 and Y396 as potential residues phosphorylated by Abl. Peptides 
corresponding to target consensus sequences for 1) PKC, 2) c-Abl, 3) EGFR, 4) INSR, 5) JNK1, 
6) PKA, 7) CDC2, 8) Erk1/2, 9) APK, 10) GSK3, and 11) p38, were included as positive 
controls. (b) The array was then incubated with the phosphatase PP1 to identify sites capable of 
displaying PP1 mediated reversible phosphorylation. The results from subsequent 
autoradiography analysis demonstrated very little dephosphorylation occurring at any of the 
scoring peptides. 
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Initial assessments of the results obtained in Figure 4.2.1.a indicated that the positive controls for 
Protein Kinase C (PKC) (peptide 1) and Cell Division Controlling Protein 2 (CDC2) (peptide 7) 
were phosphorylated, however, the Abl target sequence (peptide 2) was not. They also showed 
that many of the peptides were capable of being phosphorylated by Abl kinase, however, closer 
inspection of scoring sequences revealed that many of the negative controls had been 
phosphorylated as well. By only considering those phosphorylated peptides where the negative 
control did not register as a hit, the results indicated that Y395 and Y396 (peptides 184-188), 
may represent sites of Abl phosphorylation.  
 
Next, due to its previously described interaction with Pico, the array was incubated with an 
activated form of the phosphatase PP1. The subsequent results generated following examination 
of autoradiography fluorescence (Figure 4.2.1.b) revealed very little decrease in the levels of 
phosphorylation across all of the peptides. Any reduction in signal observed was in line with the 
expected decay of γ-32P, indicating that no PP1 mediated dephosphorylation occurred at these 
sites. While this result may have been expected given PP1s preference towards serine and 
threonine compared to Abl's predilection for tyrosine, many of the scoring peptides only 
contained serine or threonine. Taken together with the appearance of phosphorylated negative 
controls and apparent serine/threonine phosphorylation by a predominantly tyrosine specific 
kinase, this finding raised some significant questions over the validity of this investigation. 
 
Lastly, as a means of cleaning the peptide array for further investigations with other kinases, the 
membrane was exposed to λ protein phosphatase (λPP). λPP displays activity towards 
phosphorylated serine, threonine and tyrosine residues, however, much like PP1, very little 
change in phosphorylation state was observed across all of the peptides following 
autoradiography analysis (data not shown). Consequently, before any further investigations could 
be performed, the peptide array was left for a sufficient amount of time to allow the γ-32P to 
decay through numerous half lives. 
 
The next kinase assessed was the serine/threonine specific Erk1/2, selected due to its role in 
many growth and migration related signalling cascades although, the recent link with RIAM 
mediated FA disassembly has lent further support for this choice (Colo et al., 2012a). Before 
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commencing the investigation, autoradiography analysis was performed to confirm sufficient γ-
32
P decay (data not shown), and following a satisfactory outcome, the peptide array was 
incubated with γ-32P ATP and activated Erk1. Erk1 was chosen over Erk2 as it showed slightly 
greater homology with the Drosophila homolog Rolled, although both peptides display 
significant sequence identity (over 85%) with each other (Boulton and Cobb, 1991). The results 
generated following autoradiography examination are shown in Figure 4.2.2. 
 
 
 
Figure 4.2.2. Results of peptide array following exposure to γ-32P ATP and the 
serine/threonine kinase Erk1. (a) The peptide array was incubated with γ-32P ATP and 
activated Erk1 kinase before being assessed by autoradiography to determine the sites of 
phosphorylation. Analysis revealed the results obtained were almost identical to (b) those 
observed following exposure to Abl kinase, casting significant doubts over all findings made 
from this investigation. 
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Analysis of the results shown in Figure 4.2.2. revealed that the sites of phosphorylation identified 
following exposure to Erk1 were almost identical to those observed in Abl kinase. Significant 
differences were only detected in the positive controls, where the Jnk target sequence (peptide 5) 
displayed notable levels of phosphorylation by Erk1, and at S949 (peptides 551-552), which 
exhibited phosphorylation of the WT peptide and negative control by Abl but not Erk1. Similar 
results were also obtained following incubation with both PP1 and λPP as neither phosphatase 
yielded any discernable reduction in phosphorylation levels across all peptides (data not shown). 
 
While these findings cast significant doubts over the viability of the peptide array in ascertaining 
potential sites of phosphorylation within Pico, one final experiment was carried out using the 
serine/threonine p38 kinase. As with Erk1, before any experimentation was carried out the array 
was left for a period of time to allow the γ-32P to decay thoroughly. The results obtained from 
autoradiography analysis following incubation of the membrane with γ-32P ATP and p38 were 
exactly the same as those acquired after exposure to Erk1. Indeed, a similar lack of detectable 
dephosphorylation was observed when the array was incubated with PP1 and λPP. Consequently, 
given the seemingly erroneous results obtained from this analysis, the design of phospho- and 
dephospho-mimetic mutants was performed using data from the Bodenmiller et al. 2007 screen 
alone. 
 
4.3. Designing Pico mutant constructs 
 
Previous work performed in the Bennett lab has demonstrated that overexpression of the Pico 
short transcript, but not the long, leads to an increase in tissue growth and cell migration. 
Conversely, knockdown of Pico through RNAi caused reduced growth and retarded migration 
(Lyulcheva et al., 2008, Lyulcheva, 2006, Taylor, 2010). As a means of confirming that these 
knockdown phenotypes did not result from erroneous off target effects of the dsRNA, an RNAi 
resistant WT Pico short construct was designed by exploiting codon redundancy to enable 
confirmatory rescue experiments to be performed. The resulting transcript was intended to be 
resistant to both commercially available and in house RNAi constructs, while the codon usage 
was also tailored for efficient translation within the Drosophila system. All subsequent mutants 
were designed using this WT construct as their foundation, making them RNAi resistant as well.  
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Figure 4.3.1. Schematic representation of the Pico mutant constructs designed. A variety of 
RNAi resistant mutant constructs have been generated with potential alterations to binding of  
Enabled (LA), Ras (RE/RR), PP1 (F816A), and MAPKs (MAPK). Two further mutants 
displaying phosphomimetic (S819D) and permanently dephosphorylated (S819A) properties for 
the serine at position 819 were also generated. 'P' denotes the site of phosphorylatyion while '*' 
designates modified regions within each of the constructs. 
 
Based on domain analysis and previous work presented in the literature, the following binding 
site and de/phosphomimetic mutants were designed (Figure 4.3.1.): 
 
LA Seven leucine to alanine point mutations introduced to characteristic Drosophila EVH1 
 binding sites (LPPPP) identified within the C-terminus of Pico are predicted to interfere 
 with direct Enabled interactions. As Enabled has previously been shown to interact with 
 Profilin, it is possible this alteration may also affect associations with chickadee (Krause 
 et al. 2002). 
 
RE (A270K) Previous work performed by Fridman et al. assisted in the identification of an 
 alanine at position 270 that may enhance Pico's ability to interact with Ras or Rap when 
 exchanged for lysine (Fridman et al., 2000). 
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RR (K272A) Findings presented by Shirouzu et al. formed the basis for changing a lysine at 
 residue 272 to alanine in the hope of diminishing Pico's capacity to bind with Ras or Rap 
 (Shirouzu et al., 1999). 
 
F816A Previous work performed in the Bennett lab identified a phenylalanine at position 816 
 which prevents direct interactions with PP1 when replaced with an alanine (Lyulcheva, 
 2006, Bennett et al., 2006). 
 
MAPKUsing the MAPK consensus sequence developed in Chapter 3, it was hoped that 
 exchanging two lysines and a leucine found within the conserved MAPK
site1
 binding 
 region  to alanine (K221A; K224A; L229A) will inhibit Pico's potential ability to interact 
 with MAPKs. 
 
S819A The phosphorylation mapping screen performed by Bodenmiller et al. identified the 
 serine at residue 819 as a potential site of phosphorylation. Substituting the serine for an 
 alanine would yield a peptide incapable of being phosphorylated at this position 
 (Bodenmiller et al., 2007). 
 
S819D Replacing the serine at position 819 with a phosphomimetic aspartic acid was hoped to 
 sufficiently replicate the effects of phosphorylation previously observed by Bodenmiller 
 et al. at this site (Bodenmiller et al., 2007). 
 
The precise sites of each mutation, along with the WT construct DNA sequence, is shown in 
Appendix 3. It should be noted that despite Bodenmiller et al. 2007 identifying three potentially 
phosphorylated residues in Pico, phospho- and dephospho-mimetic mutants were only generated 
for the serine found at position 819. This was due to low confidence in phosporylation at 
positions 624 and 627 as they were each detected only once in the screen, while pS819 was 
observed 18 times (Bodenmiller et al., 2007).  
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4.4. Generatinging Pico constructs 
 
Once designed, the RNAi resistant Pico
WT
 construct was synthesised by BioPioneer Inc and 
inserted into a Gateway® pDONR221 entry vector to enable simple shuttling of the gene into 
appropriate destination vectors via LR recombination. As the Pico
LA
, Pico
F816A
, Pico
S819A
 and 
Pico
S819D
 mutants had also been devised by that point, BioPioneer developed these constructs as 
well using the pDONR221 Pico
WT
 vector as a backbone.  
 
To create the Pico
RE
, Pico
RR
 and Pico
MAPK
 mutant constructs, site-directed mutagenesis of the 
pDONR221 Pico
WT
 vector was attempted using PCR. Briefly, overlapping primers 
complementary to the proposed mutational sites, but possessing specific changes required for 
each construct, were synthesised. They were used in conjunction with a high fidelity Taq based 
DNA polymerase to amplify the complete pDONR221 Pico
WT
 vector via PCR, before the 
resultant products were exposed to the endonuclease DpnI. DpnI specifically cleaves methylated 
DNA created by DNA methyltransferases (DNMTs) present within the host cell of the parental 
Pico
WT
 strand, but not the PCR reaction mix. Consequently, only the pDONR221 Pico
WT
 vector 
DNA was digested, leaving the new mutants untouched and able to be transformed into 
chemically competent cells following end joining by DNA ligase. However, despite repeated 
rounds of gradient PCR and various alterations to the reaction mix's composition, neither agarose 
gel electrophoresis nor direct transformation into competent cells yielded any positive results 
(data not shown). 
 
Instead, as the Pico
RE
, Pico
RR
 and Pico
MAPK
 mutational sites were in close proximity, it was 
deemed practical to employ BioPioneer to generate short inserts corresponding to a region of 
Pico situated between single SacI and SalI sites containing the desired modifications (Figure 
4.4.1.). These sequences were then inserted into an appropriate vector to enable replication 
within transformed cells. Both the mutant and pDONR221 Pico
WT
 vectors were digested with 
SacI and SalI and run on an agarose gel to separate the products (data not shown). The resultant 
444bp and 4790bp bands were cut from the mutant and pDONR221 Pico
WT
 lanes respectively, 
before being purified with a gel extraction kit. T4 DNA ligase was utilised to join the cohesive 
end termini together and the products transformed into competent cells. These cells were 
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subsequently plated onto selective media and single colonies picked. A variety of techniques, 
such as PCR, restriction digestion, and sequencing, were then employed to validate the newly 
formed constructs (data not shown). 
 
 
 
Figure 4.4.1. Schematic diagram showing SacI-SalI restriction sites within the 
Pico
RE/RR/MAPK
 mutant and pDONR221 Pico
WT
 vectors. a) Pico
RE
, Pico
RR
 and Pico
MAPK
 
mutant vector SacI-SalI restriction map. b) pDONR221 Pico
WT
 vector SacI-SalI restriction map. 
The regions mutated in the Pico
RE
, Pico
RR
 and Pico
MAPK
 constructs are highlighted in red. 
 
4.5. Insertion of constructs into flies 
 
Following successful generation of the RNAi resistant Pico constructs within the pDONR221 
entry vector, an appropriate destination vector needed to be selected to enable their expression 
within flies using the Drosophila GAL4-UAS system. As the constructs had been designed with a 
stop codon, an appropriate tag could only be translated at the N-terminus. Accordingly, the 
pTVW (1091) vector from the Drosophila Genomics Resource Centre (DGRC) was identified as 
a suitable candidate. pTVW (1091) possesses a UASt promoter to enable expression under the 
direction of GAL4, and an N-terminal Venus tag. Venus is an enhanced Yellow Fluorescent 
Protein (YFP) flurophore derived from Green Fluorescent Protein (GFP) following the addition 
of several mutations (Rekas et al., 2002). Venus was chosen due to its superior and robust 
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fluorescent properties, in addition to its successful use in pulldown and Fluorescence Resonance 
Energy Transfer (FRET) experiments (Nagai et al., 2002). 
 
 
 
Figure 4.5.1. Agarose gel electrophoresis to validate pTVW Pico vectors following LR 
recombination. NdeI-SacII restriction digests were performed on pTVW Pico vectors following 
LR recombination. The resulting products were run on an agarose gel and confirmed correct 
orientation of the inserted constructs. 
 
LR recombination was performed to shuttle the constructs from the pDONR entry clones into 
pTVW destination vectors. The products of this reaction were transformed into competent cells 
selected for the presence of amp
r
 and the absence of a toxic ccdB gene in unrecombined 
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destination vectors. NdeI and SacII restriction digestion was used to verify accurate insertion and 
orientation of the Pico constructs within the pTVW vectors. The results confirming correct 
incorporation by gel electrophoresis of the restriction products is shown in Figure 4.5.1. 
 
Following validation of the destination vectors, transgenic flies possessing copies of the UAS-
controlled Venus tagged Pico constructs were generated through P-element mediated germline 
transformation by Genetic Services. Briefly, the Pico constructs, positioned between P-element 
ends and alongside a white
+
 minigene marker within the pTVW vectors, were injected into W
1118
 
embryos along with the helper vector pUChsDelta2-3 to provide a source of P-element 
transposase. The P-element, with UASt-Venus Pico as its cargo, was then randomly transposed to 
an indiscriminate chromosomal site (Spradling and Rubin, 1982, Sentry and Kaiser, 1992). The 
resulting flies were then returned for further analysis. 
 
4.6. Characterisation of Venus Pico fly lines 
 
A total of 10 lines were created for each Venus-Pico mutant construct by Genetic Services, 
however, not all progeny were viable as the random nature of P-element insertion can lead to the 
formation of sickly stocks. Those that did survive were characterised to determine the insert's 
chromosome location and relative expression level.  
 
4.6.1. Analysis of insert chromosome location 
 
The progeny were initially screened for non-white eyes indicating that the constructs, now 
permanently associated with a white
+
 minigene, had successfully been transformed into the 
germline cells. The chromosome harbouring each independent insert was determined by crossing 
individual transgene-carrying males to w; Tft/CyO and then crossing the male progeny to w; 
Tft/CyO; MKRS/TM6B. Table 4.6.1. details which chromosome the constructs were inserted into 
for each line. Following characterisation, each insert was then balanced with an appropriate, 
dominantly marked, balancer chromosome to prevent recombination and enable stock 
maintenance (Greenspan, 2004). 
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Fly Line Chromosome Loc. Fly Line Chromosome Loc. 
Pico WT Line 1 3 F816A Line 8 1 
Pico WT Line 2 3 F816A Line 9 3 
Pico WT Line 3 3 F816A Line 10 3 
Pico WT Line 4 2 MAPK Line 1 3 
Pico WT Line 5 3 MAPK Line 2 1 
Pico WT Line 6 3 MAPK Line 3 3 
Pico WT Line 7 3 MAPK Line 4 3 
Pico WT Line 8 3 MAPK Line 5 3 
Pico WT Line 9 1 MAPK Line 8 2 
Pico WT Line 10 1 MAPK Line 9 3 
LA Line 2 3 MAPK Line 10 3 
LA Line 3 2 S819A Line 1 3 
LA Line 5 3 S819A Line 2 2 
LA Line 6 3 S819A Line 3 1 
LA Line 7 2 S819A Line 5 3 
LA Line 8 3 S819A Line 6 2 
LA Line 9 3 S819A Line 7 2 
LA Line 10 3 S819A Line 8 2 
Ras Enh Line 1 2 S819A Line 9 2 
Ras Enh Line 2 3 S819A Line 10 2 
Ras Red Line 2 2 S819D Line 2 3 
Ras Red Line 3 2 S819D Line 3 2 
Ras Red Line 4 3 S819D Line 4 1 
Ras Red Line 8 3 S819D Line 5 3 
Ras Red Line 10 2 S819D Line 6 3 
F816A Line 2 3 S819D Line 7 3 
F816A Line 3 2 S819D Line 8 2 
F816A Line 5 2 S819D Line 9 3 
F816A Line 6 2 S819D Line 10 3 
F816A Line 7 2   
 
Table 4.6.1. Chromosomal location of Venus tagged Pico inserts. Chromosomal location of 
UAS-Venus tagged Pico inserts in each transgenic fly line. 
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4.6.2. Analysis of Venus Pico expression levels 
 
Due to the random nature of P-element insertion, constructs may be located in regions of 
generally high (euchromatin) or low (heterochromatin) gene expression, dictating in turn the 
expression levels of the construct itself. As such, the relative Venus-Pico expression level was 
assessed for each line. Initial attempts to express the transgenes using the ubiquitous da-GAL4 
and act5C-GAL4 drivers failed to produce any viable larvae or adult flies expressing the Pico 
constructs, indicating high Pico levels may significantly disrupt correct larval development and 
cause lethality.   
 
To combat this lethal effect, the characteristically segmented enGAL4 driver was used and found 
to yield viable larvae. Consequently, verification and analysis of ectopic protein expression was 
first carried out by visualisation of fluorescent Venus in larvae carrying the enGal4 driver and 
one copy of the transgene of interest (Figure 4.6.1.). Subsequent attempts to confirm expression 
levels through Western blot analysis using anti-Pico (3531) and anti-GFP (ABfinity) proved 
unsuccessful, however, the images generated from the initial visualisation experiments were 
deemed sufficiently accurate to enable appropriate lines for each construct to be selected for 
future use (Figure 4.6.1.).  
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Figure 4.6.1. Visualisation of Venus-Pico expression under the control of enGAL. 
Visualisation experiments were carried out to assess the relative expression levels of Venus-Pico 
under the control of enGAL4 for each mutant construct line. 
 
4.6.3. Selection of Venus-Pico lines 
 
Once characterisation was completed, appropriate lines were selected from each construct for use 
in future experiments. Only lines with constructs located on either the second or third 
chromosome were considered as some prospective investigations would not be possible with 
transcripts located on the first. From those lines remaining, suitable choices were made based on 
their relative expression levels, characterised as either high (e.g. Pico
WT
 2), moderate (e.g. 
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Pico
WT
 4), or low (e.g. Pico
LA
 2). As some constructs, such as Pico
F816A
 and Pico
S189A
, possessed 
lines displaying only high or moderate expression levels, selected lines were placed into one of 
two apposite groupings (high expression or moderate expression) in accordance with their 
observed level of transcription. Pico
WT
 line 2 and Pico
WT
 lines 4 and 6 were chosen as 
comparative controls for the high and moderate groups respectively, enabling accurate 
conclusions to be made about the mutational effects without confounding expressional effects 
when analysing phenotypic outcomes of the mutant constructs. Figure 4.6.2. displays the line 
selected for each construct and indicates which of the two expression groupings they have been 
placed into. 
 
 
 
Figure 4.6.2. Visualisation of selected Venus-Pico lines. Venus-Pico lines were selected based 
on their chromosome location and relative expression levels. Selected lines were subsequently 
placed into high or moderate expression groupings to enable suitable comparisons to be made 
during analysis of their phenotypic effects. 
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4.7. Expressing constructs in S2 cells 
 
As with expression of the transcripts in flies, appropriate destination vectors needed to be 
selected to enable expression of the Pico constructs within Drosophila embryo derived S2 cells 
(Schneider, 1972). Two suitable vectors were subsequently identified, the first of which was a 
metallothionein promoted N-terminal Protein A tag (pMt-PtA) vector kindly supplied by Paolo 
D’Avino (University of Cambridge). The use of a copper sulphate induced metallothionein 
promoter allowed tight control over the expression of each construct, limiting any potential 
toxicity and enabling a range of time course assays to be carried out. pAVW (1087) from the 
DGRC was the second vector deemed appropriate and consists of a constitutively active act5c 
promoter and an N-terminal Venus-tag to facilitate in a variety of imaging experiments. 
 
Again, LR recombination was performed to shuttle the constructs from pDONR entry clones into 
the selected destination vectors. The resulting products were transformed into competent cells 
and selected for on ampicillin plates. As no sequence data was available for pMt-PtA, accurate 
confirmation of correct insertion for this vector was not possible. However, SacI-SalI restriction 
digestion was at least able to verify insertion had taken place (data not shown). NdeI and SacII 
restriction digestion was used to verify correct insertion and orientation of the Pico constructs 
within the pAVW vectors, with the confirmatory results from gel electrophoresis shown in Figure 
4.7.1. 
 
Stably transfected lines were generated by co-transfecting S2 cells with each construct and the 
Blasticidin resistance gene pCoBlast using Cellfectin. The cell lines were maintained with 
Complete Schneider's medium containing toxic Blasticidin to continually select for successfully 
transfected cells. Despite repeated attempts using a wide range of CuSO4 concentrations, it was 
not possible to express PtA tagged Pico. In addition, constitutive expression of the Venus-Pico 
constructs appeared to be toxic, with the stably transfected cell lines all demonstrating 
significantly diminished growth rates and sickly appearance. Consequently, investigations were 
performed to assess the potential use of transiently transfected cells for imaging and pulldown 
experiments. 
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Figure 4.7.1. Agarose gel electrophoresis to validate pAVW Pico vectors following LR 
recombination. NdeI-SacII restriction digests were performed on pAVW Pico vectors following 
LR recombination. The resulting products were run on an agarose gel and confirmed correct 
orientation of the inserted constructs. 
 
Initial investigations using Cellfectin as a reagent for transient transfection of pAVW Pico yielded 
promising results, with an estimated efficiency of approximately 70-80% being observed in a 
number of experiments (data not shown). However, at an early stage in this study, Cellfectin was 
discontinued by the manufacturer and replaced with Cellfectin II, which despite its namesake, 
had a different composition to its predecessor (Invitrogen, personal communication). Despite 
repeated attempts to optimise, Cellfectin II failed to exhibit a transfection efficiency above 1%.  
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Figure 4.7.2. Confocal analysis of suitable reagent for transient transfection of S2 cells. A 
range of commercial reagents were examined by confocal microscopy to identify the most 
suitable for transient transfection of S2 cells with pAVW Pico. Effectene was established as the 
most appropriate with a transfection efficiency of around 15-20%. 
 
Consequently investigations were carried out to identify a suitable transfection reagent for use in 
S2 cells. Figure 4.7.2. shows results from the most successful compounds tested. The majority of 
reagents examined failed to achieve a transfection efficiency above 1%. However, Effectene 
consistently displayed an efficiency between 15-20%. Indeed, co-transformation of more than 
one construct regularly exhibited an efficiency of around 10% when the Effectine dose was 
increased in proportion to the number of constructs used. As such, all subsequent analysis of the 
Pico constructs in S2 cells utilised Effectine mediated transient transfection. 
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4.8. Discussion 
 
The work described in this chapter has led to the design and generation of an RNAi resistant 
Pico
WT
 construct capable of being used in a range of rescue experiments. It has also facilitated in 
the development of Pico mutant constructs predicted to have a reduced affinity for Enabled, 
Chickadee, Ras, PP1, and MAPK, enabling the role that these interactions play in MRL 
functionality to be ascertained. In addition, phospho and dephospho mimetic constructs have 
been created to examine the effects of phosphorylation on Pico's associations and overall 
activity. Lastly, the constructs were inserted into flies subsequently characterised to allow 
selection of lines suitable for future work, while a mechanism for transient expression in S2 cells 
has been developed to enable localisation experiments to be performed.  
 
4.8.1. Prospective investigations 
 
Previous work performed in the Bennett lab had already examined Pico's capacity to directly 
bind with several factors through yeast two-hybrid assays. However, these investigations were 
limited to confirming interactions in vitro and did not assess the role of these associations on 
Pico functionality (Taylor, 2010). By examining the protein binding capabilities of the WT and 
mutant constructs through co-immunoprecipitation, it is hoped that a more complete 
understanding of the responsibility certain interactions have on Pico's functionality will be 
developed. Initially, it was intended that pulldown experiments would be performed using S2 
cells as they generally offer cleaner extracts than flies, however, as it was only possible to 
transiently express the constructs at a relatively low efficiency in this system, other means of 
precipitating ectopic Pico complexes were ultimately utilised.  
 
Past analysis of Lpd and RIAM have found that both predominantly localise to lamellipodial 
tips, providing significant support for their role in cellular migration. (Krause et al., 2004, 
Lafuente et al., 2004). Prior to this report, only preliminary research had been carried out to 
assess Pico's localisation, however, this was performed within whole tissues with very little work 
done in single cells (Lyulcheva, 2006). Work performed by Rogers et al. 2002 has demonstrated 
a method for inducing lamella formation in S2 cells through the use of Concanavalin A (ConA) 
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coated coverslips. Subsequent experimentation completed in the Valle lab using the 
aforementioned technique confirmed the presence of numerous actin regulatory proteins within 
the lamellae of S2 cells and validated the ConA mediated approach for studying localisation 
(Rogers et al., 2003). Evaluating Pico's localisation within S2 cells will be crucial for accurately 
understanding its function, while assessing the positioning of the mutant constructs may enable a 
greater comprehension of how interactions affect Pico's ability to localise and operate correctly. 
Analysis of Pico's co-localisation with various binding partners could further assist with 
understanding how its associated proteins aid in overall functionality while lending further 
support to findings from the co-immunoprecipitation experiments. 
 
Given the plethora of powerful tools available within the Drosophila system, a wide range of 
prospective investigations can be carried out to assess the effects of the mutant constructs on 
growth and migration. Previous investigations have already confirmed Pico's role in growth and 
proliferation, with overexpression in wing discs leading to an increase in wing size, while RNAi 
mediated knockdown caused smaller wings to develop (Lyulcheva et al., 2008). Similar 
experiments performed in border cells has demonstrated a role for Pico in cellular migration. 
Ectopic overexpression of Pico was found to promote migration of the border cell cluster 
towards the oocyte, while depletion of pico by RNAi resulted in retarded migration of the cluster 
relative to wild type (Figure 4.8.1.a) (Taylor, 2010). Pico's ability to promote Ras mediated 
overgrowth has also been demonstrated through analysis of larval brains and a Drosophila 
metastasis model (Taylor, 2010, Pagliarini and Xu, 2003). Expression of constitutively active 
Ras
V12
 alone was found to cause some tissue overgrowth, however, when overexpressed in 
conjunction with ectopic Pico, a dramatic increase in tissue overgrowth was observed, with some 
cases of secondary metastases being reported (Figure 4.8.1.b) (Taylor, 2010, Lyulcheva, 2006). 
Using these methods to analyse the mutant constructs will enable a thorough understanding of 
how protein interactions and phosphorylation function in determining Pico's role in growth and 
migration. 
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Figure 4.8.1. Examples of phenotypic analysis to assess Pico's functional effects. (a) In wild 
type egg chambers, the position of the migrating border cells labelled with GFP (green) is 
typically in line with, or slightly behind, the end of the columnar follicle cells (signified by the 
dotted lines). Ectopic overexpression of Pico promoted migration of the cluster towards the 
oocyte while depletion through RNAi slowed migration of the border cell cluster relative to wild 
type (Taylor, 2010). (b) As a means of assessing overgrowth, UAS-GFP was expressed in the 
eye-antennal discs of Drosophila larvae. When constitutively active Ras
V12
 was expressed alone, 
a small amount of overgrowth was observed compared to wild type, however, when 
overexpressed in conjunction with ectopic Pico, a dramatic increase in GFP-marked tissue was 
seen with some larvae exhibiting metastases at ectopic sites (Lyulcheva, 2006). 
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5. Pico's interactions 
 
5.1. Introduction 
 
Given the substantial role associated proteins play in determining overall MRL functionality, a 
significant amount of work has focused on identifying potential partners and their respective 
binding sites. Previous research has confirmed that RIAM and Lpd interact with the actin 
regulatory proteins Ena/VASP and profilin through the proline rich and SH3 binding motifs 
distributed amongst their unstructured C-terminal regions (Lafuente et al., 2004, Krause et al., 
2004). In addition, RIAM and Lpd share a capacity to bind to the cytoskeletal protein Talin via 
N-terminal amphipathic helices, enabling Integrin activation and promotion of cell adhesion (Lee 
et al., 2009).  
 
Despite retaining significant sequence homology and possessing the ability to interact with many 
similar proteins, Lpd and RIAM display subtle differences in their binding preferences. RIAM 
has been shown to interact predominantly with active Rap-1 in a process requiring both the RA 
and PH domains, although it can bind active Ras with a lower affinity (Lafuente et al., 2004, 
Bos, 2005). In contrast, Lpd associates with active K-Ras, N-Ras, H-Ras, R-Ras and Rac, 
however no interaction with Rap-1 has yet been observed (Rodriguez-Viciana et al., 2004, 
Jenzora et al., 2005, Krause et al., 2004). RIAM and Lpd also differ in their PI binding 
preferences, with RIAM associating with PI(3)P and PI(5)P, while Lpd interacts with PI(3,4)P2 
(Jenzora et al., 2005, Krause et al., 2004, Lemmon, 2007). Since PIs represent early polarizing 
molecules during cell activation, the differential binding capacities may contribute to the distinct 
localisations characteristic of these proteins (Lemmon, 2003, Colo et al., 2012b). More recently, 
associations specific to each paralogue have been described, with Lpd shown to bind both 
srGAP3 and the tyrosine kinase c-Abl, while an interaction between RIAM and PLC-γ1 has also 
been reported (Endris et al., 2011, Michael et al., 2010, Patsoukis et al., 2009). The binding 
differences between these two similar paralogues highlights the need to properly assess the 
precise associations found within the other, more divergent orthologues if they are to be used in 
furthering our understanding of MRL function. 
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Surprisingly, though a plethora of phenotypic data has been reported, very little is currently 
known about Mig10s binding partners. To date, only interactions with an activated form of the 
Rac1 homolog CED-10, and the WRC protein ABI-1, have been described (Quinn et al., 2008, 
McShea et al., 2013). All other potential associations have only been theorised upon using co-
localisation studies, mutational analysis, and direct interactions of other MRL homologues 
presented in the literature (Quinn and Wadsworth, 2008). A little more has been reported 
concerning the binding partners of Pico, with yeast-two-hybrid assays confirming direct 
interactions with activated Ras and Rap, Enabled, Chickadee, and PP1 (Taylor, 2010). However, 
further validation of these interactions using an in vivo system has yet to be performed and 
identification of the sites of binding had not been carried out. 
 
5.1.1. Aims 
 
The intention of the investigations performed in this chapter was to first confirm the findings of 
the yeast-two-hybrid assays in vivo through co-immunoprecipitation studies, while the ability of 
Pico to interact with homologues of the other MRL binding partners described in the literature 
was also assessed. Following identification of a potential MAPK binding site in Chapter 3, a 
selection of apposite MAPKs were examined for associations with Pico, as well as RIAM and 
Lpd. Subsequent hits were assessed further using the MAPK mutant construct to ascertain if the 
proposed site was necessary for binding, before mass spectrometry was performed to identify 
novel binding proteins of Pico to be later verified by co-IP studies. 
 
The mutant constructs generated in Chapter 4 were then assessed by co-immunoprecipitation to 
determine their effect on Pico's interactions before further analysis was performed to elucidate 
the involvement of Pico-bound MAPKs in the phosphorylation of Pico-Ser 819 through the use 
of a phospho-specific antibody. Finally the functional role of this phosphorylation site in Pico 
was investigated to determine how it affected Pico’s associations with other proteins by using the 
phospho- and dephospho-mimetic constructs. 
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5.2. Pico's interactions 
 
As a means of confirming and broadening the findings from the yeast-two-hybrid assays 
performed previously within the Bennett lab showing interactions with Ras, Rap, Enabled, 
Chickadee, and PP1, co-IPs were carried out using ectopically expressed Venus-Pico
WT
. Due to 
the low transient transfection efficiency and general toxicity observed in stable lines, S2 cells 
could not be used as an expression vehicle for Venus-Pico. Consequently, expression of Venus-
Pico
WT
 was carried out in flies However, as with S2 cells, ectopic Venus-Pico was found to be 
toxic and caused lethality during early larval development when used in combination with a 
ubiquitous driver such as act5C-GAL4 and da-GAL4. The alternative enGAL4 driver, employed 
during the analysis of Pico expression levels, only appeared to initiate transcription during the 
larval stage as no discernable expression was observed in adult flies (Harrison et al., 1995). 
Attempts to precipitate Venus-Pico from enGAL driven larvae failed due to insufficient 
quantities of the transcript and difficulties in sufficiently lysing the tissues (data not shown). 
Instead, the heat shock inducible hsGAL4 driver was used to express the Venus-Pico constructs 
from which Venus-positive flies were selected for before co-immunoprecipitation, SDS-PAGE, 
and western blotting was carried out to identify complexed proteins (Halfon et al., 1997).  
 
For each experiment, total extracts made from lysed samples before the addition of GFP-Trap 
magnetic particles were used to confirm the presence of the protein under investigation, while 
co-IPs from W
1118
 flies lacking Venus-tagged Pico were employed as a negative control. To 
avoid overexposure of the positive control lanes, the quantities of total lysates and co-IP samples 
were normalised to yield broadly similar band intensities. This typically meant positive control 
lanes represented roughly 1/4 of a fly, while the IPs corresponded to approximately 7 flies. For 
all experiments where a negative result was observed, the corresponding co-IP sample was 
examined for the presence of Talin to confirm successful precipitation had occurred. 
 
5.2.1. Pico co-immunoprecipitates with expected binding partners 
 
To verify previous findings from the yeast-two-hybrid assays (Taylor, 2010), immunoblotting 
was performed on Venus-tagged Pico
WT
 co-IP samples to test for the presence of PP1, Enabled, 
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and Chickadee. The results presented in Figure 5.2.1. show the existence of both PP1 and 
Chickadee within the Pico
WT
 immunoprecipitates, indicating that Pico interacts with both 
proteins. It was not possible, however, to prove Enabled association as optimisation of the 5G2-
Enabled specific antibody for use in western blots was unsuccessful (data not shown). Lastly, 
due to the previously documented interaction of Talin with both Lpd and RIAM (Lee et al., 
2009), the presence of Rhea, the Drosophila Talin homologue, was also examined in Pico
WT 
precipitates. The data shown in Figure 5.2.1. confirmed the presence of Rhea in the co-IP sample 
and demonstrates Pico's ability to complex with the Talin homolog in vivo. 
 
 
 
Figure 5.2.1. Immunoblots of PP1, Chickadee, and Talin from Venus-Pico
WT
 pulldown 
expreriments. Co-immunoprecipitation was performed on flies expressing Venus-Pico
WT
 using 
GFP-Trap magnetic beads. The resulting samples were examined via immunoblot analysis to 
ascertain the presence of PP1, Chickadee, Enabled, and Rhea in the pulldown. The findings 
indicate that Pico associates with PP1, Chickadee and Rhea in vivo, however, analysis of 
Enabled was inconclusive. 
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5.2.2. Pico interacts with Ras but not Rap 
 
 
 
Figure 5.2.2. Immunoblots of Ras and Rap from Venus-Pico
WT
 pulldown experiments. 
Pulldowns were carried out on flies expressing Venus-Pico
WT
 under the control of hs-GAL4 
using GFP-Trap. The samples were then examined by western blotting to determine if Ras or  
Rap interact with Pico. The results showed Pico complexes with Ras but not Rap, although it is 
possible interactions with Rap occur at low levels. 
 
Previous work performed within the Bennett lab had already demonstrated by yeast-two-hybrid 
analysis that Pico directly binds the active forms of both Ras and Rap, but not their wild type or 
dominantly negative forms. Furthermore, these associations were observed using both a full-
length Pico construct and a partial fragment containing only the RA and PH domains (Taylor, 
2010). Consequently, co-IP and immunoblotting was performed to ascertain if these interactions 
also occurred in vivo.  
 
The results shown in Figure 5.2.2. suggest that Pico binds Ras but not Rap in vivo, although, care 
should be noted in this result as a failure to detect Rap interaction does not necessarily confirm 
an inability to bind Rap. Indeed, it may be that Pico, much like RIAM, is capable of associating 
with both GTPases, but displays a preference for Ras or binds Rap only under certain 
circumstances (Lafuente et al., 2004, Bos, 2005). 
110 
 
5.2.3. Pico interacts with activated Rolled but not Jnk 
 
 
 
Figure 5.2.3. Western blots of Erk1/2, activated Erk1/2 and Jnk using Venus-Pico
WT
 co-IP 
samples. Pulldowns were performed on flies expressing Venus-Pico
WT
 using GFP-Trap 
magnetic beads before being examined by immunoblot analysis to establish the presence of 
Rolled, activated Rolled, and Jnk within the co-IPs. The findings showed Pico was able to 
interact with both Rolled and activated Rolled, but not Jnk. 
 
Identification of the highly conserved MAPK binding site described in Chapter 3 strongly 
suggested MRL may have a conserved ability to bind MAPK. As such, Pico's capacity to 
associate with members from each of the three principal MAPK families, Erk, Jnk, and p38, was 
assessed (Muda et al., 1996). Initially, interactions with the Erk1/2 homologue, encoded by 
rolled, was examined by co-IP and immunoblotting due to the well documented role Erk family 
kinases play in both cell growth and migration (Cargnello and Roux, 2011). The data presented 
in Figure 5.2.3. suggests Pico can associate with Rolled in vivo. Next, the ability of Pico to 
interact with activated Rolled was investigated through the use of an antibody specific to the di-
phosphorylated form of Erk1/2. Results shown in Figure 5.2.3. confirm Pico's capacity to interact 
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with activated Rolled, however, the data was unable to determine if Pico associates exclusively 
with the active form or not. 
 
Lastly, analysis was performed to determine if Pico associates with Jnk family members. The 
evidence from Figure 5.2.3. suggests Pico does not interact with Jnk family kinases, although, as 
with Rap, this cannot be considered categorical due to the nature of co-IPs. Unfortunately it was 
not possible to assess p38 associations as an antibody capable of detecting the Drosophila 
isoform could not be procured. 
 
5.2.4. Pico binds directly to Rolled at the conserved MAPK binding site 
 
 
 
Figure 5.2.4. Immunoblot of Erk1/2 from Venus-Pico
WT
 and Venus-Pico
MAPK
. Co-
immunoprecipitation was carried out on hs-GAL4 flies expressing Venus-Pico
WT
 and Venus-
Pico
MAPK
 using GFP-Trap beads. The subsequent pulldowns were examined by western blotting 
to determine if Rolled was present. The findings indicated that while Pico
WT
 can associate with 
Rolled, the MAPK-binding mutant was unable to, suggesting that Pico might bind directly to 
Rolled via the conserved MAPK binding site. 
 
Following confirmation of Pico-Rolled associations, the capability of the MAPK-binding mutant 
Pico
MAPK
 to also interact with Rolled was assessed to determine if the conserved MAPK binding 
site was critical for binding. The results presented in Figure 5.2.4. indicates Pico
WT
 associates 
with Rolled, however, Pico
MAPK
 failed to interact. Taken together with the known properties of 
the MAPK motif, this finding implies Pico binds Rolled directly through the conserved MAPK 
binding site described in Chapter 3.  
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5.2.5. Lpd and RIAM also exhibit Erk1/2 interactions at the conserved MAPK binding site 
 
 
 
Figure 5.2.5. Western blots of Erk1/2 from Lpd-S, Lpd-CC, and RIAM pulldowns. Co-
immunoprecipitation was carried out on arm-GAL4 flies expressing (a) FLAG-Lpd-S, and (b) 
Myc-Lpd-CC before western blotting was performed to ascertain the presence of Rolled. The 
results showed wild type Lpd-S was able to interact with Rolled, while the Lpd coiled-coil 
mutant (Lpd-CC) could not. (c) A SUMO tagged RIAM fragment (residues 147-174) was 
incubated with total lysates from Hela cells, S2 cells and whole adult flies. The protein was then 
pulled down using SUMO-Qapture resin and immunoblot analysis carried out to establish 
whether associations with either Erk1/2 or Rolled had occurred. '-' indicates samples incubated 
with SUMO-Qapture resin alone, while '+' denotes lysates where SUMO-RIAM peptide had 
been added before co-immunoprecipitation took place. The findings revealed that the shortened 
RIAM peptide was sufficient to enable interactions with Erk1/2 and Rolled within Hela, S2 and 
Drosophila systems. 
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Having shown direct binding of Pico to Rolled through the conserved MAPK motif, experiments 
were carried out to determine whether Lpd and RIAM displayed a similar ability. A FLAG-
tagged wild type Lpd construct expressed in adult flies using the arm-GAL4 driver was 
immunoprecipitated using anti-FLAG bound to Protein G Sepharose before Western blot 
analysis was performed to ascertain if Rolled was present in the precipitates. As with the Venus-
Pico
WT
 experiments, W
1118
 flies lacking any tagged ectopic protein were utilised as a negative 
control, while total lysates confirmed the presence of the protein under investigation. The results 
shown in Figure 5.2.5.a confirm that Lpd is able to associate with the Drosophila Erk1/2 
homologue Rolled, despite being from a highly diverged species. 
 
Next, the ability of Myc tagged Lpd-CC, a construct possessing a mutated coiled-coil motif, to 
interact with Rolled was assessed to establish if direct binding also occurred at the conserved 
MAPK site in Lpd. Again, using the arm-GAL4 driver, Myc-Lpd-CC and a Myc-tagged Pico WT 
construct were expressed in adult flies and pulled down through co-immunoprecipitation. The 
resulting samples were then assessed by western blotting to determine if Rolled was present. 
Figure 5.2.5.b reveals that Myc-Pico, but not Myc-Lpd-CC, was able to bind Rolled, suggesting 
that Lpd, much like Pico, binds Erk1/2 or Rolled directly via one of its conserved MAPK sites. 
While it may seem this data points to interactions occurring at the site positioned within the 
coiled-coil motif, it is possible that disruption to this region also interferes with the second site 
situated at the N-terminus of the RA domain. 
 
As a means of determining whether RIAM is able to interact with Erk1/2 or Rolled, and also to 
ascertain whether the MAPK binding motif within the coiled-coil region plays a role in this 
association, a short SUBO-tagged peptide consisting of RIAM residues 147-174 was kindly 
provided by Thomas Zacharchenko (University of Liverpool). This region contains the coiled-
coil motif enclosing the conserved MAPK
site1
 site, but lacks the MAPK
site2
 binding motif 
positioned at the N-terminus of the RA domain. Structural studies were performed by the 
Barsukov lab (University of Liverpool) to confirm protein folding had occurred and verify purity 
of the peptide prior to any analysis being carried out.  
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Extracts were made from Hela cells, S2 cells, and whole adult flies using RIPA buffer before the 
SUMO-RIAM peptide was incubated with each sample. The RIAM peptide was then pulled 
down by SUMO-Qapture resin and the resulting samples boiled in SDS-PAGE buffer and 
analysed by western blotting for the presence of Erk1/2 and Rolled. Samples of total extracts 
were used to confirm presence of the protein under investigation, while lysates incubated with 
SUMO-Qapture resin alone acted as negative controls. The findings presented in Figure 5.2.5.c 
demonstrate that the short RIAM peptide was able to bind Erk1/2 and Rolled within Hela, S2 and 
Drosophila systems. Further control experiments demonstrated that the RIAM peptide was 
unable to associate with either Ras or Talin (data not shown), validating the procedures carried 
out. Taken together, these results suggest that Erk1/2 binds directly to both Lpd and RIAM via 
the conserved MAPK
site1
 binding motif situated within the coiled-coil region, however, the 
binding ability and functionality of MAPK
site2
 remains unclear. 
 
5.3. Novel interactions identified by Mass Spectrometry 
 
Pico had so far been shown to associate with Chickadee, Rhea, Ras, Rolled and PP1 in vivo, 
while potential Enabled interactions were also deemed highly likely based on previous work 
performed within the lab and findings presented in the literature (Taylor, 2010, Colo et al., 
2012b). As a means of identifying novel interaction partners and generating further evidence to 
support the current findings, mass spectrometry was carried out on Venus-Pico
WT
 pulldowns. 
Co-IPs performed on W
1118
 flies using GFP-Trap were also analysed by mass spectrometry to 
provide a comparable control.  
 
5.3.1. SDS PAGE mass spectrometry identifies Fasciclin 1 as a potential complex partner 
 
Initially, mass spectrometry on coomassie-stained bands cut out SDS-PAGE gels was carried out 
to identify proteins in complex with Pico. Co-IP samples were run out on a gel alongside 
controls (Figure 5.3.1.) and eight individual bands subjected to mass spectrometry by the Beynon 
lab using a Bruker AmaZon before analysis of the raw data was completed using PEAKS 6. 
Initial findings appeared perplexing and were eventually considered inaccurate as manual 
examination of the unprocessed data highlighted more appropriate solutions that corresponded 
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better with the expected outcomes. Consequently Mascot was employed instead to assess the raw 
data, with the findings displayed in Figure 5.3.1. 
 
 
 
Figure 5.3.1. Results from SDS-PAGE mass spectrometry. Co-immunoprecipitation was 
performed on W
1118
 and hs-GAL4 Venus-Pico
WT
 flies using GFP-Trap magnetic beads. The 
resulting samples were separated by one dimensional SDS-PAGE and stained using coomassie 
blue. The eight bands highlighted in the figure were cut out and analysed by mass spectrometry 
to determine their spectral pattern before their identity was confirmed by Mascot. Pico, Fasciclin, 
FXR1, PABP, and 60S ribosomal protein were classified from the Pico
WT
 pulldown. 
 
Pico was recognised in multiple bands (bands 3, 4, and 6), most likely representing degradation 
products of the full-length protein, confirming its successful precipitation by GFP-trap. Myosin 
heavy chain was also discovered (band 2), however a faint band of approximately the same 
weight can be seen in the W
1118
 co-IP, indicating that this may be an artefact of pulldowns using 
GFP-Trap. It is unclear why this banding is much stronger in the Venus-Pico
WT
 pulldown, 
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although it may be caused by actual interactions with Pico or an increase in myosin levels 
following Pico overexpression.  
 
Strangely, the RNA binding Fragile X mental retardation syndrome protein 1 (FXR1) (band 5), 
Polyadenylate binding protein (PABP) (band 7), and 60S ribosomal protein (band 8) were 
identified, with no comparative bands being seen in the W
1118
 co-IP. It is thought these factors 
may have been pulled down with partially synthesised Pico still undergoing translation, as the 
targeted Venus tag is situated at the N-terminus and will have been generated first. Interestingly, 
the homophilic cell adhesion molecule Fasciclin 1 was also discovered from a very distinctive 
high molecular weight band (band 1). No corresponding band of equal size was observed in the 
W
1118
 co-IP and given its established role in cell adhesion, represents a respectable novel 
candidate for further study (Elkins et al., 1990). However, it should be noted that Fasciclin 1 has 
a predicted weight of 73 kDa, while the band analysed appears to have a molecular weight well 
in excess of 150 kDa, which is far in excess of what might be expected even if the protein were 
extensively glycosylated (Wang et al., 1993).  
 
5.3.2. Mass spectrometry of total pulldowns isolates cdc42 as another potential Pico interactor 
 
Despite yielding some potentially useful findings, various flaws were identified in the SDS-
PAGE mediated mass spectrometry. Notably, numerous bands were observed in the Venus-
Pico
WT
 lane of the coomassie stained SDS gel, however, only a few were extracted and analysed 
due to them being deemed either too close together or insufficiently stained to enable accurate 
selection. Also, of those bands examined, none corresponded to the already well characterised 
associated proteins identified from the yeast-two-hybrid and co-IP investigations, highlighting 
the limitations of this process. Consequently, mass spectrometry was performed on total GFP-
trap pulldowns from Venus-Pico
WT
 and W
1118
 flies using an LTQ Velos. The overall spectral 
readouts from each pulldown is shown in Figure 5.3.2. 
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Figure 5.3.2. Complete spectra from total W
1118
 and Venus-Pico
WT
 pulldowns. Complete 
spectra of GFP-trap pulldowns from (a) W
1118
 and (b) Venus-Pico
WT
 expressing flies. The 
spectra show significant similarities and indicate that many of the proteins identified may be 
artefacts bound to the GFP-Trap beads. 
 
The complete spectral readouts from Venus-Pico
WT
 and W
1118
 pulldowns shown in Figure 5.3.2. 
revealed numerous individual proteins in both samples. In addition, the similarities of the peak 
distributions suggested many of the proteins were present in both samples, implying that the 
majority of recognised peptides were probably artefacts bound to the GFP-trap beads and not 
specifically complexed with Pico. Indeed, closer inspection revealed over 350 different proteins 
had been identified by PEAKS 6 and Mascot in each sample, of which only 35 were unique to 
the Venus-Pico
WT
 co-IP. A complete list of proteins found exclusively in each pulldown can be 
found in Appendix 4.  
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Figure 5.3.3. Manually annotated example spectra for Pico and its previously identified 
associated partners. Total GFP-Trap mediated pulldowns from Venus-Pico
WT
 and W
1118
 were 
analysed by mass spectrometry. The resulting data was examined by PEAKS 6 and Mascot 
before proteins unique to the Venus-Pico
WT
 co-IP were rationalised to select for those involved 
in regulation, growth, and migration only. (a) Pico, along with its previously identified 
interacting proteins (b) Ras, (c) PP1 α87B,  and (d) PP1 β9C were identified by both programs, 
while (e) Chickadee was only detected using the more sophisticated Mascot software. To 
confirm these findings, manual analysis of the mass spectra was performed and compared to the 
software's calculated sequence shown in the top right corner of each graph.  
 
A rationalisation process was carried out to eliminate proteins unrelated to regulation, growth, or 
migration. Those remaining were manually assessed to confirm correct identification before 
further conclusions were made. As expected, Pico was identified numerous times, with 39 unique 
peptides recognised covering 40% of the total sequence (Figure 5.3.3.a). Interestingly, the 
previously characterised Pico binding partners Ras and PP1 were detected by both software 
packages, whereas Chickadee was only pinpointed via the more advanced Mascot software. 
Distinctive Ras peptides were detected twice and corresponded to 11% of the total sequence 
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(Figure 5.3.3.b), while peptides for PP1 α87B (Figure 5.3.3.c) and PP1 β9C (Figure 5.3.3.d) were 
each observed only once and covered just 3% of their respective sequences. PEAKS 6 was 
unable to identify Chickadee as the complex nature pertaining to the large 22mer peptide, 
containing various modifications and di/tri-meric residue states, could only be resolved using the 
more sophisticated Mascot software (Figure 5.3.3.e). Although just one peptide corresponding to 
Chickadee was discovered, it did cover 17% of the total sequence and had a low degree of 
calculation error. 
 
In addition to identifying the previously characterised Pico binding partners, PEAKS 6 and 
Mascot both revealed the presence of cdc42 exclusively within the Venus-Pico
WT
 co-IP sample. 
A total of two unique peptides were observed and found to correspond with 11% of the total 
protein sequence, while the manual analysis shown in Figure 5.3.4. confirmed correct software 
identification. Given cdc42's acknowledged role in stimulating signalling cascades controlling 
cytoskeletal remodelling, cell polarity establishment, migration, proliferation, and transcription, 
it represents another suitable candidate for further study (Chi et al., 2013).  
 
Interestingly, neither Enabled, Rolled, or Fasciclin 1 were identified by either PEAKS 6 or 
Mascot in either the Venus-Pico
WT
 and W
1118
 total pulldowns. Regardless of this, repeated 
attempts were made to determine whether fasciclin1 and cdc42 were associated with Pico via 
immunoblot analysis of Venus-Pico
WT
 co-IPs. Unfortunately, it was not possible to optimise the 
available antibodies for use in western blotting, preventing any auxiliary investigations from 
being carried out (data not shown).  
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Figure 5.3.4. Manually annotated mass spectrums corresponding to the two cdc42 peptides 
detected. Mass spectrometry was performed on total co-IPs from W
1118
 and Venus-Pico
WT
 and 
analysed by PEAKS 6 and Mascot. Proteins unique to the Venus-Pico
WT
 pulldown were 
rationalised to select for those involved in regulation, growth, and migration. In addition to 
identifying the well characterised Pico associated proteins Ras, PP1 and Chickadee, this 
investigation also discovered cdc42 as a potentially novel interacting protein, a finding 
confirmed by manual analysis of the spectra. The software's predicted sequence is shown in the 
top right corner of each graph (lower case letters indicate some uncertainty in residue identity). 
 
5.4. Analysis of Pico mutant constructs 
 
Having established the binding properties of wild type Pico, experiments assessing the binding 
abilities of the site-directed Pico mutants were performed. As with the Venus-Pico
WT
 
investigations, hs-GAL4 was used to express the Venus-tagged mutant constructs, while 
pulldowns were carried out with GFP-Trap. Also, total extracts made from lysed samples before 
the addition of GFP-Trap magnetic particles were utilised to confirm the presence of the protein 
under investigation, whereas co-IPs from W
1118
 were employed as a negative control. 
 
5.4.1. The putative EVH1-binding motifs are not crucial for interactions with Chickadee 
 
Co-IPs of the Venus-Pico
LA
 mutant were assessed to determine whether the seven leucine to 
alanine mutations introduced to the characteristic Drosophila EVH1 binding sites (LPPPP) 
interfered with Pico's potential associations. Enabled is predicted to bind to Pico via one or more 
of Pico’s EVH1-binding motifs, however, since both Pico and Chickadee have been reported to 
bind to Enabled (Lyulcheva et al., 2008, Krause et al., 2002), association of Chickadee with Pico 
may be indirect. The results shown in Figure 5.4.1. indicate that Pico
LA
 can successfully complex 
with Chickadee as well as Rolled, PP1, Ras, and Rhea. This indicates that the leucine containing 
proline rich regions are not crucial for Chickadee interactions and although it was not possible to 
confirm whether Pico
LA
 disrupted binding to Enabled, an equivalent set of mutations in Lpd does 
abrogate Enabled binding (Matthias Krause, personal communication), therefore suggesting that 
binding of Chickadee to Pico is not via Enabled.  
124 
 
 
 
Figure 5.4.1. Immunoblots of Erk1/2, PP1, Ras, Chickadee, and Talin from Venus-Pico
LA
 
mutant pulldowns. Co-immunoprecipitation was performed on flies expressing the Venus-
Pico
LA
 mutant using GFP-Trap magnetic beads. The resulting samples were examined via 
immunoblot analysis to confirm the presence of Rolled, PP1, Ras, Chickadee, and Rhea in the 
pulldown. The findings showed that the Pico
LA
 mutant can associate with Rolled, PP1, Ras, 
Chickadee, and Rhea iv vivo, indicating that the leucine containing proline rich regions are not 
crucial for Chickadee interactions, although they may still be involved in binding with Enabled. 
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5.4.2. RA mutations have no discernable effect on Ras or Rap binding 
 
 
 
Figure 5.4.2. Western blots of Erk1/2, PP1, Ras, Chickadee, and Talin from Venus-Pico
RE
 
and Pico
RR
 mutant pulldowns. Pulldowns were carried out on hs-GAL4 flies expressing the 
Venus-tagged Pico
RE
 and Pico
RR
 mutant constructs using GFP-Trap. The resulting samples were 
then examined by western blotting to determine if Rolled, PP1, Ras, Chickadee, and Rhea were 
present. The results showed that both the Pico
RE
 and Pico
RR
 mutants were able to interact with 
Rolled, PP1, Ras, Chickadee, and Rhea iv vivo, implying that the desired alterations to Pico's 
affinity for Ras had not been achieved.   
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Pulldowns from the Venus-tagged Pico
RE
 and Pico
RR
 mutant constructs, designed to exhibit 
increased and reduced affinities for Ras respectively, were examined. The findings displayed in 
Figure 5.4.2. indicate no discernable alterations in Ras binding had been achieved in either 
mutant, and that they were both still capable of interacting with Rolled, PP1, Chickadee, and 
Rhea. A further investigation assessing Rap interactions was also carried out to determine if the 
modifications present in either construct enabled Rap binding, however, as with wild type Pico, 
no association was observed (data not shown).  
 
5.4.3. Protein Phosphatase 1 (PP1) is not required for Pico's interactions 
 
At first the Venus-tagged Pico
F816A
 mutants ability to interact with Protein Phosphatase 1 was 
assessed to determine whether replacement of the phenylalanine at position 816 with an alanine 
was sufficient to prevent direct binding as had been previously described (Lyulcheva, 2006). The 
results presented in Figure 5.4.3. show that PP1 is unable to bind Pico
F816A
, therefore providing 
further evidence that direct binding between the two proteins occurs via the N-terminally located 
site and not at the conserved motif positioned within the RA domain (Chapter 3.3.). 
 
Accordingly, the effects of PP1 binding on Pico's interactions with its other associated factors 
was examined. The outcomes illustrated in Figure 5.4.3. showed that the PP1 binding mutant was 
able to complex with Rolled, Ras, Chickadee, and Rhea, suggesting that binding of Pico to PP1 
is not required for Pico to interact with these associated factors.  
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Figure 5.4.3. Immunoblots of PP1, Erk1/2, Ras, Chickadee, and Talin from Venus-Pico
F816A
 
mutant pulldowns. Co-immunoprecipitation using GFP-Trap was performed on flies expressing 
the Venus-Pico
F816A
 mutant construct. The resulting pulldowns were studied by western blot 
analysis to detect for the presence of PP1, Rolled, Ras, Chickadee, and Rhea. The results 
indicated that Pico
F816A
 was incapable of interacting with Protein Phosphatase 1, but could still 
complex with Rolled, Ras, Chickadee, and Rhea; indicating that PP1 binds directly to Pico via 
this site and that association with PP1 is not required for the other interactions to occur.  
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5.4.4. MAPK binding is required for interactions with PP1 
 
 
 
Figure 5.4.4. Western blots of PP1, Ras, Chickadee, and Talin from Venus-Pico
MAPK
 
mutant pulldowns. Pulldowns using GFP-Trap were carried out on hs-GAL4 flies expressing 
the Venus-tagged Pico
MAPK
 construct already shown to lack binding with Rolled. The resulting 
samples were then examined by immunoblotting to determine if PP1, Ras, Chickadee, and Rhea 
were present in the pulldowns. The findings showed that not only was the Pico
MAPK
 mutant 
unable to bind Rolled, but it was also incapable of interacting with PP1, indicating that Rolled 
plays a role in PP1 binding. The results also revealed that the MAPK-binding mutant could 
associate with Ras, Chickadee, and Rhea, demonstrating that Rolled was not required for the 
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other interactions to occur and that the residue changes within this construct had not caused 
extensive disruption to the tertiary structure. 
 
Earlier work (Figure 5.2.4.) had already demonstrated that Pico
MAPK
 was incapable of binding 
Rolled. Consequently, pulldowns from Venus-tagged Pico
MAPK
 were examined to determine 
whether Rolled binding had any effect on PP1, Ras, Chickadee and Rhea interactions. The 
results shown in Figure 5.4.4. indicate that Pico
MAPK
 mutant is unable to bind to PP1, but can still 
complex with Ras, Chickadee and Rhea. This suggests that Rolled is involved in PP1 binding but 
is not required for the other interactions to occur. Furthermore, these findings show that the 
residue changes within this construct does not cause extensive disruption to the tertiary protein 
structure. 
 
5.5. Effects of Phosphorylation 
 
In addition to studying the effects of individual binding site mutations on MRL functionality, it 
was also important to assess the role phosphorylation played in regulating Pico's interactions, 
especially following confirmation that Pico binds MAPK and PP1, and the effect Rolled 
interactions had on PP1s association. 
 
5.5.1. Rolled is involved in phosphorylation of serine 819 
 
Previous work presented in the literature had identified the Ser 819 as a site of phosphorylation 
within Pico (Bodenmiller et al., 2007), while earlier findings discussed in this chapter showed 
direct interactions between the MAPK Rolled and Pico. Taken together with the discovery that 
Rolled may be involved in PP1 binding at a motif adjacent to the proposed phosphorylation site, 
it was hypothesised that Rolled might phosphorylate the serine at this position. Subsequent 
target-sequence analysis using Phospho.ELM revealed Pico-Ser 819 to be a potential target of 
Erk1/2 (Dinkel et al., 2012), while more direct approaches utilising a phospho-specific antibody 
designed to specifically recognise Pico phosphorylated at this site was also carried out. 
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Figure 5.5.1. Confirmation of Rolled's involvement in phosphorylation of serine at position 
819. (a) Total extracts from W
1118
, hs-GAL4 Pico
WT
, and hs-GAL4 Pico
MAPK
 flies were analysed 
by western blotting to ascertain the levels of serine 819 phosphorylation using a phospho specific 
antibody. The results showed that the MAPK-binding mutant displayed very little apparent 
phosphorylation at this site compared to Venus-Pico
WT
, even though GFP staining indicated 
slightly higher levels of the ectopic protein within the Pico
MAPK
 sample. Pico
S819A
 and Pico
S819D
 
total extracts were also included to enable validation of the phospho-Pico antibody (b) Wing 
discs expressing Venus-tagged Pico
WT
 (green) under the control of en-GAL4 were stained with 
the phospho specific antibody (red) and visualised by confocal microscopy. (c) The findings 
following linear plot profiling indicate that the levels of phosphorylated Pico are notably higher 
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in cells expressing the ectopic protein compared with those that are not. (d) en-GAL4 Pico
MAPK
 
(green) was also expressed in wing discs subsequently stained with the phospho specific 
antibody (red) and visualised under a confocal microscope. (e) The linear plot profiling results 
show that the levels of phosphorylated Pico remain the same between cells expressing ectopic 
Pico
MAPK
 and those that do not, implying that Pico
MAPK
 cannot be phosphorylated at Ser 819. 
When combined, these data suggest that Pico-bound Rolled is involved in phosphorylation of the 
Serine at position 819 within Pico. 
 
Extracts from W
1118
 and hs-GAL4 flies expressing Venus-Pico
WT
 and Venus-Pico
MAPK
 were 
examined by immunoblotting with an antibody raised against a Pico peptide mimicking 
phosphorylation at Ser 819. Further control blots were carried out using anti-GFP to determine 
the amount of ectopic protein present in the samples. The results displayed in Figure 5.5.1.a 
indicate that the MAPK-binding mutant exhibits very little phosphorylation compared to Venus-
Pico
WT
, even though the GFP staining indicates comparable levels of ectopically expressed Pico 
protein. The ability of the phospho-specific antibody to recognise Pico
S819D
 but not Pico
S819A
 in 
total extracts indicates that the antibody fails to recognise Pico that is not phosphorylated at this 
site. Overall, these findings provide support for the specificity of the phospho-Pico antibody and 
suggest that Rolled is involved in the phosphorylation of Pico at position 819. 
 
As a means of providing further evidence to support this conclusion, wing discs dissected from 
en-GAL4 larvae characteristically expressing Venus-Pico
WT
 in the posterior compartment were 
stained with the phospho-specific antibody and visualised by confocal microscopy (Figure 
5.5.1.b). The graphical representation of relative fluorescence levels presented in Figure 5.5.1.c 
shows that the levels of phosphorylated Pico were considerably higher in cells expressing Venus-
Pico
WT
 compared with those that did not. Contrastingly, wing discs from en-GAL4 Venus-
Pico
MAPK
 larvae stained with the phospho specific antibody shown in Figure 5.5.1.d indicated 
that the levels of phosphorylated Pico were the same in cells expressing the ectopic MAPK-
binding mutant and those that did not (Figure 5.5.1.e). This confirmed that Pico
MAPK
, unable to 
interact with Rolled, could not be phosphorylated at serine 819. When combined with the 
findings from en-GAL4 Venus-Pico
WT
, this result further supports the hypothesis that Rolled is 
involved in phosphorylation of Pico at position 819. 
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5.5.2. Phosphorylation of Serine 819 is important for PP1 binding 
 
 
Figure 5.5.2. Immunoblots of Erk1/2, PP1, Ras, Chickadee, and Talin from Venus-Pico
S819A
 
and Pico
S819D
 mutant pulldowns. Pulldowns were carried out on hs-GAL4 flies expressing the 
Venus-tagged Pico
S819A
 and Pico
S819D
 mutant constructs using GFP-Trap. The samples were 
examined by western blot analysis to detect for the presence of Rolled, PP1, Ras, Chickadee, and 
Rhea. The results indicated that the non-phosphorylatable Pico
S819A
 mutant was unable to bind 
PP1, although it could associate with the other interaction partners. Conversely, the 
phosphomimetic Pico
S819D
 construct was found to bind PP1, as well as Rolled, Ras, Chickadee 
and Rhea, suggesting that phosphorylation of serine 819 plays a key role in PP1 binding. 
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Lastly, co-IPs from the Venus-tagged Pico
S819A
 and Pico
S819D
 mutant constructs were examined 
to determine if phosphorylation of Ser 819 had any effect on Rolled, PP1, Ras, Chickadee and 
Rhea interactions. The findings displayed in Figure 5.5.2. show that the dephosphorylated 
Pico
S819A
 mutant was unable to bind PP1, although it could associate with the other interaction 
partners. Conversely, the phosphomimetic Pico
S819D
 construct was found to interact with PP1, as 
well as Rolled, Ras, Chickadee and Rhea, indicating that phosphorylation of Ser 819 enables PP1 
to bind with Pico, and that PP1 interactions do not significantly affect associations with the other 
binding partners. 
 
5.6. Discussion 
 
The work described in this chapter provides further evidence that Pico interacts with Ras, PP1, 
and Chickadee in vivo through both immunoblot analysis and mass spectrometry; supporting 
previous findings from yeast-two-hybrid studies of Pico, and investigations assessing the 
associations formed by the other MRL orthologs (Taylor, 2010, Krause et al., 2004, Lafuente et 
al., 2004). Indeed, taken together with the results from bioanalysis, site directed mutational 
examination, and yeast-two-hybrid assays, these findings strongly imply that Ras, PP1, and 
Chickadee bind to Pico directly. The investigations also indicated that Pico, much like Lpd and 
RIAM, could complex with the Talin homolog Rhea, although neither direct interaction or a 
protein region mediating this association was identified (Lee et al., 2009).  
 
Unfortunately, it was not possible to verify Enabled binding to Venus-Pico by co-IP as the 
Enabled antibody could not be optimised for use in western blots, and mass spectrometry failed 
to identify any analogous peptides. It should be noted that an inability to identify proteins 
through mass spectrometry does not necessarily confirm an absence, as large peptides, highly 
folded proteins, and disulphide rich proteins are often problematic to detect (Lubec and Afjehi-
Sadat, 2007). However, based on the well established interactions between MRL proteins and 
Ena/VASP described within the literature, in addition to findings from the yeast-two-hybrid 
assays, it is likely that Pico binds directly to Enabled via its C-terminal proline rich motifs 
(Krause et al., 2004, Lafuente et al., 2004, Taylor, 2010) 
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5.6.1. MRL proteins directly bind Erk1/2 via the highly conserved MAPK motif 
 
Bioanalysis performed in Chapter 3 highlighted the presence of a highly conserved MAPK 
binding site adjacent to the RA domain in all MRL proteins (MAPK
site1
), while a second motif 
positioned at the N-terminus of the RA domain was discovered in Lpd, RIAM and Mig-10 
(MAPK
site2
). Neither of these sites had previously been described in the literature, however, 
western blots of Pico
WT
 and Lpd co-IPs confirmed that the Erk1/2 MAPK homolog Rolled was 
able to interact with both proteins in vivo (Colo et al., 2012b). Furthermore, Lpd and Pico 
constructs possessing mutations within MAPK
site1
 were unable to bind Rolled, while a short 
RIAM peptide containing only the coiled-coil motif but not MAPK
site2
 was able to interact with 
both Erk1/2 and Rolled. These findings revealed that the MRL proteins are able to interact 
directly with Erk1/2 or Rolled via the highly conserved MAPK
site1
 binding site, however, the 
functionality of MAPK
site2
 is still unclear. Recent studies have shown the coiled-coil region, 
within which the conserved MAPK
site1
 motif is contained, is involved in homodimeric 
interactions in Lpd (Chang et al., 2013). As yet it is unknown how these associations affect 
Erk1/2 binding, or whether MAPK
site2
 compensates should MAPK
site1
 be blocked. 
 
5.6.2. Rolled phosphorylates Pico at Serine 819 to enable PP1 binding 
 
Experiments performed in this chapter indicated that Pico is capable of interacting with activated 
Rolled. Further studies utilising Pico
MAPK
, which disrupts binding to MAPK, implicate Rolled in 
the phosphorylation of Serine 819, a residue situated next to the PP1 binding motif. Interestingly, 
PP1 was not detected in precipitates containing Pico
S819A
, a non-phosphorylatable Pico mutant, 
by Western blotting, whilst the phosphomimetic Pico
S819D
 construct was, contrastingly, shown to 
interact. This suggests that phosphorylation of Ser 819 allows direct associations with PP1. 
When combined, these findings enable a mechanism to be proposed whereby Rolled binds 
directly to Pico via the conserved MAPK motif and phosphorylates Ser 819 when in an activated 
state. This modification may cause a conformational change in Pico's structure, thereby 
facilitating binding to PP1. 
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Neither Rolled nor PP1 appeared to affect Pico's ability to complex with any of its other 
recognised interaction partners. Given their well established roles in regulation, this finding 
suggests that PP1, and possibly Rolled, may function in controlling the activity of Pico's 
associated proteins rather than its affinity towards them (Cohen, 2002, Nishimoto and Nishida, 
2006). Consequently, until further phenotypic analysis is carried out on the respective mutants, it 
will not be possible to determine the overarching effects these regulatory proteins have.  
 
5.6.3. Limitations in the procedures carried out 
 
Idealy pulldowns would have been performed on endogenous Pico as a means of identifying 
complexed proteins, however, due to antibody limitations ectopic expression of a Venus-tagged 
peptide was required for successful and accurate precipitation. Also, while Western blot analysis 
of Venus-Pico co-IPs was successfully carried out to confirm interactions with Rolled, PP1, Ras, 
Chickadee, and Rhea, corresponding pulldowns using the associated partners as bait were not 
examined. This was due to the impracticalities associated with optimising co-IPs with a range of 
different antibodies within the time frame available. In addition, there would have been 
significant difficulties recognising Pico within the pulldowns as the GFP antibody could only 
adequately detect Venus-tagged proteins when present in high quantities, while the Pico specific 
antibody designed in-house did not work on immunoblots. However, it should be noted that a 
wealth of complementary evidence exists to support the majority of findings from the co-
immunoprecipitation experiments, meaning a failure to perform corresponding pulldowns does 
not impede sound inferences being formed. 
 
Next, mass spectrometry indicating potential interactions with cdc42 and Fasciclin 1 was only 
performed once. Usually this type of analysis would be repeated at least two more times before 
firm conclusions could be made, however, due to cost issues and limitations in the quality of 
results generated from the initial investigation, this form of assessment was not carried out again. 
Consequently, given the inability of cdc42 and Fasciclin 1 to be detected in pulldowns following 
issues surrounding antibody optimisation, it is not possible to sufficiently conclude if that these 
associations take place.  
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Lastly, due to the variable nature of hs-GAL4 mediated expression, in addition to inconsistencies 
surrounding the pulldown efficiency of GFP-Trap (most notable in the disparity between 
Chickadee blots), it was not feasible to accurately compare subtle differences in binding 
affinities. As such, it was only possible to precisely corroborate either affirmative or negative 
associations between a construct and its interaction partner, meaning the apparent semblance in 
Ras binding between the Pico
RE
 and Pico
RR
 mutants may not be veritable. 
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6. Pico localisation 
 
6.1. Introduction 
 
A seminal paper presented by Abercrombie described three fundamental structures present 
within migrating cells; the lamellipodia, filopodia, and membrane ruffles (Abercrombie, 1980). 
The lamellipodium constitutes a thin layer of cytoplasm about 0.2 μm thick which protrudes at 
the front of spreading and migrating cells as shown in Figure 6.1.1. (Small et al., 2002). It is 
formed from the force generated by actin polymerisation pushing against the leading edge when 
coupled to the traction providing extracellular matrix (Ridley et al., 2003, Le Clainche and 
Carlier, 2008).  
 
 
 
Figure 6.1.1. Illustrative cell possessing distinctive lamellipodia and membrane ruffles. 
Illustrative image of a cell in the process of spreading across a substrate. The annotations 
highlight (a) the lamellipodium, (b) lateral membrane ruffles, (c) radial membrane ruffles, (d) the 
leading edge, and (e) the cytoplasm. 
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Depending on the cell type and condition, the lamellipodium can vary from around 1 μm to 5 μm 
in breadth (Small et al., 2002). Contained within this structure are small bundles of actin 
filaments termed 'ribs', which are believed to form the precursors for finger-like filopodia 
protrusions that extend beyond the leading edge to sense the surrounding environment (Small, 
1988, Le Clainche and Carlier, 2008). As the plasma membrane continues to expand at the cell 
front, material is constantly recycled from the leading edge via retrograde membrane ruffles 
(Wurtzel et al., 2012). These are found to occur in cellular zones undergoing rapid reorganisation 
of the plasma membrane and often precede the formation of a lamellipodium (Mahankali et al., 
2011). When viewed down a microscope, membrane ruffles appear as regions of the 
lamellipodium which curl upwards, and can be found both at, or behind, the leading edge as 
demonstrated in Figure 6.1.1. (Abercrombie, 1980, Small et al., 2002).  
 
6.1.1. MRL localisation 
 
The presence of a characteristic PH domain strongly implies that MRL proteins possess the 
ability to localise at the cell membrane via interactions with phosphoinositides. Indeed, studies 
found that RIAM is present within both the cytoplasm and lamellipodia, whereas Lpd 
predominantly localises at the plasma membrane (Lafuente et al., 2004, Jenzora et al., 2005, 
Krause et al., 2004). It is thought this variation in cellular localisation is due to the differential PI 
binding preferences displayed by their PH domains, with RIAM primarily binding PI(3)P and 
PI(5)P, while Lpd interacts with PI(3,4)P2 (Jenzora et al., 2005, Krause et al., 2004, Lemmon, 
2008). Interestingly, MIG-10 has been found to localise asymmetrically within peripheral 
regions of the lamellipodia in response to external directional signals such as UNC-6 or SLT-1, 
enabling control over the directionality of cellular migration (Quinn et al., 2006). 
 
In line with these findings, functional studies within single cells have revealed RIAM to be 
involved in promoting F-actin formation, cell spreading, and lamellipodia formation, while Lpd 
controls lamella protrusion velocity through regulation of actin branching density as well as F-
actin levels (Lafuente et al., 2004, Krause et al., 2004). Overexpression of MIG-10 has also been 
found to encourage lamellipodial formation in a similar manner (Quinn et al., 2006). 
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Further investigations assessing co-localisation have lent additional support to previous findings 
generated from MRL binding analysis, with Lpd, RIAM, and MIG-10 shown to co-localise 
alongside Ena/VASP and F-actin at lamellipodia and filopodia tips, while RIAM was positioned 
together with vinculin and actin at early focal adhesions (Jenzora et al., 2005, Lafuente et al., 
2004, Krause et al., 2004, Quinn et al., 2006). Contrastingly, very little work has so far been 
carried out assessing the subcellular localisation of Pico. This form of investigation is important 
not only for establishing Pico's cellular distribution, but also for determining where in the cell 
interactions with its associated partners are likely to take place. 
 
6.1.2. Aims 
 
The aim of the research presented in this chapter was to examine Pico's localisation at the 
subcellular level in adherent Drosophila S2 cells that had been induced to spread and project 
lamellipodia (Rogers et al., 2002, Rogers et al., 2003). Initially a time course assay was 
performed to ascertain how Pico's localisation changed as the cells spread on the substrate as 
well as enabling an optimal time for fixation to be established for immunofluorescent antibody 
staining. Experiments assessing the localisation of Pico's binding partners alone was carried out 
and the results compared to findings from the Vale lab to validate the procedures and fixation 
time used (Rogers et al., 2003). Co-localisation experiments were then performed to confirm if 
Pico and the binding proteins identified in Chapter 5 occupy overlapping subcellular 
distributions, which would provide support that these proteins interact in vivo and not just in cell 
extracts. The ability of the mutant constructs to localise to the same position as wild type Pico 
was also assessed prior to further co-localisation studies being carried out to determine if the 
mutants affected the distribution of Pico-binding proteins. Lastly, co-expression studies were 
implemented using wild type wing discs to assess if endogenous Pico and its binding partners are 
expressed in the same tissues at the same time. 
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6.2. Assessing cell spreading on ConA coated plates 
 
Previous work reported by Rogers et al. 2002 demonstrated a means of inducing cell spreading 
and lamella formation in S2 cells through the use of ConA coated substrates. Further work 
carried out within the Valle lab confirmed the presence of numerous actin regulatory proteins 
within the lamellae and leading edge of S2 cells using similar techniques (Rogers et al., 2003). 
Consequently, experiments evaluating Pico's localisation within S2 cells spread on ConA coated 
plates were designed, however, repeated attempts to replicate the phenotype generated in these 
papers were unsuccessful using the recommended cell line (Rogers et al., 2002, Rogers et al., 
2003). It was observed that S2 cells, normally grown in suspended cell cultures, would merely 
rest on the surface of the substrate and fail to attach regardless of the ConA concentration or cell 
density (Figure 6.2.1.a) (Schneider, 1972). Instead, the more adherent S2R+ (S2 receptor plus) 
cell line, differing mainly though the possession of the wingless receptors Dfrizzled-1 and 
Dfrizzled-2 (Yanagawa et al., 1998), was tested and found to successfully bind and spread across 
the ConA coated substrate leading to the formation of well defined lamellipodia (Figure 6.2.1.b). 
The size of the lamella varied between cells from around 1 μm to 7 μm in breadth and often 
contained distinctive membrane ruffles in both lateral and less frequent radial formations, 
however, no filopodia were detected in any of the studies carried out. 
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Figure 6.2.1. Capacity of S2 and S2R+ cells to spread on ConA coated substrates. 
Representative figures of (a) S2 and (b) S2R+ cells spread on ConA coated glass plates. S2 cells 
grown in suspended cultures rested on the substrate surface and failed to attach. Conversely, the 
more adherent S2R+ cells successfully bound and spread across the coated plates, leading to the 
formation of well defined lamellipodia with distinct membrane ruffles. 
 
6.3. Pico localisation 
 
Next, subcellular distribution of Pico during S2R+ cell spreading on ConA coated surfaces was 
assessed through fixed time course assays. Attempts to detect endogenous Pico using an antibody 
generated in-house failed to yield sufficient levels of staining for accurate imaging to be 
performed (data not shown). This antibody had been successfully used to stain a variety of 
tissues during previous research carried out within the Bennett lab (Lyulcheva, 2006, Taylor, 
2010), implying that the endogenous levels of Pico may be low in S2R+ cells. Therefore, cells 
were transiently transfected with a plasmid capable of ectopically expressing Venus-Pico
WT
 
under the control of an act5c promoter. Transfected cells were plated onto ConA coated glass 
plates and fixed with paraformaldehyde after different time points before confocal imaging of the 
Venus-tagged protein. Analysis of the resulting images showed that cells in the same field of 
view landed and initiated spreading across the substrate at different times, indicating a degree of 
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heterogeneity in the behaviour of cells within each population.  Therefore to capture how the 
distribution of Venus-Pico might be affected during the spreading process, only cells displaying 
a novel morphology absent in earlier time points were analysed. Also, images were only taken of 
cells expressing Pico at optimal levels, as high quantities caused large aggregates to form, 
whereas too little prevented sufficient detection. The change in Venus-Pico distribution during 
the progression of cell attachment through to spreading was supported by preliminary time-lapse 
imaging experiments carried out when Cellfectin I was still available (data not shown). 
 
Representative images from each time point are shown in Figure 6.3.1. Before cell spreading had 
commenced, ectopic Pico is distributed within the cytoplasm and generally displays a slightly 
heightened accumulation at the cell membrane. Within 5 minutes of adhering to the substrate, 
cells began to exhibit early signs of spreading, during which Pico remained localised within the 
cytoplasm, but could also be found in low quantities at the leading edge. As the cells continued 
to expand rapidly during the next 20 minutes, Pico's distribution at the leading edge began to 
increase, however, noticeably elevated levels of Pico were observed within highly active 
membrane ruffles, which form exclusively during this rapid extension phase. Pico still remained 
within the cytoplasm, though, after 30 minutes, cells begin to reach their maximal size and 
membrane ruffling was no longer observed. While cell size no longer increased, Pico was still 
able to accumulate at the leading edge of the lamella. However, by 45 minutes Pico had 
dissociated from the leading edge and was only found within the cytoplasm. When combined, 
these data indicated that Pico is present at the leading edge and highly active membrane ruffles 
only when the cells are spreading, strongly implicating Pico in processes involved in membrane 
remodelling and cellular migration. 
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Figure 6.3.1.  Time course examining the localisation of Venus-Pico during spreading of 
S2R+ cells. As S2R+ cells spread across the ConA coated substrate, Venus-tagged Pico localised 
to the leading edge and highly active membrane ruffles. Once cells reached their maximum size, 
membrane ruffles no longer formed and Venus-Pico gradually dissociated from the leading edge, 
eventually residing only within the cytoplasm. 
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6.4. Localisation of Pico interacting proteins 
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Figure 6.4.1. Localisation of Pico interacting proteins. S2R+ cells allowed to spread on ConA 
coated plated were fixed and stained for Chickadee, Enabled, Talin/Rhea, Ras, Erk1/2/Rolled, 
and PP1 to ascertain their cellular distribution. All the proteins were found to localise within the 
cytoplasm, however, Enabled, Rhea, Ras, and to some extent Rolled, also accumulated at the 
leading edge. Interestingly, both Chickadee and PP1 were observed at small 'puncta' within the 
lamella (indicated with arrow), while only Chickadee exhibited significant nuclear distribution. 
 
To determine the distribution of Pico-interacting proteins, fixed S2 cells were stained by indirect 
immunofluorescence using primary antibodies to the proteins of interest. Based on findings from 
the time course assays, in addition to the methodology described by Rogers et al. 2003, it was 
decided that cells would be allowed to spread for 30 minutes on ConA treated plates before 
fixation and staining. This timing was proven to yield the greatest number of cells at both the 
rapid expansion and maximal spreading stages represented by the 20 and 30 minute images in 
Figure 6.3.1. respectively. 
 
To validate the fixation and staining protocol, fixed cells were first stained for Chickadee and 
Enabled, whose distribution has previously been reported in S2 cells (Rogers et al., 2003). As 
previously reported, Chickadee was predominantly localised within the nucleus and cytoplasm, 
while Enabled was perceived to mainly accumulate at the leading edge and cytoplasm (Figure 
6.4.1). Interestingly, small 'puncta', apparently unconnected with focal adhesions, but reported to 
be characteristic of Chickadee's distribution, were also observed (Rogers et al., 2003).  
 
Next, fixed cells were stained for the Pico interacting proteins Rhea, Ras, Rolled, and PP1 
(Figure 6.4.1.). Rhea was found to localise largely within the cytoplasm and modestly at the cell 
front, while Ras was distributed fairly evenly amongst the cytoplasm and lamella, but displayed 
some degree of accumulation at the leading edge. Rolled was also predominantly observed 
within the cytoplasm, although low levels were detected at the cell boundary. Lastly, PP1 was 
located almost exclusively within the cytoplasm, however, 'puncta' similar to those discovered 
within chickadee stained cells were also detected. 
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6.5. Pico co-localisation 
 
While Enabled, Rhea, Ras, and Rolled all displayed cytoplasmic and leading edge distributions 
similar to that found in Pico, it did not confirm whether analogous spatial/temporal localisation 
to Pico occurs. Consequently, co-localisation studies were carried out to determine how the 
cellular distribution of Venus-Pico aligned with that of its binding partners during the rapid 
expansion and maximal extension stages of cell spreading. 
 
6.5.1. Pico accumulates at membrane ruffles during the rapid expansion phase 
 
 
 
Figure 6.5.1. Pico's accumulation at membrane ruffles during the rapid spreading phase. 
Venus-Pico
WT
 expressing S2R+ cells were spread on ConA coated plates and fixed using 
paraformaldehyde. Cells exhibiting rapid expansion were examined and shown to possess 
characteristic (a) lamellipodia, and (b) membrane ruffles, in addition to (c) a well defined leading 
edge. Further analysis revealed Pico levels are significantly higher within (d) the ruffles 
compared to (e) the leading edge. Quantification of relative Venus-Pico levels revealed a general 
three-ten fold (mean 3.73, p = <0.001) difference between membrane ruffles and leading edge. 
 
Initially, analysis of Pico's distribution during the rapid expansion phase of S2 spreading was 
carried out. The results shown in Figure 6.5.1 revealed Pico to predominantly accumulate within 
the supposedly highly active membrane ruffles which form during this period (Small et al., 
2002). Indeed, further examination using the linear plot profile tool within ImageJ indicated Pico 
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levels are generally between 3 and 10 times higher (mean 3.73, p = <0.001, t-test) within ruffles 
compared to the leading edge, and that this Pico accretion is characteristic of all ruffle formation. 
 
6.5.2. Pico co-localises with the majority of its binding partners within membrane ruffles 
 
Next, the ability of Pico to co-localise with its identified binding partners from Chapter 5.2. was 
examined in S2R+ cells displaying rapid spreading. Cells transiently expressing Venus-Pico
WT
 
were allowed to spread for 20 minutes before being fixed and stained with an appropriate 
antibody. Detected levels of Pico and the protein of interest were independent and adjusted so 
apparent fluorescence was broadly equivalent. Initially, co-localisation with the actin regulatory 
protein Chickadee was assessed. The results presented in Figure 6.5.2. indicate that within the 
membrane ruffles, characterised by the sizeable accumulation of Pico, both Pico and Chickadee 
display a notable degree of co-localisation. Contrastingly, despite the presence of reasonable 
levels of Pico at the leading edge, no corresponding accrual of chickadee was observed, implying 
associations between the two proteins only occurred within the highly active ruffles.  
 
Co-localisation between Pico and the anti-capping protein Enabled was also analysed. The 
findings displayed in Figure 6.5.3. revealed Pico and Enabled exhibit considerable levels of 
association inside membrane ruffles, as confirmed by overlap of immunofluorescent staining 
(indicated in yellow within the merged image). Indeed, during this rapid cell spreading stage, 
Enabled is found almost exclusively within ruffled regions while very little is present at the 
seemingly less active areas of the leading edge (see appendix 5 for further examples). While 
comparatively low levels of Pico were still observed at cell boundary areas devoid of ruffles, 
virtually no Enabled could be detected, suggesting that Enabled, much like Chickadee, only 
associates with Pico in ruffled regions during expansion of the lamella. 
 
Rhea-Pico co-localisation was assessed in cells exhibiting high levels of spreading as well. 
Figure 6.5.4. shows that Pico and Rhea display similarly elevated accumulation within ruffled 
regions, but also demonstrate analogous localisation at the leading edge as well as the cytoplasm. 
Taken together, these findings indicate that Pico and Rhea exhibit close associations throughout 
the cell during this phase of cell spreading. 
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Figure 6.5.2. Co-localisation between Pico and chickadee at membrane ruffles. (a) Venus-
Pico
WT
 expressing S2R+ cells spread on ConA coated plates were fixed and stained for 
Chickadee. Cells exhibiting rapid extension were selected and (b) relative levels of Pico 
examined to confirm correct identification of membrane ruffles and the leading edge. Co-
localisation studies revealed that Pico associated with Chickadee in (c) membrane ruffled 
regions, but (d) not at the leading edge. 
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Figure 6.5.3. Assessment of Pico-enabled co-localisation at membrane ruffles. (a) S2R+ cells 
expressing Venus-Pico
WT
 were spread on ConA coated plates before being fixed and stained for 
Enabled. Cells displaying rapid expansion were selected for and (b) relative levels of Pico 
assessed to allow characterisation of membrane ruffles and the leading edge. Examination 
showed strong co-localisation between Pico and Enabled within (c) membrane ruffles, however, 
none was found at (d) cell boundary regions devoid of ruffles. 
150 
 
 
 
Figure 6.5.4. Associations between Pico and rhea within membrane ruffled regions. (a) 
Venus-Pico
WT
 expressing S2R+ cells were spread on ConA coated plates, fixed and stained for 
Talin (rhea). Cells exhibiting spreading were selected and (b) levels of Pico examined to enable 
differentiation between membrane ruffles and the leading edge. Co-localisation studies revealed 
that Pico associated with Rhea in both (c) membrane ruffled regions and (d) the leading edge in 
rapidly expanding cells. 
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Additional analysis was performed to assess co-localisation between Pico and Ras. The findings 
presented in Figure 6.5.5. reveals noticeable co-localisation between Pico and Ras within 
membrane ruffles, however, lower levels of both proteins were observed at the leading edge with 
less correlation present between their relative fluorescence levels. These results suggest Pico and 
Ras only co-localise within the highly active ruffled regions during this highly expansive phase. 
 
Examination of Pico's co-localisation with the MAPK Rolled was also performed in cells 
exhibiting high rates of spreading. The results displayed in Figure 6.5.6. indicate that within the 
membrane ruffles, both Pico and Rolled display notable levels of co-localisation. Although, Pico 
is still present at the cell boundary, Rolled could not be detected, suggesting this association only 
occurs in ruffled regions during rapid expansion phase. Interestingly, the example cell presented 
in Figure 6.5.6. also displays radial rib-like ruffle structures sometimes found to run 
perpendicular to the leading edge. Much like their aforementioned counterparts, these radial 
structures exhibit significant Pico accumulation and display similar co-localisation results to 
those involved in outward cell spreading (data not shown). While an appropriate function has not 
yet been ascribed to these structures, it is thought they may assist in sideways expansion of the 
lamellipodium to prevent excessive strain being placed on the membrane as the cell develops 
outwards. However, given the striking similarities between both ruffle types, this report only 
focuses on those involved in outward extension of the cell. 
 
Lastly, co-localisation between Pico and the phosphatase PP1 within rapidly expanding S2R+ 
cells was analysed. Figure 6.5.7. shows that PP1, unlike the other proteins assessed, failed to 
significantly associate with Pico within ruffled regions, however, it did display a similar spatial 
distribution at the cell boundary although levels remain low.  
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Figure 6.5.5. Co-localisation between Pico and Ras within membrane ruffles. (a) S2R+ cells 
expressing Venus-Pico
WT
 were spread on ConA coated plates before being fixed and stained for 
Ras. Cells within the rapid extension phase were selected for and (b) relative levels of Pico 
analysed to enable characterisation of membrane ruffles and the leading edge. Co-localisation 
studies revealed Pico to be closely associated with Ras within (c) membrane ruffles, however, (d) 
cell boundary regions exhibited significantly lower levels of both proteins with little analogy. 
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Figure 6.5.6. Associations between Pico and rolled at membrane ruffled regions. (a) Venus-
Pico
WT
 expressing S2R+ cells were spread on ConA coated plates, fixed and stained for Erk1/2 
(rolled). Cells exhibiting rapid spreading were selected and (b) relative levels of Pico examined 
to confirm correct identification of membrane ruffles and the leading edge. Examinations 
showed a notable degree of co-localisation between Rolled and Pico in (c) ruffled regions but (d) 
not at the leading edge. 
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Figure 6.5.7. Examination of co-localisation between Pico and PP1 within membrane 
ruffles. (a) S2R+ cells expressing Venus-Pico
WT
 were spread on ConA coated plates before 
being fixed and stained for PP1. Cells exhibiting rapid extension were selected and (b) relative 
levels of Pico examined to confirm correct identification of membrane ruffles and the leading 
edge. Co-localisation analysis revealed that Pico does not associate with PP1 within (c) 
membrane ruffled regions, however, it did display some positional analogy (d) at the leading 
edge, although levels remain low. 
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6.5.3. Pico co-localises with some of its binding partners at the leading edge of maximally 
spread cells 
 
Following on from analysis of cells in a rapidly expanding state, investigations were performed 
on those reaching the maximal extension stage of spreading where actin dynamics are thought to 
be lower. Cells expressing Venus-Pico were allowed to spread for 30 minutes before being fixed 
and stained with an appropriate antibody. Initially, co-localisation between Pico and the actin 
regulatory proteins Chickadee, Enabled, and Rhea was assessed at the leading edge of S2R+ 
cells. The results displayed in Figure 6.5.8.a indicate very little co-localisation occurs between 
Pico and Chickadee at the cell front as Chickadee exhibits low levels outside the nucleus and 
cytoplasm. Indeed, additional analysis of the relative fluorescent levels within this region, as 
illustrated in Figure 6.5.8.b, confirms that Pico primarily gathers at the lamella boundary 
whereas Chickadee levels remained low, supporting the theory that Chickadee and Pico only co-
localise within active regions. 
 
Figure 6.5.8.c implies that Pico and Enabled display significant co-localisation at the leading 
edge, as confirmed by the distinctive yellow areas visible in the combined image. Further 
verification is provided in Figure 6.5.8.d which demonstrates substantial accumulation of both 
proteins at the cell periphery, while considerably lower levels are present within the lamella. 
Interestingly, Enabled displays a reasonably even distribution throughout the lamellipodial edge 
at this stage, in contrast to the variegated appearance observed within the rapidly expanding cells 
(Figure 6.5.3.). 
 
Rhea also displays some degree of analogous positioning with Pico at the cell front, however, 
Figure 6.5.8.e indicates that greater levels of co-localisation appears to occur within the 
cytoplasm. The relative fluorescent levels detected at the lamella boundary in Figure 6.5.8.f 
support these findings by revealing only a diminutive accretion of Rhea occurs at the leading 
edge. This finding is strikingly dissimilar to that found within the rapidly spreading cells where 
Pico and Rhea demonstrated strong co-localisation throughout the entire cell (Figure 6.5.4.), 
implying heightened association between the two proteins occurs when cells are in a highly 
active spreading state. 
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Figure 6.5.8. Co-localisation between Pico and its actin regulatory interaction partners. 
Venus-Pico
WT
 expressing S2R+ cells spread on ConA coated plates were fixed and stained for 
(a) Chickadee, (c) Enabled, and (e) Rhea, to examine co-localisation at the leading edge. The 
findings suggested that (b) Chickadee distribution displayed very little analogy with that 
observed in Pico at the cell front, while significant levels of co-localisation were detected 
between (d) Enabled and Pico at the leading edge. A more moderate correspondence was 
observed with (f) Rhea at the lamella boundary. 
 
Pico's co-localisation with the regulatory proteins Ras, Rolled, and PP1 was also examined at the 
leading edge of maximally spread S2R+ cells on ConA coated plates. The findings presented in 
Figure 6.5.9.a revealed that the distribution of Ras was dissimilar to Pico in that it was evenly 
disseminated throughout the lamella and displayed no significant accumulation at the cell front. 
Further analysis of the relative fluorescent levels shown in Figure 6.5.9.b confirmed the 
dispersed nature of Ras and revealed no discernable build up in line with Pico. This finding is 
similar to that found in Figure 6.5.5. whereby Pico and Ras failed to strongly associate at the 
leading edge and only co-localised within the highly active membrane ruffles. 
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Figure 6.5.9. Co-localisation between Pico and its regulatory protein associates. S2R+ cells 
expressing Venus-Pico
WT
 were allowed to spread on ConA coated plates before being fixed and 
stained for (a) Ras, (c) Rolled, and (e) PP1 to ascertain if co-localisation occurred at the cell 
front. The results indicated that little positional analogy exists at the leading edge between Pico 
and (b) Ras, (d) Rolled, or (f) PP1.  
 
Assessments of Rolled, illustrated in Figure 6.5.9.c, also found very little co-localisation with 
Pico at the leading edge, a result supported by further analysis of relative fluorescent levels 
within this region (Figure 6.5.9.d). Indeed, cells examined for positional analogy between Pico 
and PP1 also revealed very little correlation in localisation at the cell front (Figure 6.5.9.e). 
Figure 6.5.9.f verifies this further by demonstrating significant accumulation of Pico but not PP1 
at the cell periphery. 
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6.6. Effects of site-directed Pico mutants on localisation of Pico and its interacting partners. 
 
Following studies to determine distribution of wild type Pico and co-localisation with its 
interactors, similar experiments assessing the Pico binding and phosphorylation mutants were 
carried out. As with Pico
WT
, S2R+ cells expressing each Venus-tagged construct under the 
control of an act5c promoter were allowed to spread on ConA coated plates for 20 or 30 minutes 
before being fixed and stained to enable analysis of rapid and maximal spread cells respectively.  
 
6.6.1. The subcellular distribution of Pico binding and phosphorylation mutants resembled 
that of Pico
WT
 
 
At first, the binding and phosphorylation mutant constructs localisation within S2R+ cells 
exhibiting rapid spreading and maximal expansion was assessed to determine if these 
interactions or modifications were involved in Pico's cellular positioning. Figure 6.6.1. reveals 
that each mutant was capable of accumulating within the highly active membrane ruffles and 
localising to the lamellipodial leading edge. Consequently, these findings indicate that neither 
disruption of the MAPK/Rolled binding motif, the PP1 binding motif, or (de)phospho-mimetic 
variants of Ser 819 alter the distribution of ectopic Pico. However, due to the apparent inability 
of the Pico
LA
, Pico
RE
, and Pico
RR
 mutants to interfere with Pico's confirmed interaction partners, 
it is not possible to establish if Chickadee, Enabled, Rhea, or Ras interactions have any 
discernable effects. 
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Figure 6.6.1. Subcellular localisation of ectopically expressed Pico mutants at rapid 
spreading and maximal expansion phases. S2R+ cells expressing the Venus-tagged Pico 
mutant constructs were spread on ConA coated plates and fixed with paraformaldehyde. Cells 
displaying rapid spreading (left) and maximal expansion (right) were imaged for each construct 
to determine if alterations to binding, or phosphorylation at Ser 819, prevented Pico from 
localising to its correct position. The results showed the changes introduced to the mutants did 
not alter Pico's ability to accumulate within membrane ruffles or localise at the leading edge. 
 
6.6.2. Binding and phosphorylation mutants displayed some alterations to co-localisation 
 
Next, the ability of the binding and phosphorylation mutant constructs to co-localise with 
Chickadee, Enabled, Rhea, Ras, Rolled, and PP1 was assessed and the results compared to wild 
type Pico. Given that Pico
WT
 displayed close associations with almost all of these proteins within 
membrane ruffled regions, only S2R+ cells exhibiting rapid spreading were analysed. The 
findings revealed that the majority of mutant constructs demonstrated similar co-localisation 
outcomes to those displayed by the wild type protein (see appendix 5 for complete results), with 
only the MAPK-binding mutant and phosphomimetic Pico
S819D
 construct displaying any 
noticeable differences. 
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Figure 6.6.2. Examination of co-localisation between the MAPK-binding mutant and 
Rolled. (a) S2R+ cells expressing the Venus-Pico
MAPK
 mutant construct were spread on ConA 
coated plates before being fixed and stained for rolled. Cells exhibiting rapid extension were 
selected and (b) relative levels of Pico analysed to enable characterisation of membrane ruffles 
and the leading edge. Co-localisation studies revealed that the MAPK-binding mutant does not 
associate with Rolled in either (c) membrane ruffles or (d) at the leading edge. 
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Figure 6.6.3. Co-localisation between the Pico
S819D
 mutant and PP1. (a) Venus-Pico
S819D
 
expressing S2R+ cells were spread on ConA coated plates, fixed and stained for PP1. Cells 
exhibiting rapid spreading were selected for and (b) relative levels of Venus-Pico examined to 
confirm correct identification of membrane ruffles and the leading edge. Examinations showed a 
notable degree of co-localisation between PP1 and the Pico
S819D
 construct in both (c) membrane 
ruffled regions and (d) the leading edge. 
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The findings presented in Figure 6.6.2. revealed that the MAPK-binding mutant was unable to 
associate with rolled in either the membrane ruffles or at the leading edge. Indeed, one of the 
most striking features of these data was the complete lack of Rolled within any of the peripheral 
regions. This contrasted with the results generated using Pico
WT
 where significant co-localisation 
was found to occur within ruffled regions while some accumulation of Rolled appeared to take 
place at the cell boundary (Figure 6.5.6.). When combined, these findings confirm the inability 
of the Pico
MAPK
 mutant to bind with Rolled, and indicate its localisation to membrane ruffles and 
the leading edge is mediated by Pico. 
 
Figure 6.6.3. demonstrates that the phosphomimetic Pico
S819D
 construct strongly co-localised 
with PP1 at both the leading edge and membrane ruffled regions. Conversely, wild type Pico was 
only found to weakly accumulate alongside PP1 within boundary regions devoid of ruffles 
(Figure 6.5.7.). Consequently, these results support and extend the findings from chapter 5 
revealing phosphorylation of Ser 819 is required for interactions with PP1, and suggest Pico may 
also be involved in the recruitment of PP1 to cell boundary regions. 
 
6.7. Pico's expression and co-expression in wing discs 
 
While analysis of S2R+ cells produced significant findings relating to the potential of ectopic 
Pico to associate with its binding partners during cell spreading, it was unable to confirm if Pico 
was actually expressed alongside these other factors in normal tissues. Due to Pico's established 
role in cellular growth and migration (Lyulcheva et al., 2008, Taylor, 2010), two processes found 
to commonly occur during early development, imaginal discs which act as progenitors for many 
tissue types were examined. Of these, wing discs were selected as the most appropriate organ to 
study owing to their ease of staining and well characterised structure and developmental fate 
(Klein, 2001). Wing discs, as their name suggests, form the precursor to the Drosophila wing 
and have a well defined structure by the third instar phase of larval development consisting of the 
wing pouch, hinge region, and adepithelium (Figure 6.7.1.a). The wing pouch gives rise to the 
wing blade itself, while the hinge region forms a mobile link to the body wall and flight muscles 
developed from myoblasts present within the adepithelium (Aldaz et al., 2010). 
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Figure 6.7.1. Wing disc structure and development. (a) Structure of complete wing disc from 
third instar larvae possessing a clearly defined wing pouch, hinge regions, and adepithelium 
containing myoblasts within the adepithial layer. The hashed line represents the dorsal-ventral 
wing margin. (b) X-Z cross section of the wing pouch displaying the characteristic peripodial 
membrane and columnar epithelium. (c) Expansion of the epithelial tissues within the wing 
pouch leads to repositioning of the wing margin and apposition of the dorsal and ventral 
compartments. During the prepupal stage the disc starts to bend and evagination of the two wing 
surfaces takes place (adapted from Klein, 2001 and Aldaz et al., 2010). 
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Two distinctive cell layers make up the wing pouch: the peripodial membrane, which eventually 
contributes little to the final adult structure, and the pseudo-stratified columnar epithelium that 
gives rise to the adult epidermis (Figure 6.7.1.b) (Aldaz et al., 2010). At the third instar stage of 
larval development the wing pouch is a relatively flat bilayer epithelium, with ventral and dorsal 
compartments positioned within the same plane (Klein, 2001). However, by late third instar, the 
peripodial membrane and columnar epithelium have expanded, causing the wing margin to 
reposition and the dorsal and ventral compartments to become apposed (Figure 6.7.1.c). At the 
prepupal stage, the disc starts to bend and evagination of the two wing surfaces concludes. The 
peripodial cells remain covering almost the entire apical surface of the columnar epithelium 
before retracting and eventually disintegrating at later stages of development (Klein, 2001, Aldaz 
et al., 2010). 
 
Initially, studies examining regions of the wing pouch expressing Pico were carried out using 
W
1118
 larvae, with a representative cross section of the z-stack displayed in Figure 6.7.2. The 
tumour suppressor discs-large was stained for as a means of outlining the apico-lateral junctions 
between the columner epithelium and peripodial membrane (Janody and Treisman, 2006), while 
a Pico antibody developed in-house was used to detect the endogenous protein. The results 
revealed that Pico is predominantly expressed within basal regions of columnar epithelium in 
third instar larvae, while very little was detected at basal sites (Figure 6.7.2.). However, as larvae 
begin to enter the late third instar phase of development, Pico begins to express within basal 
areas of the columnar epithelium (data not shown). Eventually Pico is no longer expressed within 
apical columnar epithelial cells and is instead found exclusively within basal regions of the 
columnar epithelium (data not shown). It was not possible to display the findings from late instar 
larvae as the expansion and folding of the wing pouch prevented suitable z-stacks from being 
generated. Consequently, all future work was performed on wing discs derived from third instar 
larvae only. 
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Figure 6.7.2. Expression of Pico within the wing pouch of third instar larvae. (a) Optical z-
stacks were generated for wing discs from W
1118
 third instar larvae stained with discs large and 
Pico before appropriate X-Z cross-sections were selected. (b) Relative levels of fluorescence 
were analysed to determine if Pico was expressed within the peripodial membrane or columnar 
epithelium. The findings revealed that Pico is almost exclusively expressed within apical regions 
of the columnar epithelium during this stage of larval development. 
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6.7.1. Pico is co-expressed with all of its binding partners in wing discs 
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Figure 6.7.3. Co-expression of Pico and its binding partners within the wing pouch. Z-stacks 
were produced for W
1118
 third instar wing discs stained for Pico and (a) Chickadee, (c) Enabled, 
(e) Rhea, and (g) Ras. Analysis of the relative fluorescence levels shows that Pico is co-
expressed with (b) Chickadee, (d) Enabled, (f) Rhea, and (h) Ras, within the apical side of the 
columnar epithelium, although both Enabled and Rhea are also expressed within basal regions. 
 
Next, the degree of co-expression between Pico and its associated proteins was assessed to 
determine if they were naturally present in the same tissues at the same time. Co-expression 
analysis of Pico and Chickadee revealed both proteins are expressed almost exclusively within 
the apical side of columnar epithelium during the third instar stage of larval development (Figure 
6.7.3.a). Enabled was also found to be expressed by apical columnar cells along with Pico, 
however, lower levels of Enabled were detected at basal columnar regions, implying some 
expression occurred here as well (Figure 6.7.3.c). Similar findings were observed following 
analysis Pico-Rhea co-expression. Figure 6.7.3.e. shows Rhea and Pico to be expressed at high 
levels within the apical columnar epithelium, while smaller quantities of Rhea are found at the 
basal side as well. Lastly, investigations assessing co-expression of Pico and Ras revealed strong 
expression of both proteins within apical columnar cells, while very little was discovered within 
basal regions.  
 
As the Erk1/2, PP1, and in-house Pico antibodies were extracted from the same host species, it 
was not possible to co-stain wing discs with these antibodies. Consequently, wing discs were 
stained with Erk1/2 and PP1 alone and compared to the Pico expression studies performed earlier 
(Figure 6.7.2.) to determine if co-expression is likely to take place. The results presented in 
Figure 6.7.4.a revealed that Rolled is almost ubiquitously expressed throughout the wing pouch, 
with heightened levels detected in small interspersed areas of the peripodial membrane and basal 
regions of the columnar epithelium. PP1 was also found to be fairly evenly expressed within the 
wing pouch, although levels within basal regions of the columnar epithelium appeared slightly 
higher. While it can be concluded that Pico is co-expressed within the same tissues as Rolled and 
PP1, their expression pattern displays significantly less similarity than the other Pico-interacting 
proteins examined. This might be because MAPK and PP1 are pleiotropic enzymes with many 
172 
 
potential interactors, whereas Chickadee/Enabled and Rhea play more specific roles in actin 
regulation and adhesion signalling respectively. 
 
 
Figure 6.7.4. Expression of rolled and PP1 within the wing pouch. Optical z-stacks were 
generated for wing discs dissected from W
1118
 third instar larvae and stained with (a) Erk1/2 and 
(c) PP1. Relative levels of fluorescence were analysed and revealed that both (b) Rolled and (d) 
PP1 were almost ubiquitously expressed throughout the wing pouch, although Rolled was 
present in heightened levels in small interspersed apical and basal regions while PP1 quantities 
were predominantly elevated within basal regions of the columnar epithelium. 
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6.8. Discussion 
 
The results presented in this chapter have shown Pico localises at the leading edge and within the 
cytoplasm in a similar manner to RIAM and Lpd (Lafuente et al., 2004, Krause et al., 2004). In 
addition, Pico possesses the ability to accumulate inside membrane ruffles, while time course 
assays and live imaging revealed Pico's subcellular position changes as cells spread on ConA 
coated substrates. Co-localisation studies confirmed associations with Chickadee, Enabled, Rhea, 
Ras, Rolled, and possibly PP1 occurred at some of these sites, supporting the findings from 
Chapter 5 and yeast-two-hybrid assays described by Taylor, 2010. Interestingly, Venus-Pico
MAPK
 
displayed no positional analogy with Rolled, confirming impaired interactions and suggesting 
that the MAPK-binding mutant may disrupt localisation of endogenous Rolled. If Pico
MAPK
 
works by competing with endogenous Pico, then this data suggests Pico is largely responsible for 
the normal distribution of Rolled to membrane ruffles and the leading edge during S2R+ 
spreading. Furthermore, the phosphomimetic Pico
S819D
 construct exhibited increased associations 
with PP1 compared to the wild type protein, supporting the hypothesis that phosphorylation of 
Ser 819 may facilitate PP1 binding. Further analysis of developing wing discs indicated that Pico 
is expressed alongside its binding partners, confirming that these factors do exist in the same 
spatial and temporal locations and therefore have the potential to come into contact naturally, 
validating the findings from ectopic expression studies.  
 
6.8.1. Pico may predominantly associate with its complex partners in active regions 
 
Time course assays and live imaging revealed Pico accumulates within highly active membrane 
ruffles during phases of rapid cell spreading, leading to a significant depletion at lamellipodial 
tips. However, as cell spreading slows down, membrane ruffles no longer form and Pico 
becomes uniformly positioned at the leading edge. Interestingly, co-localisation with Chickadee, 
Enabled, Rhea, Ras, and Rolled predominantly took place within the dynamic ruffled regions, 
though, as expansion of the cell decreased and Pico was repositioned to the cell boundary, only 
significant positional analogy was observed with Enabled. This implies that the majority of 
Pico's interactions with its binding partners principally occur within active regions displaying 
rapid membrane reorganisation following increased actin dynamics (Small et al., 2002). 
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Interestingly, the variable nature of Pico's co-localisation indicates that composition of the Pico 
mediated complexes is not the same within different subcellular locations and may depend on 
local concentrations of interacting factors or Pico's activation state. 
 
6.8.2. The pattern of pico expression in developing wing discs is consistent with a role in wing 
growth 
 
Immunofluorescence studies revealed Pico to be expressed almost exclusively within apico-
lateral boundary regions of the wing disc columnar epithelium in early third instar larvae, 
however, Pico begins to express within basal columnar epithelial cells as the discs mature in 
middle to late third instar stages. This changing distribution may be linked to the correct 
development of the bag-like double epithelium which forms as the larvae prepares to enter the 
early prepupa phase (Figure 6.7.1.c).  
 
In order for evagination of the wing disc to commence, enhanced growth within apical tissues 
occurs, causing curvature of the wing pouch as shown in Figure 6.8.1. Once apposition of the 
dorsal and ventral compartments has begun, further expansion of the peripodial membrane and 
apical/basal columnar epithelium takes place during late third instar, providing the foundations 
for complete evagination (Klein, 2001, Aldaz et al., 2010). Consequently, given Pico's role in 
growth (Lyulcheva et al., 2008), it is thought early expression in apical columnar epithelium may 
assist with the induction of wing pouch curvature, whilst later transcription in basal columnar 
epithelial cells might enable evagination to commence. As wing discs from later stage larvae 
were not examined, it is difficult to theorise how Pico may further function in the correct 
development of the wing, although, several lines of evidence suggest it promotes coordinated 
growth and proliferation (Lyulcheva et al., 2008, Taylor, 2010). 
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Figure 6.8.1. Schematic diagram of early wing disc evagination. (a) Schematic diagram of 
wing disc during the third instar stage of larval development. The arrows denote regions of 
growth, with length indicative of the relative proliferative levels required within the apical and 
basal regions of the columner epithelium to initiate the expansion and folding of the wing pouch 
characteristic of (b) late third instar wing discs (Klein, 2001, Aldaz et al., 2010). 
 
Co-localisation studies revealed that Chickadee, Enabled, Rhea, and Ras were also 
predominantly expressed within the peripodial membrane of early third instar wing discs, whilst, 
Rolled and PP1 were more evenly distributed throughout the wing pouch. As Pico is believed to 
induce cellular proliferation through actin mediated Mal/SRF activation, highly analagous co-
expression with actin regulatory proteins that bind Pico (Chapter 5.2) strongly implies shared 
functionality in enhanced growth of the peripodial membrane. Indeed, previous studies 
performed within the Bennett lab have already demonstrated the involvement of enabled in wing 
growth, while roles in cell proliferation have also been established for profilin, talin, and Ras 
(Taylor, 2010, Ding et al., 2006, Wang et al., 2011, Drosten et al., 2010). Although Rolled and 
PP1 are also expressed within the same tissues as Pico, a low degree of co-localisation due to 
their ubiquitous distribution is indicative of their pleiotropic roles. 
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7. Pico mediated growth 
 
7.1. Introduction 
 
Pico was named according to the dramatic size reduction and early growth defect observed 
within pico mutant larvae (Lyulcheva et al., 2008). Due to early lethality of homozygous pico 
mutants, RNAi-mediated silencing of pico was utilised to further determine role of pico during 
imaginal development. Knockdown of pico in Drosophila wing discs was shown to cause a 
significant reduction in tissue growth through reduced cellular proliferation rather than induced 
apoptosis (Lyulcheva et al., 2008). Further investigations demonstrated that homozygous pico 
mutant clones generated in Drosophila imaginal discs also exhibited severe growth and 
proliferation defects and were gradually extruded from the otherwise wild type tissue (Lyulcheva 
et al., 2008). Conversely, overexpression of Pico induced hyperplastic growth at both the tissue 
and whole organism level in a dose-dependent manner, owing to co-ordinated increases in both 
cell number and size (Lyulcheva, 2006, Lyulcheva et al., 2008). 
 
Interestingly this growth phenotype appears to be closely linked to the actin/Mal/SRF 
proliferative pathway described in Chapter 1.2.2. Overexpression of pico was shown to increase 
the expression of an SRF-responsive reporter gene in mammalian cell cultures, while a 
hypomorphic mutation in blistered (bs), the Drosophila SRF homologue, impaired pico mediated 
wing overgrowth (Lyulcheva et al., 2008). Experiments also revealed that pico knockdown 
reduced F-actin levels, while overexpression increased the F:G actin ratio, providing a means for 
activating SRF through liberation of its cofactor Mal from inhibitory monomeric actin 
(Lyulcheva et al., 2008, Miralles et al., 2003, Settleman, 2003). 
 
Additional findings indicated that pico's ability to regulate cell growth and proliferation is 
dependent on the activity of EGFR. Ectopic expression of a dominant negative form of EGFR 
(EGFR
DN
), thought to interfere with signaling by forming inactive heterodimers with the wild 
type receptors, resulted in dramatically reduced, narrow wings (Kashles et al., 1991, Guichard et 
al., 1999). Wings co-expressing Pico and EGFR
DN
 resembled those of EGFR
DN
 alone, while 
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RNAi-mediated silencing of pico suppressed the overgrowth effects caused by ectopic EGFR 
(Lyulcheva et al., 2008).  
 
Ras also functionally interacts with Pico. Eye-antennal discs overexpressing constitutively 
activated Ras (Ras
V12
) are enlarged and exhibit a loss of morphology. Pico overexpression alone 
results in a slight increase in the size of the eye-antennal discs, however, the morphology of the 
imaginal tissues appear normal. Pico and Ras
V12
 co-overexpression results in dramatic 
overgrowth of the eye-antennal imaginal discs and an accompanying loss of morphology. 
Furthermore, overexpression cells (labelled with GFP) are found to invade the neighbouring 
tissues including the ventral nerve cord (Figure 4.8.1.) (Lyulcheva, 2006). Data from the yeast 
two-hybrid system indicate that Pico binds activated Ras
V12
, and not dominant negative or wild 
type Ras (Taylor, 2010). In this context therefore, Pico is likely to act downstream of Ras. 
 
As Ras acts downstream of EGFR, it is thought that EGFR activates Ras, which in turn binds to 
and stimulates Pico and its associated factors (Rodriguez-Viciana et al., 2004, Lyulcheva et al., 
2008). This leads to an increase in F-actin formation and commensurate depletion of G-actin, 
alleviating inhibition on Mal's nuclear import by monomeric actin (Miralles et al., 2003, 
Settleman, 2003). Following translocation to the nucleus, Mal complexes with SRF to enable 
transcription of proliferative genes (Posern and Treisman, 2006). 
 
7.1.1. Aims 
 
The purpose of the research presented in this chapter was to assess the level of activity displayed 
by each of the mutant constructs as a means of elucidating the role interactions and 
phosphorylation potentially play in Pico's functionality. Initially, SRE-luciferase assays were 
performed to directly confirm Pico's activation of SRF within the Drosophila system, providing 
further support for the Mal/SRF mediated Pico growth pathway described by Lyulcheva et al., 
2008. The ability of the RNAi resistant Pico
WT
 construct to rescue pico knockdown phenotypes 
in wings was then examined to confirm specificity of pico RNAi lines and validate the synthetic 
Pico transgenes. Lastly, the ability of the Pico mutant constructs to induce overgrowth within the 
wings was assessed to determine their relative level of activity.  
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7.2. Pico overexpression enhances SRF activity  
 
 
Figure 7.2.1. Assessment of Pico's ability to enhance SRF activity. Ectopic Pico was found to 
more than double SRF's apparent activity, while overexpresion of Mal, or Mal and SRF together 
causes a 4-5 and 7-8 fold increase respectively (F(3,8) = 247, p = <0.001).  
 
While the work presented by Lyucheva et al., 2008 strongly implicated the Mal/SRF pathway in 
Pico mediated cell growth and proliferation, this hypothesis was based on genetic analysis in 
flies and direct SRF activation within a heterologous mammalian system. Consequently, 
examinations were performed to assess Pico's ability to directly enhance SRF activity when 
overexpressed in a Drosophila system. This study utilised an SRE-responsive luciferase 
construct encoding the firefly luciferase reporter gene under the control of SRE tandem repeats 
and a minimal (m)CMV promoter. This reporter was transiently transfected into Drosophila 
S2R+ cells alongside a constitutively expressing Renilla luciferase construct, which acted as an 
internal control for normalising transfection efficiencies, as well as Pico
WT
, Mal, or Mal and 
SRF. The results shown in Figure 7.2.1 indicate that ectopic Pico more than doubles the apparent 
activity of SRF within S2R+ cells, confirming Pico's activation of SRF within the Drosophila 
system. Mal overexpression induced SRF activity 4-5 fold, while ectopic expression of Mal and 
SRF together elevated SRE-firefly luciferase levels by 7-8 times, validating the approach used 
(F(3,8) = 247, p = <0.001, ANOVA).  
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7.3. RNAi resistant Pico rescues pico knockdown in wings 
 
Previous research performed within the Bennett lab demonstrated that wings possessed a correct 
morphology but reduced size following RNAi mediated pico knockdown using the in-house 
designed picoRNAi
IR4
 inverted repeat construct, providing evidence for pico's role in growth and 
proliferation (Lyulcheva et al., 2008). However, this finding was challenged by Thompson, 2010 
which described a blistered and crumpled wing phenotype when silencing pico. Instead 
Thompson suggested a role for Pico in maintaining actin-dependent cellular morphology and 
questioned Mal and SRFs role in cell proliferation and tissue growth within the Drosophila 
system (Thompson, 2010). Closer examination of available pico RNAi constructs revealed that 
the commercially available NIG-Fly RNAi lines 11940R-2 and 11940R-3 possessed numerous 
latent off target effects, whereas none were detected for the in-house designed picoRNAi
IR4
, 
providing a potential explanation for the conflicting results. 
 
As a means of validating the Venus-tagged Pico constructs and confirming no erroneous off-
target outcomes were caused by picoRNAi
IR4
, rescue experiments were performed by Vincent 
Jonchere using the RNAi resistant Venus-Pico
WT
 fly lines generated in Chapter 4. The findings 
presented in Figure 7.3.1. revealed that expression of picoRNAi
IR4
 by the MS1096-GAL4 driver 
led to a 12% decrease (p = <0.001, t-test) in wing size and did not caused the dysmorphology 
phenotype described by Thompson, 2010 (Jonchere and Bennett, in press). Further analysis 
showed that expression of Venus-Pico
WT
 resulted in a 7% increase (p = <0.001, t-test) in adult 
wing size, while observations following co-expression with picoRNAi
IR4
 resembled those of 
ectopic Venus-Pico
WT
 alone (Figure 7.3.1.) (Jonchere and Bennett, in press). These findings 
proved that the Venus tag does not interfere with Pico's ability to promote growth, validating the 
use of Venus-tagged Pico constructs in growth studies; and indicated picoRNAi
IR4
 does not 
cause wing dysmorphology, supporting the findings from Lyucheva et al., 2008. 
 
To determine whether the wing dysmorphology phenotypes described by Thompson, 2010 may 
be the result of off-target effects by the 11940R-2 and 11940R-3 RNAi constructs, wings 
expressing 11940R-2 and 11940R-3 were examined by Vincent Jonchere and found to possess a 
blistered and crumpled morphology (data not shown). It was also established that unlike 
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picoRNAi
IR4
, expression of Venus-Pico
WT
 was unable to rescue the 11940R-2/11940R-3 induced 
knockdown phenotype, indicating that wing dysmorphology was a result of off-target effects by 
the NIG-Fly constructs and refuting the conclusions from Thompson, 2010 (data not shown) 
(Jonchere and Bennett, in press). 
 
 
 
Figure 7.3.1. Venus-Pico
WT
 rescue of picoRNAi
IR4
 pico silencing. (a) Flies containing 
picoRNAi
IR4
 without a driver exhibit wing sizes comparable to W
1118
, however, (b) expression of 
picoRNAi
IR4
 using the MS1096-GAL4 driver led to a 12% decrease (p = <0.001) in wing size and 
caused no discernable dysmorphology. (c) MS1096-GAL4 mediated ectopic expression of 
Venus-Pico
WT
 produced a 7% increase (p = <0.001) in wing size compared to MS1096-GAL4 
only flies, (d) while the phenotypic effects of Venus-Pico
WT
 expression were not modified by co-
expression with picoRNAi
IR4
, demonstrating resistance to RNAi-mediated knockdown (Jonchere 
and Bennett, in press). 
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7.4. Assessing Pico mutants ability to induce overgrowth  
 
Following verification of the Lyucheva et al., 2008 findings and confirmation that the Venus-tag 
does not affect Pico's functionality, analysis was carried out on the various Pico mutant 
constructs ability to induce overgrowth within wings to ascertain their relative level of activity. 
 
7.4.1. Venus-Pico mediated growth does not appear to act in a dose-dependent manner 
 
 
 
Figure 7.4.1. Venus-Pico
WT
 fails to demonstrate a dose-dependent wing growth phenotype. 
(a) Flies possessing the MS1096-GAL4 driver alone display wing sizes comparable to W
1118
. (b) 
Flies expressing Venus-Pico
WT
 at high levels (Line 2) under the control of MS1096-GAL4 
exhibit an 11% increase (p = <0.001) in wing size compared to their control, (c) while moderate 
expression (Line 4) caused a 12% increase (p = <0.001) in wing size. 
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Initially the ability of the high expressing Venus-Pico
WT
 2 and moderately expressing Venus-
Pico
WT
 4 lines to promote overgrowth in wings following MS1096-GAL4 induced expression 
was assessed (Chapter 4.6.3.). This enabled analysis of the dose depended effects of Pico 
observed in previous studies (Lyulcheva, 2006) and provided a comparable WT control for high 
and moderately expressed mutant constructs. 25 male flies were examined from each genotype 
and MS1096-GAL4>Venus-Pico wings compared to those from sibling MS1096-GAL4 control 
flies grown in the same vials to ensure identical genetic and environmental backgrounds. The 
findings presented in Figure 7.4.1. revealed wings from Venus-Pico
WT
 2 were 11% larger (p = 
<0.001, t-test) than the MS1096-GAL4 control, while Venus-Pico
WT
 4 caused a 12% increase (p 
= <0.001, t-test) in wing size compared to its control. The lack of any significant dose-dependent 
effects between the two lines indicates that either a form of control exists to regulate the activity 
of the Pico mediated complex, or the system may have become saturated preventing additional 
Pico from having an effect. Consequently, since no dose-dependent effects were observed, all 
future Venus-Pico mutants analysed were compared to an ectopic wild type growth figure of 
11% irrespective of their relative expression level. 
 
7.4.2. Some interactions play a key role in Pico's ability to induce growth and proliferation 
 
Next, the Venus-tagged Pico binding mutants were examined to ascertain how Pico's 
associations may affect its functionality. Figure 7.4.2. reveals that ectopic expression of the 
Pico
LA
, Pico
RE
, and Pico
RR
 mutant constructs yielded an 11-12% increase (p = <0.001, t-test) in 
wing size over their MS1096-GAL4 control, comparable to that observed following 
overexpression of Venus-Pico
WT
. Since these mutants had displayed no alteration in their 
binding affinities (Chapter 5.4.) or cellular localisation (Chapter 6.6.), this finding was not 
unexpected. Interestingly, both the Pico
F816A
 and Pico
MAPK
 mutants displayed significantly 
enhanced wing overgrowth compared to their controls when ectopically expressed using 
MS1096-GAL4, with 26% and 24% increases (p = <0.001, t-test) observed respectively (Figure 
7.4.2.). This effect was considerably higher than that observed in flies expressing Venus-Pico
WT
, 
even though ectopic levels were similar (Chapter 4.6.3.). This indicates that disruption of the 
PP1- and MAPK-binding motifs potentiates the effect of ectopic Pico, identifying roles for PP1 
and Rolled as potential negative regulators of Pico function.  
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Figure 7.4.2. Ectopic expression of Pico
MAPK
 and Pico
F816A
 mutants display significant 
overgrowth compared to Venus-Pico
WT
. (a) Wings from flies containing the MS1096-GAL4 
driver only were used as a comparative control. Flies expressing (b) Venus-Pico
LA
, (c) Venus-
Pico
RE
, and (d) Venus-Pico
RR
, under the control of the MS1096-GAL4 driver yielded an 11-12% 
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increase (p = <0.001) in wing size while ectopic (e) Venus-Pico
F816A
 and (f) Venus-Pico
MAPK
 
caused significant overgrowth, with 26% and 24% increases (p = <0.001) observed respectively. 
 
7.4.3. Serine 819 is fundamental in regulating Pico's activity 
 
 
 
Figure 7.4.3. Serine 819 plays a key role in Pico regulation. (a) Flies containing only the 
MS1096-GAL4 driver were utilised as a comparative control and exhibited wing sizes 
comparable to W
1118
. (b) Flies expressing the non-phosphorylatable Venus-Pico
S819A
 construct 
were found to possess wings displaying a considerable 26% increase (p = <0.001) in size, 
whereas, (c) overexpression of phosphomimetic Venus-Pico
S819D
 only caused a negligible 2% 
wing overgrowth (p = <0.001). 
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Lastly, flies expressing the non-phosphorylatable Pico
S819A
 and phosphomimetic Pico
S819D
 
constructs using the MS1096-GAL4 driver were assessed to determine the role phosphorylation 
plays in regulating Pico's activity. The results presented in Figure 7.4.3. show that ectopic 
Pico
S819A
 causes a significant 26% increase (p = <0.001, t-test) in wing size comparable to that 
observed following expression of the Pico
F816A
 and Pico
MAPK
 mutant constructs. Contrastingly, 
overexpression of Pico
S819D
 led to a negligible 2% increase (p = <0.001, t-test) in wing size, 
despite expression levels being similar to Venus-Pico
WT
 4, suggesting that phosphorylation at 
serine 819 may disrupt the ability of Pico to induce tissue overgrowth. 
 
7.5. Discussion  
 
The findings displayed in this chapter have confirmed the supposition presented by Lyucheva et 
al., 2008 indicating Pico is involved in cellular growth and proliferation through the rescue of 
RNAi mediated pico silencing. The results also revealed that the contradictory conclusions 
presented by Thompson, 2010 were caused by latent off-target effects of the NIG-Fly pico RNAi 
lines used in the study. In addition, the hypothesis that Pico stimulates growth through activation 
of the MAL/SRF pathway was further supported by findings from SRE-luciferase assays which 
showed ectopic Pico increased the apparent activity of SRF.  
 
7.5.1. PP1 and rolled appear to play a role in deactivation of the Pico mediated complex 
 
Previous research performed within the Bennett lab had demonstrated a dose-dependent increase 
in wing size relative to the quantities of ectopic Pico (Lyulcheva, 2006), however, despite Pico
WT
 
2 and Pico
WT
 4 lines displaying significantly differing expression levels, no discernable 
alteration in wing overgrowth was observed between the two. This implied that Venus-Pico
WT
 2 
and 4 are expressed at high enough levels for some other factor required for pico-mediated 
overgrowth to become limiting. Ectopic Pico
LA
, Pico
RE
, and Pico
RR
 also appeared to cause no 
difference in wing overgrowth levels when compared to flies expressing Pico
WT
, with all 
constructs found to yield an 11-12% size increase (Figure 7.5.1.). This implied that each 
construct functioned correctly, but was limited by the same inhibitory factor that prevented a 
dose dependent increase being observed between Pico
WT
 2 and Pico
WT
 4.  
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Figure 7.4.3. Overview of Pico construct induced wing overgrowth. Levels of wing 
overgrowth were assessed following MS1096-GAL4 driven expression of the Venus-Pico 
constructs. Overexpression of Pico
WT
 2 and Pico
WT
 4 both caused an 11-12% increase in wing 
size, while expression of the Pico
LA
, Pico
RE
, and Pico
RR
 mutant constructs also led to an 11-12% 
overgrowth. Ectopic Pico
F816A
 and Pico
MAPK
 mutants brought about a significant increase in wing 
size of 24-26%, a level shared by non phosphorylatable Pico
S819A
, but not the phosphomimetic 
Pico
S819D
 which demonstrated a negligible 2% increase. 
 
Interestingly, the Pico
F816A
 and Pico
MAPK
 mutant constructs caused a substantial 24-26% increase 
in wing size when expressed using the MS1096-GAL4 driver, strongly implying a role for both 
PP1 and Rolled in the negative regulation of the Pico function. Furthermore, expression of the 
non phosphorylatable Pico
S819A
 construct caused an equivalent overgrowth of 26% while 
phosphomimetic Pico
S819D
 only induced a 2% increase. These observations may not be entirely 
unrelated since previous data from this thesis indicate that Rolled may phosphorylate Pico at Ser 
819 (Chapter 5.5.1.). Additionally, Pico
S819D
, but not Pico
MAPK
 or Pico
S819A
, was able to bind PP1 
in cell extracts (Chapter 5.5.2.). These results suggest the existence of a potential 
phosphorylation cascade involving Rolled and PP1 which deactivates the Pico complex. This 
proposed pathway is examined in greater detail within the General Discussion (Chapter 8.2.). 
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8. General Discussion 
 
8.1. A novel interaction with Erk1/2/Rolled offers a means of regulating MRL proteins  
 
The findings presented in this report have provided evidence that Pico interacts with Chickadee, 
Ras, and PP1 in vivo (Chapter 5.2.), substantiating results from yeast-two-hybrid studies and 
supporting its proposed role in regulating actin dynamics (Taylor, 2010, Lyulcheva et al., 2008). 
Pico was also shown to interact with the Talin homologue Rhea (Chapter 5.2.1), suggesting a 
potential function in controlling cell adhesion as demonstrated for RIAM (Lafuente et al., 2004, 
Wolfenson et al., 2013, Colo et al., 2012a, Hernandez-Varas et al., 2011). However, wing 
dysmorphology was not observed following knockdown or overexpression of Pico, suggesting 
any effects during wing imaginal disc development may be minimal (Chapter 7.3.). The Pico 
binding partners identified were analogous to many of those discovered for other MRL 
orthologues, indicating a probable conserved functionality which is unsurprising given the high 
degree of domain homology present within the MRL family (Chapter 3.2.) (Krause et al., 2004, 
Lafuente et al., 2004, Lee et al., 2009)  
 
Interestingly, this work also highlighted a novel interaction with Rolled/MAPK, the Erk1/2 
homologue, not previously described within the literature (Colo et al., 2012b). MAPK binding 
was also found to occur with human Lpd and RIAM as well as Pico and was dependent on the 
presence of a highly conserved MAPK binding site adjacent to the N-terminus of the RA 
domain, strongly implying direct binding (Chapter 5.2.). Given the well established role Erk1/2 
plays in signal transduction, this interaction could provide another means of regulating MRL 
proteins in addition to the contribution made by binding to Ras-like GTPases (Nishimoto and 
Nishida, 2006, Colo et al., 2012b). Potential functions of Pico-bound MAPK are discussed 
further below. 
 
8.2. Pico interacts with most of its associated proteins within dynamic membrane regions  
 
Previous research had shown that RIAM localises within both the cytoplasm and lamellipodia of 
cells in culture, whereas Lpd is predominantly found at the tips of lamellipodia and filopodia 
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(Lafuente et al., 2004, Krause et al., 2004). Localisation studies presented in this report revealed 
Pico to also accumulate within the cytoplasm and at the leading edge of Drosophila cells, 
however, time course assays and live imaging demonstrated Pico's localisation to be dynamic 
and change as cell spreading rates varied (Chapter 6.3.). Interestingly, Pico was shown to 
accumulate within active membrane ruffles, representing regions undergoing rapid 
reorganisation of the plasma membrane, when S2R+ cells were rapidly expanding (Chapter 
6.5.1.). A similar accrual of RIAM or Lpd within these structures has not yet been reported  
(Colo et al., 2012b).  
 
Furthermore, co-localisation studies established that Pico accumulated within membrane ruffles 
alongside the majority of its binding partners, suggesting Pico's associations may occur 
predominantly within areas of heightened actin remodelling (Chapter 6.5.2.). Surprisingly, 
Rogers et al., 2003 made no mention of membrane ruffle accrual for Enabled or Chickadee when 
studying actin regulatory protein localisation, however, this study, much like those assessing Lpd 
and RIAM positioning, only examined cells which had reached their maximal size and possessed 
no ruffles (Lafuente et al., 2004, Krause et al., 2004). 
 
8.3. The proposed Pico mediated growth pathway  
 
Genetic analysis performed by Lyulcheva et al., 2008 revealed that Pico acts downstream of 
EGFR. Pico was also shown to interact with the active form of Ras, another effector of EGFR, 
via the conserved RA domain (Taylor, 2010). Additional studies, such as the overgrowth analysis 
described in Chapter 4.8.1., have shown Pico's activity to be greatly enhanced by the presence of 
constitutively active Ras
V12
, further implicating Ras-like GTPases in Pico's activation 
(Lyulcheva, 2006). Lyulcheva et al., 2008 also suggested that Pico induces growth through 
alterations in the G:F actin ratio and activation of Mal/SRF, a finding further supported by the 
SRE luciferase assays presented in Chapter 7.2.  
 
This led to the proposal that EGF stimulated EGFR activates Ras, which in turn binds to Pico 
and facilitates its function (Lyulcheva et al., 2008). This causes an alteration in actin dynamics, 
via the actin regulators Ena and Chickadee, leading to an increase in filamentous actin levels and 
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a corresponding depletion of monomeric actin (Taylor, 2010). This is proposed to reduce the 
inhibitory binding of G-actin to MAL, enabling translocation of MAL to the nucleus where it 
complexes with SRF to facilitate in the transcription of SRE-containing genes involved in 
cellular growth and proliferation (Figure 8.3.1.) (Miralles et al., 2003, Settleman, 2003, Posern 
and Treisman, 2006). 
 
Interestingly, the findings presented in this report indicate the existence of a potential 
deactivation pathway involving Rolled and PP1 that limits the effects of ectopic Pico on wing 
overgrowth (Figure 8.3.1.). Active Rolled binds Pico, most likely via the highly conserved 
MAPK binding motif (Chapter 5.2.4.). Once bound, Rolled phosphorylates Pico at Ser 819 
allowing Pico to bind PP1 through the C-terminal PP1 binding site (Chapter 5.5.). Suppression of 
Pico-mediated growth by the PP1 binding phospho-mimetic Pico
S819D
 variant, in addition to the 
enhanced proliferative effects of the non PP1 binding Pico
MAPK
, Pico
F816A
 and Pico
S819A
 
constructs compared to Pico
WT
, indicate that binding to PP1 is a molecular constrain on Pico 
function (Chapter 7.4.). The mechanism through which PP1-mediated functional inhibition 
occurs remains unclear, but many of the Pico-associated proteins are phosphoproteins and might 
be relevant substrates for the phosphatase. 
 
Furthermore, recent RNA-seq data has shown that overexpression of MAL leads to elevated 
transcription of rolled (Vincent Jonchere, personal communication). This offers a potential 
means of negatively regulating Pico-mediated growth through a MAL/SRF induced MAPK 
feedback loop. Increased levels of Rolled would enhance phosphorylation of Pico at Ser 819, 
causing heightened binding of and subsequent deactivation by PP1 (Figure 8.3.1.). 
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Figure 8.3.1. Overview of the proposed Pico mediated growth pathway. Activated EGFR 
stimulates Ras which in turn binds to Pico and activates the Pico mediated complex. The 
activated complex enhances F-actin formation leading to depletion of G-actin and a subsequent 
reduction in levels of inhibitory G-actin bound to MAL. Unbound MAL translocates to the 
nucleus where it complexes with SRF enabling transcription of a subset of SRE-containing genes 
including rolled and those involved in cellular proliferation. Increased levels of Rolled enhances 
phosphorylation of Pico at Ser 819 allowing PP1 to bind and deactivate the complex. Novel 
conclusions are highlighted by red arrows. 
 
It remains unclear whether Rolled/PP1 plays a role in controlling Pico's effect on cellular 
migration, or if a similar mechanism exists for regulating RIAM and Lpd, especially given the 
lack of an analogous C-terminal PP1 binding motif (Chapter 3.3.). However, a recent report by 
Colo et al., 2012a has demonstrated that Erk1/2 activates an integrin-RIAM mediated feedback 
loop involved in the disassembly of FAs. In addition, RIAM silenced cells have been found to 
display decreased activation of Erk1/2 and PI3K, as well as impaired tumor growth and delayed 
metastasis, suggesting RIAM may induce activation of Erk1/2 and PI3K during a cellular 
proliferative process (Hernandez-Varas et al., 2011). These findings, taken together with the 
comparable Erk1/2 binding (Chapter 5.2.4.), suggest that a similar MAPK mediated MRL 
deactivation loop may exist for RIAM and Lpd. 
 
8.4. Future work  
 
8.4.1. Validating the proposed Pico pathway 
 
Although the work presented in this report has provided evidence of a putative Pico-mediated 
growth pathway, many aspects of the model require further validation. The genetic analysis 
performed by Lyulcheva et al., 2008 intimating Pico-mediated growth downstream of EGFR is 
convincing, however, it could be further supported by examining synergistic enhancement of 
SRF activity by Pico and stimulated EGFR when co-expressed within the SRE luciferase system 
(Chapter 7.2). While this would provide a more direct indication of EGFR's effect on Pico, 
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conclusive deductions cannot be made until a suitable marker of Pico-mediated complex 
activation is established (e.g. Ras/Rap binding or phosphorylation at a specific site). 
 
Discovering whether Ras-like GTPases are responsible for activation of the Pico mediated 
complex is also essential for accurately understanding the pathway. The current model requires 
assumptions to be made based upon Pico's interactions with activated Ras/Rap (Taylor, 2010, 
Chapter 5.2.2.), Ras/Rap functionality (Zwartkruis and Bos, 1999), and the significantly 
enhanced tissue overgrowth observed following co-expression of Pico with constitutively active 
Ras
V12
 (Lyulcheva, 2006). It is therefore crucial for a suitable Ras binding mutant of Pico to be 
generated either through deletion of the RA domain or introduction of more extensive alterations. 
This would enable interaction and functional studies to be carried out as a means of determining 
whether Ras/Rap binding was central to Pico's associations and activity. Further investigations 
assessing the effect of Ras
V12
 expression on Pico-mediated SRF activity using the SRE luciferase 
assay may also provide further supporting evidence (Chapter 7.3). 
 
As the peptide array failed to identify target sequences for Erk1/2/Rolled-mediated Pico 
phosphorylation (Chapter 4.2.), Mass Spectrometry could instead be employed to assess potential 
MAPK phosphorylation sites through comparisons of Pico
WT
 and Pico
MAPK
 (Shou et al., 2002). 
This may enable further phosphomimetic and non-phosphorylatable constructs to be developed, 
allowing the role of Pico phosphorylation to be elucidated via additional interaction and 
functional studies. Mass spectrometry could also be used to assess the mechanism through which 
PP1 deactivates the Pico mediated complex by comparing the phosphorylation states of Pico and 
its associated proteins in a Pico
WT
 and Pico
F816A
 background.  
 
Lastly, increased expression of rolled has only been demonstrated following overexpression of 
MAL (Vincent Jonchere, personal communication). As such, RT-qPCR should be carried out to 
confirm whether ectopic Pico can also induce elevated transcription of rolled in order to confirm 
whether a potential MAPK feedback loop exists. Analysis of relative Rolled protein levels could 
also be carried out through Western blotting of pico knockdown, wild type, and Pico
WT
 
expressing flies. 
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8.4.2. Further analysis of Pico 
 
Due to time constraints it was not possible to assess Pico's effect on metastasis of Ras
V12
-induced 
tumours or in the border cell migration model outlined in Chapter 4.8.1. Consequently, analysis 
of the Pico mutants within these systems would enable validation of the wing overgrowth results 
and confirm whether Rolled and PP1 play a similar role in regulating Pico's induction of cell 
migration. Two distinct phases of border cell invasion exist during the migration of border cells 
across the egg chamber; an initial rapid polarised cell behaviour followed by a slow dynamic 
collective migration (Bianco et al., 2007). By investigating the effect of pico silencing and 
ectopic Pico expression on border cell migration using live imaging techniques (Prasad et al., 
2011) would allow further insights into Pico mediated adhesion and protrusion dynamics to be 
developed.  
 
Lastly, while the co-localisation studies presented in Chapter 6.5.2 suggested that Pico 
predominantly associates with its binding partners within active membrane ruffles, co-
localisation is not evidence of physical interaction. Consequently, Fluorescence Resonance 
Energy Transfer (FRET), a technique which assesses spectral absorbance between two 
fluorophores in close proximity (1-10nm), could also be carried out to ascertain the cellular 
location of Pico's interactions and validate the co-localisation findings (Chen et al., 2006). In 
addition, the ability of Pico's binding partners to localise within membrane ruffles or at the 
leading edge could be assessed in spreading S2R+ cells following pico knockdown. This would 
confirm whether Pico is crucial to the recruitment of associated factors to subcellular locations. 
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1. WTETKKQSFKQTG 
2. LEKIGEGTYGTVF 
3. PTAENPEYLGLDV 
4. GRKGSGDYMPMSP 
5. LLPTPPLSPSRRS 
6. KEFGVERSVRPTD 
7. KSNVKIQSTPVKQ 
8. LVEPLTPSGEAPN 
9. IHFWSTLSPIAPR 
10. GSRSRTPSLPTPP 
11. ASATVSKTETSQV 
12. MANLEDSQESELDQILGE 
13. MANLEDAQESELDQILGE 
14. ANLEDSQESELDQILGEL 
15. ANLEDSQEAELDQILGEL 
16. LDQILGELSLLEAQISYT 
17. LDQILGELALLEAQISYT 
18. LDQILGELSLLEAQIAFA 
19. SLLEAQISYTEASMLPAM 
20. SLLEAQIAYTEASMLPAM 
21. ALLEAQISFAEAAMLPAM 
22. SLLEAQISFTEASMLPAM 
23. ALLEAQIAYAEAAMLPAM 
24. SLLEAQISYAEASMLPAM 
25. ALLEAQIAFTEAAMLPAM 
26. AQISYTEASMLPAMCAPS 
27. AQISYTEAAMLPAMCAPS 
28. AQIAFAEASMLPAMCAPA 
29. MLPAMCAPSAGAQIAPPP 
30. MLPAMCAPAAGAQIAPPP 
31. QIAPPPGVTQLPGSAPTM 
32. QIAPPPGVAQLPGSAPTM 
33. QIAPPPGVTQLPGAAPAM 
34. PGVTQLPGSAPTMVSMSA 
35. PGVTQLPGAAPTMVSMSA 
36. PGVAQLPGSAPAMVAMAA 
37. TQLPGSAPTMVSMSASSS 
38. TQLPGSAPAMVSMSASSS 
39. AQLPGAAPTMVAMAAAAA 
40. PGSAPTMVSMSASSSRSH 
41. PGSAPTMVAMSASSSRSH 
42. PGAAPAMVSMAAAAARAH 
43. SAPTMVSMSASSSRSHRT 
44. SAPTMVSMAASSSRSHRT 
45. AAPAMVAMSAAAARAHRA 
46. TMVSMSASSSRSHSRTNS 
47. TMVSMSAASSRSHSRTNS 
48. AMVAMAASAARAHARANA 
49. TMVSMSASASRSHSRTNS 
50. AMVAMAAASARAHARANA 
51. TMVSMSASSARSHSRTNS 
52. AMVAMAAAASRAHARANA 
53. SMSASSSRSHSRTNSTIS 
54. SMSASSSRAHSRTNSTIS 
55. AMAAAAARSHARANAAIA 
56. SASSSRSHSRTNSTISAD 
57. SASSSRSHARTNSTISAD 
58. AAAAARAHSRANAAIAAD 
59. SSSRSHSRTNSTISADVS 
60. SSSRSHSRANSTISADVS 
61. AAARAHARTNAAIAADVA 
62. SRSHSRTNSTISADVSSC 
63. SRSHSRTNATISADVSSC 
64. ARAHARANSAIAADVAAC 
65. SRSHSRTNSAISADVSSC 
66. ARAHARANATIAADVAAC 
67. HSRTNSTISADVSSCSSS 
68. HSRTNSTIAADVSSCSSS 
69. HARANAAISADVAACAAA 
70. NSTISADVSSCSSSGISE 
71. NSTISADVASCSSSGISE 
72. NAAIAADVSACAAAGIAE 
73. NSTISADVSACSSSGISE 
74. NAAIAADVASCAAAGIAE 
75. SADVSSCSSSGISENGHG 
76. SADVSSCASSGISENGHG 
77. AADVAACSAAGIAENGHG 
78. SADVSSCSASGISENGHG 
79. AADVAACASAGIAENGHG 
80. SADVSSCSSAGISENGHG 
81. AADVAACAASGIAENGHG 
82. SSCSSSGISENGHGLGLV 
83. SSCSSSGIAENGHGLGLV 
84. AACAAAGISENGHGLGLV 
85. GLVLGGPGSAGMMVQPPP 
86. GLVLGGPGAAGMMVQPPP 
87. QPPPPGGMTMGITLGVVT 
88. QPPPPGGMAMGITLGVVT 
89. QPPPPGGMTMGIALGVVA 
90. PGGMTMGITLGVVTPREP 
91. PGGMTMGIALGVVTPREP 
92. PGGMAMGITLGVVAPREP 
93. MGITLGVVTPREPRTESP 
94. MGITLGVVAPREPRTESP 
95. MGIALGVVTPREPRAEAP 
96. VVTPREPRTESPDNDSAF 
97. VVTPREPRAESPDNDSAF 
98. VVAPREPRTEAPDNDAAF 
99. TPREPRTESPDNDSAFSD 
100. TPREPRTEAPDNDSAFSD 
101. APREPRAESPDNDAAFAD 
102. RTESPDNDSAFSDTVSLL 
103. RTESPDNDAAFSDTVSLL 
104. RAEAPDNDSAFADAVALL 
105. SPDNDSAFSDTVSLLSSE 
106. SPDNDSAFADTVSLLSSE 
107. APDNDAAFSDAVALLAAE 
108. DNDSAFSDTVSLLSSESS 
109. DNDSAFSDAVSLLSSESS 
110. DNDAAFADTVALLAAEAA 
111. DSAFSDTVSLLSSESSAS 
112. DSAFSDTVALLSSESSAS 
113. DAAFADAVSLLAAEAAAA 
114. FSDTVSLLSSESSASSNT 
115. FSDTVSLLASESSASSNT 
116. FADAVALLSAEAAAAANA 
117. FSDTVSLLSAESSASSNT 
118. FADAVALLASEAAAAANA 
119. TVSLLSSESSASSNTSLQ 
120. TVSLLSSEASASSNTSLQ 
121. AVALLAAESAAAANAALQ 
122. TVSLLSSESAASSNTSLQ 
123. AVALLAAEASAAANAALQ 
124. LLSSESSASSNTSLQQQQ 
125. LLSSESSAASNTSLQQQQ 
126. LLAAEAAASANAALQQQQ 
127. LLSSESSASANTSLQQQQ 
128. LLAAEAAAASNAALQQQQ 
129. SESSASSNTSLQQQQQQQ 
130. SESSASSNASLQQQQQQQ 
131. AEAAAAANTALQQQQQQQ 
132. SESSASSNTALQQQQQQQ 
133. AEAAAAANASLQQQQQQQ 
134. HGQHGGQQSGANSITKAD 
135. HGQHGGQQAGANSITKAD 
136. HGQHGGQQSGANAIAKAD 
137. GGQQSGANSITKADKIQL 
138. GGQQSGANAITKADKIQL 
139. GGQQAGANSIAKADKIQL 
140. QQSGANSITKADKIQLAL 
141. QQSGANSIAKADKIQLAL 
142. QQAGANAITKADKIQLAL 
143. QLALHKLESAPIRRLFVK 
144. QLALHKLEAAPIRRLFVK 
145. RRLFVKAFTSDGASKSLL 
146. RRLFVKAFASDGASKSLL 
147. RRLFVKAFTADGAAKALL 
148. RRLFVKAFTADGASKSLL 
149. RRLFVKAFASDGAAKALL 
150. KAFTSDGASKSLLVDERM 
151. KAFTSDGAAKSLLVDERM 
152. KAFAADGASKALLVDERM 
153. FTSDGASKSLLVDERMGC 
154. FTSDGASKALLVDERMGC 
155. FAADGAAKSLLVDERMGC 
156. ERMGCGHVTRLLADKNHV 
157. ERMGCGHVARLLADKNHV 
158. DKNHVQMQSNWALVEHLG 
159. DKNHVQMQANWALVEHLG 
160. ELLVDNLMTWHSDAGNRV 
161. ELLVDNLMAWHSDAGNRV 
162. VDNLMTWHSDAGNRVLFQ 
163. VDNLMTWHADAGNRVLFQ 
164. FQQRPDKVTLFLRPELYL 
165. FQQRPDKVALFLRPELYL 
166. FQQRPDKVTLFLRPELFL 
167. TLFLRPELYLPGPQMAPG 
168. TLFLRPELFLPGPQMAPG 
169. ALFLRPELYLPGPQMAPG 
170. PGCQHDEQTRQMLLDEFF 
171. PGCQHDEQARQMLLDEFF 
172. MLLDEFFDSHNQLQMDGP 
173. MLLDEFFDAHNQLQMDGP 
174. QLQMDGPLYMKADPKKGW 
175. QLQMDGPLFMKADPKKGW 
176. DPKKGWKRYHFVLRSSGL 
177. DPKKGWKRFHFVLRSSGL 
178. DPKKGWKRYHFVLRAAGL 
179. KRYHFVLRSSGLYYFPKE 
180. KRYHFVLRASGLYYFPKE 
181. KRFHFVLRSAGLFFFPKE 
182. KRYHFVLRSAGLYYFPKE 
183. KRFHFVLRASGLFFFPKE 
184. FVLRSSGLYYFPKEKTKN 
185. FVLRSSGLFYFPKEKTKN 
186. FVLRAAGLYFFPKEKAKN 
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187. FVLRSSGLYFFPKEKTKN 
188. FVLRAAGLFYFPKEKAKN 
189. LYYFPKEKTKNTRDLACL 
190. LYYFPKEKAKNTRDLACL 
191. LFFFPKEKTKNARDLACL 
192. FPKEKTKNTRDLACLNLF 
193. FPKEKTKNARDLACLNLF 
194. FPKEKAKNTRDLACLNLF 
195. NLFHGHNVYTGLGWRKKW 
196. NLFHGHNVFTGLGWRKKW 
197. NLFHGHNVYAGLGWRKKW 
198. LGWRKKWKSPTDYTFGFK 
199. LGWRKKWKAPTDYTFGFK 
200. LGWRKKWKSPADFAFGFK 
201. WRKKWKSPTDYTFGFKAV 
202. WRKKWKSPADYTFGFKAV 
203. WRKKWKAPTDFAFGFKAV 
204. KKWKSPTDYTFGFKAVGD 
205. KKWKSPTDFTFGFKAVGD 
206. KKWKAPADYAFGFKAVGD 
207. KKWKSPTDYAFGFKAVGD 
208. KKWKAPADFTFGFKAVGD 
209. FGFKAVGDSSLGKSCRSL 
210. FGFKAVGDASLGKSCRSL 
211. FGFKAVGDSALGKACRAL 
212. FGFKAVGDSALGKSCRSL 
213. FGFKAVGDASLGKACRAL 
214. VGDSSLGKSCRSLKMLCA 
215. VGDSSLGKACRSLKMLCA 
216. VGDAALGKSCRALKMLCA 
217. SSLGKSCRSLKMLCAEDL 
218. SSLGKSCRALKMLCAEDL 
219. AALGKACRSLKMLCAEDL 
220. MLCAEDLPTLDRWLTAIR 
221. MLCAEDLPALDRWLTAIR 
222. MLCAEDLPTLDRWLAAIR 
223. LPTLDRWLTAIRVCKYGK 
224. LPTLDRWLAAIRVCKYGK 
225. LPALDRWLTAIRVCKFGK 
226. LTAIRVCKYGKQLWDSHK 
227. LTAIRVCKFGKQLWDSHK 
228. LAAIRVCKYGKQLWDAHK 
229. KYGKQLWDSHKSLLEDLC 
230. KYGKQLWDAHKSLLEDLC 
231. KFGKQLWDSHKALLEDLC 
232. KQLWDSHKSLLEDLCLSR 
233. KQLWDSHKALLEDLCLSR 
234. KQLWDAHKSLLEDLCLAR 
235. SLLEDLCLSRDDAVSQSS 
236. SLLEDLCLARDDAVSQSS 
237. ALLEDLCLSRDDAVAQAA 
238. CLSRDDAVSQSSFAASMR 
239. CLSRDDAVAQSSFAASMR 
240. CLSRDDAVSQAAFAAAMR 
241. SRDDAVSQSSFAASMRSE 
242. SRDDAVSQASFAASMRSE 
243. ARDDAVAQSAFAAAMRAE 
244. SRDDAVSQSAFAASMRSE 
245. ARDDAVAQASFAAAMRAE 
246. VSQSSFAASMRSESISSI 
247. VSQSSFAAAMRSESISSI 
248. VAQAAFAASMRAEAIAAI 
249. SSFAASMRSESISSISSA 
250. SSFAASMRAESISSISSA 
251. AAFAAAMRSEAIAAIAAA 
252. FAASMRSESISSISSAVP 
253. FAASMRSEAISSISSAVP 
254. FAAAMRAESIAAIAAAVP 
255. ASMRSESISSISSAVPSQ 
256. ASMRSESIASISSAVPSQ 
257. AAMRAEAISAIAAAVPAQ 
258. ASMRSESISAISSAVPSQ 
259. AAMRAEAIASIAAAVPAQ 
260. RSESISSISSAVPSQCGS 
261. RSESISSIASAVPSQCGS 
262. RAEAIAAISAAVPAQCGA 
263. RSESISSISAAVPSQCGS 
264. RAEAAAIASAVPAQCGA 
265. SSISSAVPSQCGSVSSAI 
266. SSISSAVPAQCGSVSSAI 
267. AAIAAAVPSQCGAVAAAI 
268. SAVPSQCGSVSSAISSMS 
269. SAVPSQCGAVSSAISSMS 
270. AAVPAQCGSVAAAIAAMA 
271. VPSQCGSVSSAISSMSNS 
272. VPSQCGSVASAISSMSNS 
273. VPAQCGAVSAAIAAMANA 
274. VPSQCGSVSAAISSMSNS 
275. VPAQCGAVASAIAAMANA 
276. CGSVSSAISSMSNSTSGR 
277. CGSVSSAIASMSNSTSGR 
278. CGAVAAAISAMANAAAGR 
279. CGSVSSAISAMSNSTSGR 
280. CGAVAAAIASMANAAAGR 
281. VSSAISSMSNSTSGRTSR 
282. VSSAISSMANSTSGRTSR 
283. VAAAIAAMSNAAAGRAAR 
284. AISSMSNSTSGRTSRASS 
285. AISSMSNATSGRTSRASS 
286. AIAAMANSAAGRAARAAA 
287. AISSMSNSASGRTSRASS 
288. AIAAMANATAGRAARAAA 
289. AISSMSNSTAGRTSRASS 
290. AIAAMANAASGRAARAAA 
291. MSNSTSGRTSRASSSSSS 
292. MSNSTSGRASRASSSSSS 
293. MANAAAGRTARAAAAAAA 
294. MSNSTSGRTARASSSSSS 
295. MANAAAGRASRAAAAAAA 
296. SGRTSRASSSSSSGCLSD 
297. SGRTSRAASSSSSGCLSD 
298. AGRASRASAAAAAGCLAD 
299. SGRTSRASASSSSGCLSD 
300. AGRASRAASAAAAGCLAD 
301. SGRTSRASSASSSGCLSD 
302. AGRASRAAASAAAGCLAD 
303. TSRASSSSSSGCLSDDNN 
304. TSRASSSASSGCLSDDNN 
305. AARAAAASAAGCLADDNN 
306. TSRASSSSASGCLSDDNN 
307. AARAAAAASAGCLADDNN 
308. TSRASSSSSAGCLSDDNN 
309. AARAAAAAASGCLADDNN 
310. SSSSSGCLSDDNNAFDSE 
311. SSSSSGCLADDNNAFDSE 
312. AAAAAGCLSDDNNAFDAE 
313. SDDNNAFDSEFTTGTIKR 
314. SDDNNAFDAEFTTGTIKR 
315. ADDNNAFDSEFAAGAIKR 
316. NNAFDSEFTTGTIKRKPS 
317. NNAFDSEFATGTIKRKPS 
318. NNAFDAEFTAGAIKRKPA 
319. NNAFDSEFTAGTIKRKPS 
320. NNAFDAEFATGAIKRKPA 
321. FDSEFTTGTIKRKPSMKP 
322. FDSEFTTGAIKRKPSMKP 
323. FDAEFAAGTIKRKPAMKP 
324. TGTIKRKPSMKPNLPLTT 
325. TGTIKRKPAMKPNLPLTT 
326. AGAIKRKPSMKPNLPLAA 
327. SMKPNLPLTTMTRQLKEV 
328. SMKPNLPLATMTRQLKEV 
329. AMKPNLPLTAMARQLKEV 
330. SMKPNLPLTAMTRQLKEV 
331. AMKPNLPLATMARQLKEV 
332. PNLPLTTMTRQLKEVGEI 
333. PNLPLTTMARQLKEVGEI 
334. PNLPLAAMTRQLKEVGEI 
335. QLKEVGEITICESAGGDA 
336. QLKEVGEIAICESAGGDA 
337. QLKEVGEITICEAAGGDA 
338. VGEITICESAGGDASSPE 
339. VGEITICEAAGGDASSPE 
340. VGEIAICESAGGDAAAPE 
341. CESAGGDASSPERSGTLT 
342. CESAGGDAASPERSGTLT 
343. CEAAGGDASAPERAGALA 
344. CESAGGDASAPERSGTLT 
345. CEAAGGDAASPERAGALA 
346. GDASSPERSGTLTRRHSR 
347. GDASSPERAGTLTRRHSR 
348. GDAAAPERSGALARRHAR 
349. ASSPERSGTLTRRHSRRK 
350. ASSPERSGALTRRHSRRK 
351. AAAPERAGTLARRHARRK 
352. SPERSGTLTRRHSRRKSQ 
353. SPERSGTLARRHSRRKSQ 
354. APERAGALTRRHARRKAQ 
355. SGTLTRRHSRRKSQESNG 
356. SGTLTRRHARRKSQESNG 
357. AGALARRHSRRKAQEANG 
358. TRRHSRRKSQESNGSGTL 
359. TRRHSRRKAQESNGSGTL 
360. ARRHARRKSQEANGAGAL 
361. HSRRKSQESNGSGTLKRR 
362. HSRRKSQEANGSGTLKRR 
363. HARRKAQESNGAGALKRR 
364. RKSQESNGSGTLKRRPIA 
365. RKSQESNGAGTLKRRPIA 
366. RKAQEANGSGALKRRPIA 
367. SQESNGSGTLKRRPIAVP 
368. SQESNGSGALKRRPIAVP 
369. AQEANGAGTLKRRPIAVP 
370. RPIAVPVATVVKQTEPMG 
371. RPIAVPVAAVVKQTEPMG 
372. RPIAVPVATVVKQAEPMG 
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373. PVATVVKQTEPMGSASST 
374. PVATVVKQAEPMGSASST 
375. PVAAVVKQTEPMGAAAAA 
376. VKQTEPMGSASSTSSSSN 
377. VKQTEPMGAASSTSSSSN 
378. VKQAEPMGSAAAAAAAAN 
379. TEPMGSASSTSSSSNSTP 
380. TEPMGSAASTSSSSNSTP 
381. AEPMGAASAAAAAANSAP 
382. TEPMGSASATSSSSNSTP 
383. AEPMGAAASAAAAANAAP 
384. TEPMGSASSASSSSNSTP 
385. AEPMGAAAATAAAANAAP 
386. PMGSASSTSSSSNSTPTP 
387. PMGSASSTASSSNSTPTP 
388. PMGAAAAASAAANAAPAP 
389. PMGSASSTSASSNSTPTP 
390. PMGAAAAAASAANAAPAP 
391. PMGSASSTSSASNSTPTP 
392. PMGAAAAAAASANAAPAP 
393. SASSTSSSSNSTPTPTPS 
394. SASSTSSSANSTPTPTPS 
395. AAAAAAAASNAAPAPAPA 
396. SSTSSSSNSTPTPTPSIC 
397. SSTSSSSNATPTPTPSIC 
398. AAAAAAANSAPAPAPAIC 
399. SSTSSSSNSAPTPTPSIC 
400. AAAAAAANATPAPAPAIC 
401. SSSSNSTPTPTPSICAKP 
402. SSSSNSTPAPTPSICAKP 
403. AAAANAAPTPAPAICAKP 
404. SSNSTPTPTPSICAKPPP 
405. SSNSTPTPAPSICAKPPP 
406. AANAAPAPTPAICAKPPP 
407. NSTPTPTPSICAKPPPGD 
408. NSTPTPTPAICAKPPPGD 
409. NAAPAPAPSICAKPPPGD 
410. CAKPPPGDSASLMCSSTL 
411. CAKPPPGDAASLMCSSTL 
412. CAKPPPGDSAALMCAAAL 
413. KPPPGDSASLMCSSTLDS 
414. KPPPGDSAALMCSSTLDS 
415. KPPPGDAASLMCAAALDA 
416. DSASLMCSSTLSLDSLPP 
417. DSASLMCASTLSLDSLPP 
418. DAAALMCSAALALDALPP 
419. DSASLMCSATLSLDSLPP 
420. DAAALMCASALALDALPP 
421. DSASLMCSSALSLDSLPP 
422. DAAALMCAATLALDALPP 
423. SLMCSSTLSLDSLPPPPP 
424. SLMCSSTLALDSLPPPPP 
425. ALMCAAALSLDALPPPPP 
426. CSSTLSLDSLPPPPPPPA 
427. CSSTLSLDALPPPPPPPA 
428. CAAALALDSLPPPPPPPA 
429. PPPPALDGSEDQDVYGSQ 
430. PPPPALDGAEDQDVYGSQ 
431. PPPPALDGSEDQDVFGAQ 
432. DGSEDQDVYGSQLSLASL 
433. DGSEDQDVFGSQLSLASL 
434. DGAEDQDVYGAQLALAAL 
435. SEDQDVYGSQLSLASLPP 
436. SEDQDVYGAQLSLASLPP 
437. AEDQDVFGSQLALAALPP 
438. QDVYGSQLSLASLPPPPP 
439. QDVYGSQLALASLPPPPP 
440. QDVFGAQLSLAALPPPPP 
441. YGSQLSLASLPPPPPPED 
442. YGSQLSLAALPPPPPPED 
443. FGAQLALASLPPPPPPED 
444. PEDVLAMNYAEPSSPSTP 
445. PEDVLAMNFAEPSSPSTP 
446. PEDVLAMNYAEPAAPAAP 
447. LAMNYAEPSSPSTPTPMS 
448. LAMNYAEPASPSTPTPMS 
449. LAMNFAEPSAPAAPAPMA 
450. LAMNYAEPSAPSTPTPMS 
451. LAMNFAEPASPAAPAPMA 
452. NYAEPSSPSTPTPMSTPM 
453. NYAEPSSPATPTPMSTPM 
454. NFAEPAAPSAPAPMAAPM 
455. NYAEPSSPSAPTPMSTPM 
456. NFAEPAAPATPAPMAAPM 
457. EPSSPSTPTPMSTPMIMP 
458. EPSSPSTPAPMSTPMIMP 
459. EPAAPAAPTPMAAPMIMP 
460. SPSTPTPMSTPMIMPNSN 
461. SPSTPTPMATPMIMPNSN 
462. APAAPAPMSAPMIMPNAN 
463. SPSTPTPMSAPMIMPNSN 
464. APAAPAPMATPMIMPNAN 
465. STPMIMPNSNGSLPPAVP 
466. STPMIMPNANGSLPPAVP 
467. AAPMIMPNSNGALPPAVP 
468. MIMPNSNGSLPPAVPAKP 
469. MIMPNSNGALPPAVPAKP 
470. MIMPNANGSLPPAVPAKP 
471. GGLKAAPPYKAPPDYVGP 
472. GGLKAAPPFKAPPDYVGP 
473. GGLKAAPPYKAPPDFVGP 
474. PPYKAPPDYVGPALLPGP 
475. PPYKAPPDFVGPALLPGP 
476. PPFKAPPDYVGPALLPGP 
477. PPPAQKKVSFADSPVLLR 
478. PPPAQKKVAFADSPVLLR 
479. PPPAQKKVSFADAPVLLR 
480. QKKVSFADSPVLLRRKMC 
481. QKKVSFADAPVLLRRKMC 
482. QKKVAFADSPVLLRRKMC 
483. VLLRRKMCSPEPVLPQRS 
484. VLLRRKMCAPEPVLPQRS 
485. VLLRRKMCSPEPVLPQRA 
486. PEPVLPQRSPSTTLSCHS 
487. PEPVLPQRAPSTTLSCHS 
488. PEPVLPQRSPAAALACHA 
489. VLPQRSPSTTLSCHSSSS 
490. VLPQRSPATTLSCHSSSS 
491. VLPQRAPSAALACHAAAA 
492. VLPQRSPSATLSCHSSSS 
493. VLPQRAPATALACHAAAA 
494. VLPQRSPSTALSCHSSSS 
495. VLPQRAPAATLACHAAAA 
496. QRSPSTTLSCHSSSSAGS 
497. QRSPSTTLACHSSSSAGS 
498. QRAPAAALSCHAAAAAGA 
499. STTLSCHSSSSAGSAYQT 
500. STTLSCHASSSAGSAYQT 
501. AAALACHSAAAAGAAFQA 
502. STTLSCHSASSAGSAYQT 
503. AAALACHASAAAGAAFQA 
504. STTLSCHSSASAGSAYQT 
505. AAALACHAASAAGAAFQA 
506. TLSCHSSSSAGSAYQTYA 
507. TLSCHSSSAAGSAYQTYA 
508. ALACHAAASAGAAFQAFA 
509. CHSSSSAGSAYQTYAPGP 
510. CHSSSSAGAAYQTYAPGP 
511. CHAAAAAGSAFQAFAPGP 
512. SSSSAGSAYQTYAPGPML 
513. SSSSAGSAFQTYAPGPML 
514. AAAAAGAAYQAFAPGPML 
515. SSAGSAYQTYAPGPMLPP 
516. SSAGSAYQAYAPGPMLPP 
517. AAAGAAFQTFAPGPMLPP 
518. SSAGSAYQTFAPGPMLPP 
519. AAAGAAFQAYAPGPMLPP 
520. PRADVARLSSLSNGSSSE 
521. PRADVARLASLSNGSSSE 
522. PRADVARLSALANGAAAE 
523. PRADVARLSALSNGSSSE 
524. PRADVARLASLANGAAAE 
525. DVARLSSLSNGSSSEVTS 
526. DVARLSSLANGSSSEVTS 
527. DVARLAALSNGAAAEVAA 
528. LSSLSNGSSSEVTSPKRL 
529. LSSLSNGASSEVTSPKRL 
530. LAALANGSAAEVAAPKRL 
531. LSSLSNGSASEVTSPKRL 
532. LAALANGASAEVAAPKRL 
533. LSSLSNGSSAEVTSPKRL 
534. LAALANGAASEVAAPKRL 
535. SNGSSSEVTSPKRLQESA 
536. SNGSSSEVASPKRLQESA 
537. ANGAAAEVTAPKRLQEAA 
538. SNGSSSEVTAPKRLQESA 
539. ANGAAAEVASPKRLQEAA 
540. TSPKRLQESASNPPRDFL 
541. TSPKRLQEAASNPPRDFL 
542. AAPKRLQESAANPPRDFL 
543. PKRLQESASNPPRDFLKD 
544. PKRLQESAANPPRDFLKD 
545. PKRLQEAASNPPRDFLKD 
546. QKCKAEPATTPHEVLGFR 
547. QKCKAEPAATPHEVLGFR 
548. QKCKAEPATAPHEVLGFR 
549. EVLGFRDFSNEDLLAAHN 
550. EVLGFRDFANEDLLAAHN 
551. LLAAHNLNSGANSSHYYR 
552. LLAAHNLNAGANSSHYYR 
553. LLAAHNLNSGANAAHFFR 
554. HNLNSGANSSHYYRETAN 
555. HNLNSGANASHYYRETAN 
556. HNLNAGANSAHFFREAAN 
557. HNLNSGANSAHYYRETAN 
558. HNLNAGANASHFFREAAN 
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559. NSGANSSHYYRETANVSH 
560. NSGANSSHFYRETANVSH 
561. NAGANAAHYFREAANVAH 
562. NSGANSSHYFRETANVSH 
563. NAGANAAHFYREAANVAH 
564. NSSHYYRETANVSHWVRK 
565. NSSHYYREAANVSHWVRK 
566. NAAHFFRETANVAHWVRK 
567. YYRETANVSHWVRKHYEY 
568. YYRETANVAHWVRKHYEY 
569. FFREAANVSHWVRKHFEF 
570. VSHWVRKHYEYAHNALYE 
571. VSHWVRKHFEYAHNALYE 
572. VAHWVRKHYEFAHNALFE 
573. HWVRKHYEYAHNALYENV 
574. HWVRKHYEFAHNALYENV 
575. HWVRKHFEYAHNALFENV 
576. YEYAHNALYENVHAQSAA 
577. YEYAHNALFENVHAQSAA 
578. FEFAHNALYENVHAQAAA 
579. LYENVHAQSAAAAGVPGS 
580. LYENVHAQAAAAAGVPGS 
581. LFENVHAQSAAAAGVPGA 
582. AAAAGVPGSGEATTPPLP 
583. AAAAGVPGAGEATTPPLP 
584. AAAAGVPGSGEAAAPPLP 
585. GVPGSGEATTPPLPPPPG 
586. GVPGSGEAATPPLPPPPG 
587. GVPGAGEATAPPLPPPPG 
588. GVPGSGEATAPPLPPPPG 
589. GVPGAGEAATPPLPPPPG 
590. PLPPPPGNSVAAKKRPPP 
591. PLPPPPGNAVAAKKRPPP 
592. PPPPPPKRSDKTHLTNRV 
593. PPPPPPKRADKTHLTNRV 
594. PPPPPPKRSDKAHLANRV 
595. PPPPPPKRSDKAHLTNRV 
596. PPPPPPKRADKTHLANRV 
597. PPPPPPKRSDKTHLANRV 
598. PPPPPPKRADKAHLTNRV 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Pico
WT
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>PicoWT (size=3108bp) 
 
ATGGCGAATCTCGAAGACAGCCAAGAGAGCGAACTCGATCAAATTTTGGGAGAACTGTCCCTCCTCGAAGCCCAGAT
CTCCTATACCGAAGCGAGCATGTTACCGGCGATGTGCGCCCCCAGTGCCGGAGCGCAGATCGCCCCACCCCCAGGCG
TCACCCAGCTCCCCGGATCGGCCCCCACCATGGTGAGCATGAGCGCGAGCAGCAGCCGCAGCCACAGCCGCACGAAC
TCGACGATAAGCGCCGATGTGTCCAGCTGTAGCTCCAGCGGCATCAGCGAAAACGGCCATGGCCTCGGCTTGGTGCT
GGGAGGACCGGGCTCCGCCGGCATGATGGTCCAACCGCCCCCACCAGGTGGAATGACGATGGGCATCACCCTCGGAG
TGGTGACCCCACGCGAGCCCCGGACGGAGAGCCCCGATAACGATAGCGCCTTCTCGGATACCGTGAGCCTGCTGAGC
TCCGAGAGCAGCGCCAGCTCCAACACCAGCCTGCAACAGCAACAACAGCAACAGCAGCAGCAACACCATCAGCATCA
GCAGCATCACCAGCACCAGCAACAGCAACAGAAGCCGCAGCTGGCCGGAGCCGAGAAGCTGCACCACCACGGCGTGC
ACGGACAGCACGGCGGCCAGCAGAGCGGCGCCAACTCGATCACCAAGGCCGATAAGATCCAGCTGGCCCTGCACAAG
CTGGAGAGCGCCCCCATCCGCCGCCTGTTTGTGAAGGCCTTTACCTCCGATGGTGCGAGCAAGTCCCTGCTGGTCGA
TGAGCGCATGGGCTGCGGACACGTGACCCGCCTGCTGGCCGACAAGAACCACGTGCAGATGCAGAGCAACTGGGCCC
TGGTGGAGCACCTGGGCGATCTGCAGATGGAGCGCCTGTTCGAGGATCACGAGCTGCTGGTCGACAACCTGATGACC
TGGCACTCCGATGCCGGCAACCGCGTGCTGTTCCAGCAGCGCCCCGATAAGGTGACCCTGTTCCTGCGCCCCGAGCT
GTACCTGCCAGGCCCACAGATGGCCCCAGGATGCCAGCACGATGAGCAGACCCGCCAGATGCTGCTGGATGAGTTCT
TCGATAGCCACAACCAGCTGCAGATGGATGGCCCCCTGTACATGAAGGCCGATCCCAAGAAGGGCTGGAAGCGCTAC
CACTTCGTGCTGCGCTCCTCCGGCCTGTACTACTTCCCCAAAGAAAAGACCAAGAACACCCGCGATCTGGCCTGCCT
GAACCTGTTCCACGGCCACAACGTGTACACCGGCCTGGGCTGGCGCAAGAAGTGGAAGAGCCCCACCGATTACACCT
TCGGCTTCAAGGCCGTCGGTGATAGCAGCCTGGGAAAGAGCTGCCGCAGCCTGAAGATGCTGTGCGCCGAGGATCTG
CCAACCCTGGATCGCTGGCTGACCGCCATCCGCGTGTGCAAGTACGGCAAGCAGCTGTGGGATTCCCACAAGTCGCT
GCTGGAGGATCTGTGCCTGAGCCGCGACGATGCCGTGAGCCAGAGCAGCTTCGCCGCCAGCATGCGCAGCGAGTCCA
TCAGCTCCATCTCCAGCGCCGTGCCAAGCCAGTGCGGCAGCGTGTCCAGCGCCATCTCCTCCATGAGCAACAGCACC
TCCGGCCGCACCAGCCGCGCCTCCAGCAGCTCCTCCAGCGGCTGCCTGAGCGACGATAACAACGCCTTCGATAGCGA
GTTCACCACCGGCACCATCAAGCGCAAGCCCAGCATGAAGCCCAACCTGCCCCTGACCACCATGACCCGCCAACTCA
AAGAAGTCGGAGAGATAACGATTTGCGAATCGGCCGGAGGTGACGCGAGCAGCCCCGAGAGAAGCGGCACCCTGACC
CGCCGGCACTCCCGCAGAAAGAGCCAAGAATCCAATGGATCCGGAACCCTGAAACGTCGTCCAATCGCGGTCCCCGT
CGCGACCGTGGTGAAACAAACCGAACCCATGGGATCCGCGTCCTCCACCTCCAGCTCCTCGAATTCCACCCCGACCC
CGACCCCATCCATCTGTGCCAAGCCCCCACCCGGCGATAGCGCCAGCCTGATGTGCAGCTCCACCCTGAGCCTGGAT
AGCCTGCCACCACCCCCCCCACCACCCGCCCTGGATGGCAGCGAGGATCAGGATGTGTACGGCAGCCAGCTGTCGCT
GGCCTCCCTGCCGCCACCGCCACCCCCCGAGGACGTGCTGGCCATGAACTACGCCGAGCCCAGCTCCCCCAGCACCC
CAACCCCCATGAGCACCCCCATGATCATGCCCAACAGCAACGGATCCCTGCCCCCAGCCGTGCCAGCCAAGCCCATG
AAGCCCGCCGTGAAGCAGGCCGCGGGCGGACTGAAGGCCGCCCCACCCTACAAGGCCCCACCCGACTACGTGGGCCC
AGCGCTGCTGCCCGGACCCCCCCTGCCGCCACCACCGCCAGCCCAGAAGAAGGTCTCCTTCGCCGATAGCCCCGTGC
TGCTGCGCCGCAAGATGTGCAGCCCAGAGCCAGTGCTGCCCCAGCGCTCCCCCAGCACCACCCTGTCCTGCCATAGC
AGCAGCTCCGCCGGAAGCGCCTATCAGACCTACGCCCCAGGCCCTATGTTGCCACCACGCGCCGACGTCGCCCGCCT
GAGCAGCCTGTCCAACGGCAGCTCCAGCGAGGTGACCAGCCCAAAGCGCCTGCAGGAAAGCGCCTCCAACCCCCCCC
GCGATTTCCTGAAGGATCTGCAGCGCGTGATGCGCAAGAAGTGGCAGGTCGCCCAGAAGTGCAAGGCCGAGCCAGCC
ACCACGCCGCATGAGGTGCTGGGCTTCCGCGATTTCAGCAACGAGGACCTGCTGGCCGCCCACAATCTGAACTCCGG
CGCCAACAGCTCCCACTACTACCGCGAGACCGCCAACGTGTCCCACTGGGTGCGCAAGCACTACGAGTACGCCCACA
ACGCCCTGTACGAGAACGTGCATGCCCAGTCGGCCGCCGCTGCCGGAGTGCCCGGCTCCGGCGAGGCTACGACGCCA
CCGCTGCCGCCACCGCCAGGCAACAGCGTGGCCGCCAAGAAGCGCCCACCGCCCCCACCCCCCAAGCGCAGCGATAA
GACCCACCTGACCAACCGCGTGTAATAG 
Pico mutated sites 
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MANLEDSQESELDQILGELSLLEAQISYTEASMLPAMCAPSAGAQIAPPPG
VTQLPGSAPTMVSMSASSSRSHSRTNSTISADVSSCSSSGISENGHGLGLVL
GGPGSAGMMVQPPPPGGMTMGITLGVVTPREPRTESPDNDSAFSDTVSLLS
SESSASSNTSLQQQQQQQQQQHHQHQQHHQHQQQQQKPQLAGAEKLHH
HGVHGQHGGQQSGANSITKADKIQLALHKLESAPIRRLFVKAFTSDGASKS
LLVDERMGCGHVTRLLADKNHVQMQSNWALVEHLGDLQMERLFEDHEL
LVDNLMTWHSDAGNRVLFQQRPDKVTLFLRPELYLPGPQMAPGCQHDEQ
TRQMLLDEFFDSHNQLQMDGPLYMKADPKKGWKRYHFVLRSSGLYYFPK
EKTKNTRDLACLNLFHGHNVYTGLGWRKKWKSPTDYTFGFKAVGDSSLG
KSCRSLKMLCAEDLPTLDRWLTAIRVCKYGKQLWDSHKSLLEDLCLSRDD
AVSQSSFAASMRSESISSISSAVPSQCGSVSSAISSMSNSTSGRTSRASSSSSS
GCLSDDNNAFDSEFTTGTIKRKPSMKPNLPLTTMTRQLKEVGEITICESAGG
DASSPERSGTLTRRHSRRKSQESNGSGTLKRRPIAVPVATVVKQTEPMGSA
SSTSSSSNSTPTPTPSICAKPPPGDSASLMCSSTLSLDSLPPPPPPPALDGSED
QDVYGSQLSLASLPPPPPPEDVLAMNYAEPSSPSTPTPMSTPMIMPNSNGSL
PPAVPAKPMKPAVKQAAGGLKAAPPYKAPPDYVGPALLPGPPLPPPPPAQ
KKVSFADSPVLLRRKMCSPEPVLPQRSPSTTLSCHSSSSAGSAYQTYAPGP
MLPPRADVARLSSLSNGSSSEVTSPKRLQESASNPPRDFLKDLQRVMRKK
WQVAQKCKAEPATTPHEVLGFRDFSNEDLLAAHNLNSGANSSHYYRETA
NVSHWVRKHYEYAHNALYENVHAQSAAAAGVPGSGEATTPPLPPPPGNS
VAAKKRPPPPPPKRSDKTHLTNRV 
 
Unique peptides - Pico
WT
 mass spectrometry 
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Accessory gland-specific peptide 26Aa OS=Drosophila melanogaster GN=Acp26Aa PE=1 SV=2 
- [MS2A_DROME] 
Accessory gland-specific peptide 70A OS=Drosophila sechellia GN=Acp70A PE=2 SV=1 - 
[A70A_DROSE] 
Ataxin-2 homolog OS=Drosophila melanogaster GN=Atx2 PE=1 SV=1 - [ATX2_DROME] 
Box A-binding factor OS=Drosophila melanogaster GN=srp PE=1 SV=2 - [SRP_DROME] 
Calmodulin OS=Drosophila melanogaster GN=Cam PE=1 SV=2 - [CALM_DROME] 
Cdc42 homolog OS=Drosophila melanogaster GN=Cdc42 PE=1 SV=1 - [CDC42_DROME] 
Centaurin-gamma-1A OS=Drosophila melanogaster GN=cenG1A PE=1 SV=2 - 
[CEG1A_DROME] 
Centrosome-associated zinc finger protein CP190 OS=Drosophila melanogaster GN=Cp190 
PE=1 SV=2 - [CP190_DROME] 
Chromatin-remodeling complex ATPase chain Iswi OS=Drosophila melanogaster GN=Iswi 
PE=1 SV=1 - [ISWI_DROME] 
Copia protein OS=Drosophila melanogaster GN=GIP PE=1 SV=3 - [COPIA_DROME] 
Defective chorion-1 protein (Fragments) OS=Drosophila erecta GN=dec-1 PE=3 SV=2 - 
[DEC1_DROER] 
Ejaculatory bulb-specific protein 1 OS=Drosophila melanogaster GN=Peb PE=1 SV=1 - 
[PEB1_DROME] 
Enhancer of mRNA-decapping protein 3 OS=Drosophila melanogaster GN=Edc3 PE=1 SV=1 - 
[EDC3_DROME] 
Heat shock protein 22 OS=Drosophila melanogaster GN=Hsp22 PE=1 SV=4 - 
[HSP22_DROME] 
Heat shock protein 68 OS=Drosophila melanogaster GN=Hsp68 PE=1 SV=1 - 
[HSP68_DROME] 
Kinesin-like protein Klp59C OS=Drosophila melanogaster GN=Klp59C PE=1 SV=1 - 
[KI59C_DROME] 
Major heat shock 70 kDa protein Ba OS=Drosophila melanogaster GN=Hsp70Ba PE=2 SV=2 - 
[HSP72_DROME] 
Maternal protein exuperantia OS=Drosophila melanogaster GN=exu PE=1 SV=2 - 
[EXU_DROME] 
Muscle segmentation homeobox OS=Drosophila melanogaster GN=Dr PE=2 SV=2 - 
[HMSH_DROME] 
PERQ amino acid-rich with GYF domain-containing protein CG11148 OS=Drosophila 
melanogaster GN=CG11148 PE=1 SV=1 - [PERQ1_DROME] 
Phosrestin-1 OS=Drosophila melanogaster GN=Arr2 PE=1 SV=2 - [ARRB_DROME] 
Phosrestin-2 OS=Drosophila melanogaster GN=Arr1 PE=1 SV=1 - [ARRA_DROME] 
Probable RNA-binding protein orb2 OS=Drosophila melanogaster GN=orb2 PE=1 SV=1 - 
[ORB2_DROME] 
Profilin OS=Drosophila melanogaster GN=chic PE=1 SV=1 - [PROF_DROME] 
Unique peptides - Pico
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Protein encore OS=Drosophila melanogaster GN=enc PE=1 SV=2 - [ENC_DROME] 
Putative mitochondrial inner membrane protein OS=Drosophila melanogaster GN=CG6455 
PE=2 SV=4 - [IMMT_DROME] 
Ras-like protein 1 OS=Drosophila mojavensis GN=Ras85D PE=3 SV=1 - [RAS1_DROMO] 
Ras-related protein Rab-3 OS=Drosophila melanogaster GN=Rab3 PE=1 SV=1 - 
[RAB3_DROME] 
Serine/threonine-protein phosphatase alpha-1 isoform OS=Drosophila melanogaster 
GN=Pp1alpha-96A PE=1 SV=1 - [PP11_DROME] 
Serine/threonine-protein phosphatase beta isoform OS=Drosophila melanogaster GN=flw PE=1 
SV=1 - [PP1B_DROME] 
Transient-receptor-potential-like protein OS=Drosophila melanogaster GN=trpl PE=1 SV=2 - 
[TRPL_DROME] 
Transport and Golgi organization protein 1 OS=Drosophila melanogaster GN=Tango1 PE=1 
SV=2 - [TGO1_DROME] 
UPF0363 protein CG9853 OS=Drosophila melanogaster GN=CG9853 PE=1 SV=1 - 
[U363_DROME] 
UPF0505 protein CG8202 OS=Drosophila melanogaster GN=CG8202 PE=2 SV=3 - 
[U505_DROME] 
 
 
Unique peptides - W
1118
 mass spectrometry 
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Acetylcholinesterase OS=Drosophila melanogaster GN=Ace PE=1 SV=1 - [ACES_DROME] 
Atlastin OS=Drosophila melanogaster GN=atl PE=1 SV=1 - [ATLAS_DROME] 
Cathepsin L OS=Drosophila melanogaster GN=Cp1 PE=1 SV=2 - [CATL_DROME] 
Interference hedgehog OS=Drosophila willistoni GN=iHog PE=3 SV=1 - [IHOG_DROWI] 
Longitudinals lacking protein, isoforms J/P/Q/S/Z OS=Drosophila melanogaster GN=lola PE=1 
SV=4 - [LOLA5_DROME] 
Polycomb group protein Pc OS=Drosophila melanogaster GN=Pc PE=1 SV=1 - [PC_DROME] 
Protein lap4 OS=Drosophila melanogaster GN=scrib PE=1 SV=1 - [LAP4_DROME] 
Salivary glue protein Sgs-8 OS=Drosophila melanogaster GN=Sgs8 PE=2 SV=1 - 
[SGS8_DROME] 
WD repeat-containing protein on Y chromosome OS=Drosophila grimshawi GN=WDY PE=4 
SV=1 - [WDY_DROGR] 
Venus-Pico mutant co-localisation 
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(Bennett et al., 2006) 
